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SUMMARY
Growth restriction in tissue culture is a distinct 
feature of the enteric adenoviruses and they differ in this 
respect from all other subgroups of human adenoviruses. 
Ad40 cannot be passaged on Hela cells or primary HEK cells, 
but will grow in cells expressing the El region or only the 
E1B region of Ad2 or Ad5. The work described here was aimed 
at understanding the basis for this growth restriction.
In coinfection experiments Ad40 complements an Ad5 E1A 
mutant and is itself complemented by that mutant as well as 
Ad5 and Adl2 wild type and E1B 19K mutant viruses. Ad5 and 
Adl2 E1B 55K mutant viruses are complemented to some extent 
by Ad40, these mutants however do not complement Ad40 growth 
on Hela cells.
In order to study the E1B region of Ad40 a transcription 
map was determined from RNA produced at late times in 
infected KBa+b cells, using SI nuclease, primer extension 
and PCR-cDNA analysis as well as Northern blotting. E1B 
transcripts corresponding to Ad2 14S, 22S and 9S mRNAs were
identified but no 13S mRNA equivalent was detected, a 
pattern similar to that seen in the Adl2 transcription map. 
The coding potential for E1B 19K, 55K, and 15K proteins and
for ppIX is retained in the Ad40 transcripts. In addition 
novel E1A-E1B cotranscript counterparts of the 14S and 22S 
mRNAs were identified. These contain the first 40 codons of 
the E1A first exon linked to a site 4-5nt downstream of the 
ElB cap site, retaining all the coding potential of the E1B 
mRNAs. No new open reading frames are created by the 
junction, and the E1A ORF terminates with one codon added 
after the junction. The E1A-E1B junction is unusual in that 
it does not conform to splice consensus sequences and thus 
may not be generated by a conventional splicing mechanism. 
Sequences around the 5' site of the junction bear a certain 
resemblance to spliced leader sequences utilized in t r a 725-  
splicing in trypanosomes and nematodes.
A timecourse of El transcription and DNA replication 
confirmed that. ElB transcripts are not detectable at early 
times in infection, but appear around the onset of DNA
replication. The E1A-E1B cotranscripts are first seen at 
the same time as transcripts from the E1B promoter.
Transcription from the Ad40 E1B promoter was analysed in 
transient transfection assays. Chloramphenicol acetyl 
transferase (CAT) activity was measured in cell extracts 
where the CAT gene was expressed under the control of the 
E1B promoter in the presence or absence of E1A products of 
Ad5 or Ad40. Expression from the Ad40 E1B promoter was not 
detectable even in the presence of Ad5 E1A, suggesting that 
unlike its Ad5 counterpart the Ad40 E1B promoter does not 
respond to E1A transactivation. This would account for the 
lack of early E1B gene expression in tissue culture. More­
over, this suggests that in the natural host cells of the 
virus E1B early gene products may not be needed, or 
alternatively, that early expression from the Ad40 E1B 
promoter is dependent on cellular factors present in the 
natural host cell, but absent in most common tissue culture 
cell lines.
In this study Ad40 was shown to grow in an intestinal 
cell line, Int407, almost as well as in KB cells expressing 
the Ad2 El region. This provides a system in which to study 
Ad40 growth in tissue culture in the absence of complement­
ing viral gene products.
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11* INTRODUCTION
The work presented in this thesis concerns the host range 
properties of enteric adenovirus 40 in tissue culture. The 
growth restriction in cultivated cells is a distinct feature 
of the enteric adenoviruses (de Jong e t  a l ., 1983) and they 
differ in this respect from all other subgroups of human 
adenoviruses. Early region 1 of the enteric adenoviruses 
has been implicated in this host range phenotype since the 
enteric adenoviruses grow in 293 cells, a cell line trans­
formed with the El region of Ad5 (Takiff e t  a l . f 1981). The 
aim of this introduction is to give a brief overview of the 
Adenoviridae in terms of morphology and the lytic cycle, 
describe the structure and functions of early regions 1A and 
IB in some detail and finally to review current knowledge of 
the enteric adenoviruses. For general reviews of the adeno­
viruses see Ginsberg, (1984); Doerfler, (1986).
1.1. The Adenoviridae
The Adenoviridae family has two genera, Mastadenovirus 
and Aviadenovirus, encompassing adenoviruses occurring in 
mammals and birds respectively. Over 90 serotypes of Mast- 
adenoviruses have been identified, of which 42 are human 
serotypes. The first human adenoviruses were discovered by 
Rowe e t  a l .  (1953) and Hilleman and Werner (1954) and are 
now classified into six subgroups, A-F (see table 1), based 
on immunological, biological, morphological and biochemical 
criteria. They cause a number of diseases in humans, 
including respiratory, ocular, urinary and gastrointestinal 
diseases, and are important human pathogens, although they 
are not often associated with fatal diseases (White and 
Fenner, 1986; Horwitz, 1990). As well as being studied as 
pathogenic agents, much of adenovirus research has focussed 
on their use as a tool to study eucaryotic molecular 
biology. A great deal of information has been collected by 
the use of adenovirus mutants; for an extensive review of 
adenovirus genetics see Williams, (1986). The complete DNA
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2sequence of Ad2 has been determined (Roberts, R.J. e t  a l . ,
1986) and this serotype and the 
been most extensively studied, 
understanding of adenoviruses is 
involving those two serotypes and 
following sections.
closely related Ad5 have 
Much of our current 
therefore based on work 
this is reflected in the
1.1.1. Morphology
Adenoviruses are non-enveloped icosAhedral particles 
containing linear double stranded DNA of 20-30xl06 dalton, 
and several virus encoded polypeptides. The capsid consists 
of 252 capsomers (Horne e t  a l . ,  1959). Pentons lie at the 
12 vertices and 240 hexons form the facets (Ginsberg e t  a l . ,  
1966) .
Hexons contain 3 identical polypeptide chains (protein 
II) (Griitter and Franklin, 1974; Akusjarvi e t  a l .  , 1984). 
The three-dimensional structure of the Ad2 hexon has been 
determined by X-ray crystallography (Roberts, M.M. e t  a l . ,  
1986); the hexon trimer has a triangular top superimposed on 
a pseudohexagonal base. Hexons carry type, group, intrasub­
group and intersubgroup antigenic determinants (Norrby, 
1969; Norrby and Wadell, 1969). Type-specific antigen 
determinants have been demonstrated on the virion surface 
(Norrby, 1969; Willcox and Mautner, 1976) while most group- 
specific determinants appear to be internal.
Pentons consist of penton base and filamentous projec­
tions, the fibres; the penton base is probably a pentamer of 
protein III and the fibre a trimer of protein IV (van 
Oostrum and Burnett, 1985), although alternative structures 
have been suggested (Devaux e t  a l ., 1982, 1984; Green e t
a l . ,  1983). Recent crystallography studies have confirmed 
the trimeric structure of the fibre and provided further 
details of the structure (Devaux e t  a l . ,  1990; Ruigrok e t  
a l . ,  1990). Most Aviadenoviruses have two fibres per penton 
base while Mastadenoviruses have one; a possible exception 
is human Ad41 which contains two fibre genes (Pieniazek, 
N.J. e t  a l ., 1990), although it is not yet known if both are
3expressed. The fibre contains the sites responsible for 
interaction of the virus with cellular receptors (Levine and 
Ginsberg, 1967; Philipson, 1967). It carries type specific 
antigenic determinants and depending on fibre length can 
also carry subgroup- and intersubgroup-specific determinants 
(Pettersson e t  a l . ,  1968; Pettersson and Hoglund, 1969; 
Norrby, 1968, 1969; Wadell and Norrby, 1969).
In addition to the hexons and pentons, protein Ilia and 
ppIX also form a part of the outer capsid; protein Ilia has 
been assigned to the vertex region (Everitt e t  a l . , 1973) 
whereas ppIX is associated with hexons and has a stabilizing 
effect on the capsid (Colby and Shenk, 1981; Furcinitti e t
a l .  , 1989). ppIX is essential for the packaging of full 
length genomes since it is dispensable only for virions con­
taining DNA of less than genomic size (Ghosh-Choudhury e t
a l . ,  1987).
The core consists of viral DNA tightly bound to protein 
VII, in association with proteins V, VI and p (Russell and 
Precious, 1982). Protein V is also associated with hexon, 
penton and protein Ilia (Everitt e t  a l . ,  1975), and Nermut 
(1979), has suggested that the capsid is lined by a shell of
protein V. In addition proteins VI and VIII are associated
with hexons (Everitt e t  a l . ,  1975). Details of the arrange­
ment of DNA and the core proteins within th_ native nucleo- 
protein core are not well understood although several models 
have been discussed. Brown e t  a l . ,  (1975) proposed a 
structure of 12 large beads associated with the vertices of 
the icosahedral capsid; this model is supported by ion 
etching studies (Newcombe e t  a l . ,  1984). A second model 
predicts nucleosome-like winding of DNA around protein VII 
(Corden e t  a l . ,  1976; Nermut, 1980; Vayda e t  a l . ,  1983; 
Chatterjee e t  a l . ,  1986). Recently Wong and Hsu (1989) have 
put forward a loop-domain model where the viral DNA is 
assumed to be organized into eight supercoiled loops and 
these loops are anchored to the centre of the virus core. 
This model is consistent with the results of Brown e t  a l . ,  
(1975) and Newcombe et  a l . ,  (1984).
41.1.2. Genome structure
The adenovirus genome is a double stranded linear DNA 
molecule. A protein of 55Kd molecular weight, terminal 
protein, is covalently linked to the 5' end of each strand 
via a serine residue (Robinson et al., 1973; Rekosh e t  a l .  , 
1977; Desideiro and Kelly, 1981). The ends of the genome 
contain an inverted terminal repetition (ITR) (Garon e t  a l . , 
1972; Wolfson and Dressier, 1972). The length of the ITR is 
characteristic of each serotype but several regions within 
it have been shown to be well conserved. A 10 bp sequence 
(nt 9-18) is conserved in all serotypes and is essential for 
initiation of DNA replication (Tamanoi and Stillman, 1983; 
van Bergen e t  a l . ,  1983; Challberg and Rawlins 1984; bally 
e t  a l ., 1984; Harris and Hay, 1988). It has been suggested 
that this motif is important for the binding of the virus 
encoded replication proteins to the origin of replication 
(Rijnders e t  a l ., 1983; Kenny and Hurwitz, 1988). Other
domains within the ITRs are also required for DNA replica­
tion in Ad2 (Guggenheimer e t  a l . ,  1984; Rawlins e t  a l . , 
1984; de Vries e t  a l . ,  1985).
The Ad2 genome is 35,937 nucleotides long. The organiza­
tion of the Ad2 genome is shown in figure 1. Genes are 
expressed from both the r-strand (transcribed left to right) 
and the 1-strand (transcribed right to left). Gene 
expression can be divided into early and late phase, 
separated by the onset of DNA replication. A subset of 
genes are expressed at intermediate times. Transcription is 
initiated from a number of promoters at early and 
intermediate times. All the late genes are transcribed from 
the same promoter, the* major late promoter (MLP) (Gelinas 
and Roberts, 1977; Zain and Roberts, 1978). The 5' end of 
all the late mRNAs consists of a 201 bp tripartite leader 
sequence derived from 16.8, 19.8 and 26.9 m.u. (Berget e t
a l . ,  1977; Akusjarvi and Pettersson, 1979).
Figure 1: Organization of the Ad2 genome.
Early (E) and late (L) transcription units are indicated. 
Arrows show the location of the major RNA species, the 
arrowhead denotes the direction of transcription. Thick 
lines illustrate mRNAs expressed early after infection and 
thin lines mRNAs expressed at intermediate times after 
infection. Open arrows show sequences present in late mRNA. 
Polypeptides that have been assigned to the different 
regions are indicated; see text for further details. 
(Reproduced from Akusjarvi and Wadell, 1990).
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51.1.3. The lvtic cycle
1.1.3.1.Virus entry into cells
Adenoviruses enter cells by receptor-mediated endocytosis 
(Svensson and Persson, 1984; Svensson, 1985; Pastan e t  a l . ,
1986). The virus attachment protein is the fibre (Philipson 
e t  a l . ,  1968) but the cellular receptor has not yet been 
identified, although several cellular membrane proteins have 
been shown to bind fibre (Svensson e t  a l ., 1981; Defer e t  
a l . ,  1990). Recent experiments have indicated that differ­
ent serotypes may use different receptors, since Ad2 and Ad3 
do not compete for binding sites (Defer e t  a l ., 1990).
Morphological studies have shown that virions are 
internalized in coated vesicles and delivered to endosomes 
(Dales, 1978; Pastan e t  a l . , 1986). Further studies at the
morphological and biochemical level suggest that the viruses 
are released into the cytosol by lysis of endosomes (Dales, 
1978; Pastan e t  a l . ,  1986). Moreover, it has been suggested 
that the lytic reaction is catalysed by a viral factor which 
is activated by low pH (Pastan e t  a l . ,  1986; Wohlfart, 1988; 
Varga e t  a l . ,  1990). Morphological evidence indicates that 
following exit from endosomes, the virion releases its 
genome into the nucleus through nuclear pores (Dales, 1978).
1.1.3.2. Transcription
Adenovirus genes are transcribed by the host RNA polymer­
ase II with the exception of two genes, VA1 and VA2 which 
are transcribed by RNA Pol III (Weinmann e t  a l . ,  1976). 
Early genes are transcribed from six regions (E1A, E1B, E2, 
E3, E4 and LI) of the viral genome, prior to DNA replication 
(see figure 1). Each of these early regions contains its 
own promoter (Berk and Sharp, 1977a; Evans e t  a l . ,  1977) and 
a number of overlapping mRNAs are processed by differential 
splicing of the primary transcript from each promoter. 
Close to the onset of DNA replication, a set of intermediate 
RNAs (ppIX, IVa2, VA1 and VA2) are transcribed. Finally 
after the onset of DMA replication the late genes (L1-L5)
6are transcribed; however, the LI region is expressed at both 
early and late times (Lewis and Mathews, 1980; Miller e t  
a l .  , 1980). Unlike early RNAs, the late transcripts are 
processed from a common nuclear precursor RNA which is 
initiated from the major late promoter (MLP) (Ziff and 
Evans, 197 8).
A number of studies of adenovirus gene expression have 
demonstrated that early transcripts are temporally regu­
lated. The first region to be transcribed is the E1A region 
(Berk and Sharp 1977a; Jones and Shenk 1979b). The 
structure and function of this region will be discussed in 
detail in section 1.2. The E1A region lies near the left 
end of the genome at 1.5-4.5 m.u. in Ad2. At least five 
mRNA species are transcribed from the E1A region; they are 
all generated by differential splicing of a common nuclear 
precursor RNA (see 1.2.1. figure 2). The 13S and 12S mRNAs 
are the most abundant species early after infection while at 
late times, a shift in steady-state levels of the E1A mRNAs 
occurs, and the 9S mRNA becomes the most abundant species 
(Spector e t  a l . ,  1978; Chow e t  a l . ,  1979). The 13S and 12S 
mRNAs encode related polypeptides of 289 and 243 amino acids 
respectively; 46 internal residues are unique to the larger 
protein (Perricaudet e t  a l . ,  1979). The 289R polypeptide 
activates transcription from other early viral promoters 
(Jones and Shenk, 1979b; Ricciardi e t  a l . ,  1981; Montell e t  
a l ., 1982) .
Downstream of E1A lies the ElB region (4.6-11 m.u. in 
Ad2). The structure and function of this region will be 
described in detail in section 1.3. The E1B region of Ad2 
encodes two major overlapping mRNAs, 22S and 13S, which 
share common 5' and 3 ’ termini but differ in the extent of 
internal sequences removed by splicing (Berk and Sharp, 
1978; see 1.3.1. figure 4). The 13S mRNA encodes a 19-21
kilodalton protein (E1B 19K) and the 22S mRNA encodes the
19K protein using the first AUG and a 55K protein in a 
different reading frame, starting from the second AUG 
(Halbert e t  a l . ,  1979; Bos e t  a l . ,  1981). Two minor
species, 14S and 14. 5S, have also been identified, encoding
7the 19K protein and polypeptides related to the 55K protein 
(Virtanen and Pettersson, 1985; Anderson e t  a l . ,  1984). A 
9S mRNA encoding structural polypeptide IX is transcribed 
from a separate promoter within the E1B region at 
intermediate times. In Ad5 infected Hela cells the 22S mRNA 
is detectable at 3.5 hr p.i. and increases in abundance 
throughout early infection while the 13S mRNA remains at low 
levels during early infection with an increase at 
intermediate times (Glenn and Ricciardi, 1988).
The E2 region of Ad2 maps between 75.4 and 11.3 m.u. and 
is transcribed from the 1-strand (see figure 1). It differs 
from other adenovirus transcription units in using two 
alternative promoter sites for the initiation of transcrip­
tion (Chow e t  a l . , 1979). The promoter usage is regulated 
in a temporal manner; transcripts from the E2-early promoter 
(75.4 m.u.) appear between 2-3 hr p.i. (Nevins e t  a l . ,  1979; 
Glenn and Ricciardi, 1988) whereas following the switch from 
early to late phase the E2-late promoter (72.2 m.u.) is 
preferentially used. Like other adenovirus early promoters 
the E2-early promoter is activated by E1A gene products 
whereas an inhibitory effect on the E2-late promoter is seen 
in the presence of E1A (Rossini, 1983). In addition to 
transcriptional regulation by E1A, the E2-early promoter is 
also activated by an E4 gene product, independently or in 
synergy with E1A; the E4 ORF 6/7 protein stimulates E2 early 
gene expression by increasing the DNA binding activity of 
the cellular transcription factor E2F (Babiss, 1989; Hardy 
e t  a l . ,  1989; Reichel e t  a l . ,  1989; Huang and Hearing, 1989; 
Neill et a l . , 1990) .
Two major classes of E2 transcripts are generated by the 
usage of two different polyadenylation sites. The E2A 
transcripts use a poly A site at 62.4 m.u. while a second 
set of transcripts, E2B, bypass that signal and extend to a 
poly A site at 11.3 m.u. (Stillman e t  a l . ,  1981). Differen­
tia] splicing within E2A transcripts generates two types of 
mRNAs varying in length by about lOOnt (Berk and Sharp 
1978). Both these mRNA species encode the 72K single 
stranded DNA binding protein (DBP). This multifunctional
8polypeptide is located predominantly in the nucleus of 
infected cells and plays a variety of roles during the 
infectious cycle. It is essential for viral DNA replication 
(van der Vliet and Sussenbach, 1975), and has been
implicated in the assembly of virus particles (Nicolas e t  
a l . , 1983). DBP also affects the host range of the virus;
DBP mutants have been isolated which multiply efficiently on
monkey cells (Klessig, 1977). Monkey cells are non- 
permissive for wild type adenovirus. This involves aberrant 
splicing of fibre mRNA; in an abortive infection of monkey 
cells the fibre mRNA lacks the x and v ancillary leader 
sequences (Anderson and Klessig, 1984). This block is
overcome in these DBP mutants (Klessig and Chow, 1980). The 
DBP influences the levels to which early viral mRNAs 
accumulate (Carter and Blanton, 1978a, 1978b). Babich and
Nevins (1981) reported a reduction in half life of at least 
some early mRNAs caused by the DBP, and an inhibitory effect
on transcription from the E4 promoter has also been demon­
strated (Nevins and Winkler, 1980; Handa e t  a l . ,  1983). 
Furthermore, the DBP may autoregulate its own synthesis 
(Morin e t  a l ., 1989) and it has been shown to enhance tran­
scription from the E1A, E2-early and the major late pro­
moters (Chang and Shenk, 1990). The stimulatory effect seen 
on the MLP led to the suggestion that the DBP may play a 
role in the activation of this promoter.
The E2B region gives rise to three differentially spliced 
mRNAs (Stillman e t  a l . ,  1981; Shu e t  a l . ,  1988). Protein 
products have been assigned to two of these mRNAs; they both 
encode proteins involved in DNA replication. The longest 
E2B mRNA encompasses the ORF for the 87Kd terminal protein 
precursor (pTP) (Smart and Stillman, 1982) which serves as a
primer for DNA replication and is later cleaved, producing
the 55Kd terminal protein. The ORF found in the shortest 
E2B mRNA encodes a 140Kd DNA polymerase which is essential 
for adenovirus DNA replication (Stillman e t  a l . ,  1982).
The E3 region of Ad2 is located between 76.8 and 85.9 
m.u. and is transcribed from the r-strand (see figure 1). 
This region has been shown to be dispensable for viral
9growth in tissue culture (Jones and Shenk, 1979a). At least 
10 mRNA species are transcribed from the E3 promoter and 
these fall into two families, differing in the poly A site 
used (Berk and Sharp, 1977b, 1978; Chow e t  a l . , 1979;
Cladaras and Wold, 1985; Clad, ras e t  a l ., 1985). Region E3 
is predicted to encode at least nine proteins (Herisse e t  
a l . ,  1980; Herisse and Galibert, 1981; Cladras and Wold, 
1985). Six of these proteins have been identified in 
infected cells (see Wilson-Rawls e t  a l ., 1990) and functions 
are known for three of them. These proteins all interfere 
with host cell functions or immune response during adeno­
virus infection.
A glycoprotein, gpl9K, encoded by the E3 region, is 
localized in the membrane of the endoplasmic reticulum where 
it forms a complex with class I antigens of the major histo­
compatibility complex and retards their transport to the 
cell surface (Wold and Gooding, 1989; Gooding and Wold, 
1990) . This has been shown to prevent cell lysis by adeno- 
specific cytotoxic T-lymphocytes (Rawle e t  a l . ,  1989).
A 14.7Kd E3 protein has also been identified in infected 
cells (Persson et al., 1978; Tollefson and Wold, 1988; Wang 
e t  a l . ,  1988). This protein has been shown to prevent lysis 
of adeno-infected cells by tumor necrosis factor (TNF) and 
may mitigate the anti-viral effects of TNF i n  v i v o  (Gooding 
e t  a l . ,  1988). TNF is an immunoregulatory protein which is 
secreted by activated monocytes and macrophages and which 
has antiviral properties (Beutler and Cerami, 1989);
expression of adenovirus E1A renders cells sensitive to 
cytolysis by TNF (Duerksen-Hughes e t  a l . ,  1989); this effect 
is cell type dependent (Vanhaesebroeck e t  a l . ,  1990).
The E3-14.4Kd protein, identified by Tollefson e t  a l . ,  
(1990a) is a membrane protein which stimulates endosome- 
mediated internalization and degradation of the receptor for 
epidermal growth factor (Carlin e t  a l . ,  1989). Three
additional E3 proteins, 11.6Kd, 14.5Kd and 6.7Kd, have been 
identified in infected cells but not as yet assigned func­
tions (Wold e t  a l . ,  1984; Tollefson e t  a l . ,  1990b; Wilson-
Rawls e t al. , 1990).
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The right end of the genome contains the E4 region (91.3— 
99.1 m.u. in Ad2) which is transcribed from the 1-strand 
(see figure 1). In addition to transcriptional control by 
E1A gene products, the E4 promoter is down-regulated by the 
72K DBP (Nevins and Winkler, 1980; Handa e t  a l . ,  1983}, 
resulting in a dramatic decrease in transcription at 
intermediate times after infection following an initial 
early peak (Glenn and Ricciardi, 1988). A complex family of 
overlapping E4 mRNAs is generated during viral infection by 
alternative splicing of a primary transcript (Freyer e t  a l . , 
1984; Tigges and Raskas, 1984; Virtanen e t  a l . ,  1984), 
twelve of which have been analysed by cDNA cloning and 
sequencing. Analysis of the E4 DNA and cDNA sequences 
suggests that at least seven different polypeptides can be 
produced from this region; three E4 products have been 
immunologically identified.
The product of ORF 3 is an 11.5Kd protein (Sarnow e t  a l . , 
1982; Downey e t  a l . ,  1983). This polypeptide affects viral 
DNA replication, late protein synthesis, the shut-off of 
host cell protein synthesis and the production of infectious 
virus, but is non-essential in the presence of a functional 
E4 ORF 6 gene product (Halbert e t  a l . ,  1985; Hemstrom e t  
a l . ,  1988; Bridge and Ketner, 1989; Huang and Hearing, 
1989b) .
The gene product of ORF 6 is a 34Kd protein (Challberg 
and Ketner, 1981) which in infected cells is found physi­
cally associated with the E1B 55K protein (Sarnow e t  a l . ,
1984) as well as in a free form (Cutt e t  a l . ,  1987). Muta­
genesis studies of individual E4 ORFs have identified the 
34K protein as the only essential E4 gene product within 
infected cells (Halbert e t  a l . , 1985; Hemstrom e t  a l . ,
1988). However, a mutant virus lacking all E4 coding 
sequences is much more defective for viral growth than an 
0RF6 mutant virus, suggesting that other E4 products may 
compensate for the lack of the 34Kd protein (Halbert e t  a l . ,
1985). Studies using double mutants have demonstrated that 
El 0RF6 and 0RF3 are individually sufficient for normal 
late protein synthesis although the 0RF3 product appears to
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be slightly less effective then the 0RF6 product (Bridge and 
Ketner, 1989; Huang and Hearing, 1989b). This has led to
the conclusion that the 11.5Kd and 34Kd proteins act in
parallel in late protein synthesis. One of the roles of the
E4 gene products is to stabilize late viral mRNAs in the
nucleus (Sandler and Ketner, 1989). The 34K/55K complex acts 
either in the transport of late mRNAs or stabilization of 
late mRNAs in the cytoplasm and may act in parallel with the
11.5Kd protein in the accumulation of late viral mRNA in the 
cytoplasm (see Bridge and Ketner, 1990).
E4 ORF 6/7 is created by mRNA splicing. A 19.5Kd 
polypeptide has been identified as the product of this gene 
(Cutt e t  a l . ,  1987). This protein stimulates the DNA 
binding activity of the cellular transcription factor E2F by 
a direct complex formation between the 19.5K protein and E2F 
(Huang and Hearing, 1989a; Neill e t  a l ., 1990); E2F exerts 
positive control on transcription from the E1A (Hearing and 
Shenk, 1983, 1986) and the E2-earlv promoters (Babiss, 1989; 
Reichel e t  a l ., 1989).
The gene for structural polypeptide IX is contained 
within the E1B region. The promoter lies in E1B intron 
sequences and ppIX coding sequences are in the E1B non­
translated region; the mRNA is 3 ’ coterminal with E1B mRNAs 
(Alestrom e t  a l . ,  1980). This is the only adenovirus mRNA 
that is not spliced. Transcription is initiated from the
ppIX gene promoter at intermediate times after infection; 
there is controversy in the literature as to whether DNA 
replication is necessary and sufficient to activate this 
promoter (Matsui e t  a l ., 1986; Venkatesh and Chinnadurai,
1987) or if the promoter is inactive at early times due to 
ElB transcription through the promoter (Vales and Darnell,
1989) .
The gene for polypeptide IVa2 is transcribed from a 
promoter at 16.2 m.u. on the 1-strand, generating a spliced 
mRNA which is 3' coterminal with E2B transcripts. The 50Kd 
protein product is a major component of virus assembly 
intermediates and has been proposed to play a role in virus 
maturation (Persson e t  a l . ,  1979).
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Two small RNAs, termed virus associated RNAs (VA1 and 
VA2), are transcribed from two separate promoters near 30 
m.u. on the r-strand by RNA polymerase III (Weinman e t  a l . , 
1976). The VA RNAs accumulate in large amounts late after 
infection and are required for efficient late protein 
synthesis (Thimmappaya e t  a l . ,  1982). VA RNA binds to DAI, a 
cellular protein kinase (Katze e t  a l . ,  1987), thereby pre­
venting phosphorylation and inactivation of protein synthe­
sis initiation factor elF-2 (see O'Malley e t  a l . , 1989). VA 
RNA contains two domains, one that promotes binding to DAI 
and another that interferes with DAI activation (Mellits e t  
a l ., 1990).
The major late promoter (MLP) is located at 16.8 m.u. on
the r-strand of the Ad2 genome. At late times in infection
five mRNA families, L1-L5, are transcribed from this
promoter, differing in the poly-adenylation site used (Shaw 
and Ziff, 1980; Nevins and Wilson; 1981). Each mRNA species 
contains a. common set of three short 5 '-leader sequences, 
the tripartite leader, joined to different splice acceptor 
sites (Berget e t  a l . ,  1977; Chow e t  a l . ,  1977). During
early infection the LI mRNAs are expressed from the MLP but 
following DNA replication the L2-L5 mRNAs are also made 
(Nevins and Wilson, 1981; Shaw and Ziff, 1980). The 
molecular mechanism behind the switch between early and late 
transcription pattern from the MLP is not well understood. 
Transcription is strongly stimulated after the onset of DNA 
replication (Shaw and Ziff, 1980; Grass e t  a l . ,  1987), 
possibi... due to the particular state of the newly replicated 
DNA (Thomas and Mathews, 1980). Jansen-Durr e t  a l . ,  (1989b) 
have identified a major late promoter element within the 
first intron of the late transcript, essential for repli­
cation dependent activation of the MLP, and a cellular 
protein, downstream element factor, which binds to a 
sequence motif within this element, after the onset of DNA
replication in infected cells. Furthermore, the 72K DBP has 
been shown to stimulate transcription from the MLP, suggest­
ing a possible role in the activation of this promoter 
(Chang and Shenk, 1990) .
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Region LI encodes one structural polypeptide, protein 
Ilia, as well as the 52/55Kd proteins which have been shown 
to play a role in the assembly of infectious virus particles 
(Hasson e t  a l .  , 1989). The other late regions mostly encode 
virus structural proteins. In addition the L3 region 
encodes a protease responsible for the proteolytic cleavage 
of many viral polypeptides including the structural proteins 
VI, VII and VIII (Bhatti and Weber, 1979). The protease is 
present in virus particles at about 10 polypeptides per 
virion, primarily associated with the virion core (Anderson 
e t  a l ., 1990). Two non-structural proteins are encoded by 
the L4 region, a lOOKd protein which is involved in assembly 
of hexon capsomers (Oosterom-Dragon and Ginsberg, 1981; 
Cepko and Sharp, 1982, 1983) and required for the efficient 
translation of late mRNA (Hayes e t  a l . ,  1990), and an unre­
lated 33Kd protein of unknown function (Oosterom-Dragon and 
Anderson, 1983).
1.1.3.3. DNA replication
The virus lytic cycle is divided into early and late 
phase by the onset of DNA replication. The viral proteins
essential for replication, the terminal protein precursor 
(pTP), the adenovirus DNA polymerase (AdPol), and the DNA 
binding protein (DBP), are all expressed at early times 
from the E2 region. For a review of adenovirus DNA repli­
cation see Challberg and Kelly, 1989).
A number of studies have shown that adenovirus DNA 
replication occurs in two stages. In the initial stage
replication begins at one end of the genome and elongation
takes place using one parental strand as template and
displacing the other strand. The second stage involves the 
replication of the displaced single strand. The mechanism 
of replication is unique among eucaryotic DNA viruses but 
has a parallel in the bacteriophage ^29 (Salas, 1983). The 
precise order of events in the initiation of replication has 
not yet been resolved. The initiation reaction requires the 
interaction between the pTP and AdPol and two cellular
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nuclear factors, NFI and NFIII, which have been shown to
bind to sequences within the ITR (Nagata e t  a l . , 1983; de 
Vries e t  a l ., 1985; Jones e t  a l . ,  1987). Binding of NFI in 
the presence of pTP-AdPol complex stimulates the binding of 
dCTP to the pTP (Nagata e t  a l . ,  1983); this C residue 
becomes the first residue in the new DNA chain and is 
complementary to the G residue at the 3' end (Challberg e t  
a l . ,  1980). It is thought that the synthesis of a strand
complementary to the displaced DNA strand occurs following a 
circularization of the single stranded template by annealing 
of the ITRs (Daniell, 1976; Stow, 1982; Hay e t  a l . ,  1984). 
The resulting "panhandle" structure resembles the terminus 
of the duplex adenovirus genome and is presumably recognized 
by the same initiation machinery that operates in the first 
stage of replication (Challberg and Kelly, 1989).
1.1.3.4. Assembly of virions
The details of adenovirus assembly are not well
understood. The initial step appears to be the formation of 
the capsomers, hexon, penton base and fibre, from their 
monomeric forms in the cytoplasm and the assembly of empty 
capsids; viral DNA and core proteins are then inserted into 
the capsid, either together or separately in the nucleus
(see Philipson, 1984). An alternative mechanism has been 
suggested by Weber e t  a l . ,  (1985) whereby virion assembly is 
linked to DNA replication and capsid units assemble around 
replicating DNA. A c i s  acting packaging domain, essential 
for complete virion assembly, has been identified near the 
left end of the Ad5 genome; this domain can function in 
either orientation and near either end of the viral genome 
(Hearing e t  a l . ,  1987). This region is composed of at least 
five distinct, functionally redundant, sequence elements 
four of which contain an AT-rich repeated sequence motif 
(Grable and Hearing, 1990). These authors have suggested 
two models for the function of this packaging domain. One 
model .is that; DNA packaging protein (s) may directly
recognize and bind to those sequences thereby facilitating
15
the packaging of the viral genome; the other model suggests 
that the AT-rich sequences may introduce bends in the DNA 
and that a packaging protein(s) recognizes the overall 
structure of the DNA molecule. Virus packaging proteins 
have not so far been identified. In addition to structural 
proteins some non-structural viral proteins are known to 
affect virion assembly. The IVa2 protein is present in 
assembly intermediates and it has been suggested that this 
polypeptide may interact with viral DNA when it enters the 
capsid (Pettersson, 1984). The LI 52/55Kd proteins have 
been shown to be required for virion assembly; they may 
function late in the assembly process since intermediates 
representing capsids associated with the left end of the 
genome have been isolated from cells infected with a virus 
defective for these proteins (Hasson e t  a l . , 1989).
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1.2. Early region 1A
Early region 1A (E1A) of adenoviruses has been exten­
sively studied for a long time. Two aspects of E1A protein 
functions have mainly led to a great interest in this gene 
region; the role of E1A in gene regulation and E1A involve­
ment in cell transformation. The main emphasis here will be 
on the role of E1A in regulation of gene expression during 
the lytic cycle.
1.2.1. E1A transcription
The E1A DNA sequence has been determined for many human 
serotypes and other non-human adenoviruses (Ad2, Gingeras e t  
a l .  , 1982; Ad4, Tokunaga e t  a l . ,  1986; for a comparison of 
Ad5, Ad7 and Adl2, see van Ormondt e t  a l . ,  1980; Ad40, van 
Loon e t  a l . ,  1987b; Ishino e t  a l . ,  1988; Ad41, van Loon e t  
a l . , 1987b; Allard and Wadell, 1988; Simian adenovirus 7 
(SAV-7), Kimelman e t  a l . ,  1985; Tupaia adenovirus, 
Brinckmann e t  a l . ,  1983; mouse adenovirus 1 (MAV-1), Ball 
e t  a l . , 1988). Comparison of sequences of different adeno­
viruses has revealed three conserved domains within the E1A 
coding sequences (Kimelman e t  a l . ,  1985; Moran and Mathews, 
1987). Furthermore, these conserved regions are partly 
reflected in the E1A splicing patterns (see figure 2). E1A 
transcripts have been mapped for a number of different sero­
types and are remarkably similar (Ad2, Perricaudet e t  a l . ,  
1979; Berk and Sharp, 1978; Chow e t  a l . ,  1979; Baker and 
Ziff, 1981; Virtanen and Pettersson, 1983; Stephens and 
Harlow, 1987; Ulfendahl e t  a l . ,  1987; Ad7, Dijkema e t  a l . ,  
1980; Adl2, Sawada and Fujinaga, 1980; Saito e t  a l . ,  1981; 
Brockmann e t  a l . ,  1990; Ad40 and Ad41, van Loon e t  a l . ,  
1987b; SAV-7, Kimelman e t  a l . ,  1985; MAV-1, Ball e t  a l . ,
1989); the mouse virus differs from the other serotypes in 
having only one E1A mRNA, 3' coterminal with E1B mRNAs. 
Figure 2 shows the structure of Ad2 ElA mRNAs, which have 
been most extensively studied. The three major mRNA 
species, 13S, 12S and 9S have been identified from most 
serotypes studied so far. The mRNAs share common 5 ’ and 3' 
termini but differ in the size of the excised introns as a
Figure 2: Structure of the Ad2 E1A mRNAs and open reading 
frames.
Sedimentation values (S) for mRNAs and amino acid numbers 
for protein products are indicated. An alternative splice 
acceptor site is used to generate the 9S RNA which changes 
the open reading frame (hatched box) relative to other 
proteins. The lower panel shows a schematic representation 
of the domains of sequence conservation in the E1A proteins. 
The line at the top represents the Ad2 genome (bp). See 
text for details. (Reproduced from Nevins, 1989).
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result of linking different splice donor sites to a common 
splice acceptor site. The 12S and 13S mRNAs are translated 
in the same reading frame but their products differ by a 
block of 46 amino acids found only in the 13S product. 
Although the same splice acceptor site is used in the 9S 
mRNA, because of the pattern of the splice junction the 
second exon is read in a different reading frame to the 12S
and 13S mRNAs (Virtanen and Pettersson, 1983). Two
additional minor mRNA species have been identified in Ad2.
These 11S and 10S mRNAs contain splice junctions identical 
to those used in the 13S and 12S mRNAs respectively; in 
addition the 11S and 10S mRNAs share a splice junction where 
the splice donor site used in the 9S mRNA is linked to a 
unique splice acceptor site (see figure 2) (Stephens and
Harlow, 1987; Ulfendahl e t  a l . ,  1987).
The E1A region is the first region to be transcribed 
during a viral infection (Nevins e t  a l . ,  1979). At 1.5-2 hr 
p.i. the 12S and 13S mRNAs are detectable in the cytoplasm, 
the steady state levels of these transcripts peak at 5 hr 
p.i. and gradually decline through 12 hr p.i. (Glenn and 
Ricciardi, 1988). Transcription from the E1A promoter 
reaches maximal rate at 3 hr p.i. and that rate is main­
tained through the onset of DNA replication at 6 hr p.i.
(Nevins e t  a l . , 1979). The E1A 9S mRNA accumulates in the 
cytoplasm at late times in infection (Chow e t  a l . , 1979; 
Wilson and Darnell, 1981). Similarly, the minor 10S and 11S 
mRNAs increase in abundance late in infection (Stephens and 
Harlow, 1987).
The E1A promoter is active in the absence of any viral
factors (Nevins, 1981). This promoter consists of a TATA
box and an ATF binding site; several upstream elements are
also involved in regulation of transcription (see figure 3B 
for protein binding sites). The insertion of E1A upstream 
promoter sequences either upstream or downstream of another 
early gene confers this basal activity onto that promoter, 
indicating that these E1A sequences possess enhancer proper­
ties (Imperiale et  a l . ,  1983). Three distinct enhancer 
elements have been identified in El A upstream regions in
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Ad5. Element I is present in two copies and specifically 
regulates E1A transcription i n  v i v o  (Hearing and Shenk,
1983/ 1986). A cellular factor, EF-1A, has been shown to 
bind to these sites i n  v i t r o  (Bruder and Hearing, 1989). 
Element II is located between the two copies of element I 
and enhances transciiption from all early regions on the
chromosome in c i s  (Hearing and Shenk, 1986). The third
element, a binding site for the transcription factor E2F, is 
also present in two copies (Kovesdi e t  a l . ,  1987). These 
sites may mediate autoregulation of E1A gene expression
(Tibbetts e t  a l . ,  1986) since the E2F binding site from the 
E1A enhancer region can confer E1A inducibility on a
heterologous promoter (Kovesdi e t  a l . , 1987) and the DNA
binding activity of E2F is stimulated by E1A (Raychaudhuri 
e t  a l . , 1990); this E1A dependent activation may involve 
phosphorylation (Bagchi e t  a l . ,  1989). Transcription from
the E1A promoter is reduced around 5 fold in the absence of
E1A proteins as compared to wild type indicating that E1A
gene products have a role in regulating their own expression 
(Montell e t  a l . ,  1984; Osborne e t  a l . ,  1984). E1A upstream 
sequences may include other sites involved in transcrip­
tional regulation; Yoshida e t  a l . ,  (1989) have described 21 
binding sites of Hela cell nuclear proteins in the E1A 
upstream region. These include sites that overlap the cap 
site, TATA box and the enhancer elements described 
previously as well as sites constituting the origin of DNA 
replication. In addition to upstream sequences affecting 
ElA transcription, Osborne e t  a l . , (1984) identified a
sequence element within E1A coding sequences which enhances 
E1A transcription.
1.2.2. E1A protein products
E1A polypeptides are phosphoproteins, predominantly
localized in the nucleus of infected cells (Harlow e t  a l . ,  
1985; Tsukamoto e t  a l . ,  1986; Schmitt e t  a l . ,  1987; White e t  
a l . ,  1988b). They play a variety of roles during a lytic 
infection and are central to the process of transformation
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by adenovirus (for reviews see Berk, 1986a; Grand, 1987). 
Specific functions have been assigned to three regions 
within E1A which are well conserved between different 
serotypes.
A schematic diagram of E1A protein products is shown in 
figure 2. The presence of conserved regions (CR) I-III is 
indicated. The protein encoded by the 9S mRNA does not 
include any conserved regions and has not been assigned a 
function. CR I, which is present in the 289 residue (R) 
protein encoded by the 13S mRNA and the 243R product of the 
12S mRNA, is required for transcriptional repression, 
transformation and induction of DNA synthesis (Lillie e t  
a l ., 1987; Schneider e t  a l . , 1987; Jelsma e t  a l . ,  1989), but 
is dispensable for viral growth on Hela cells (Smith and 
Ziff, 1988). CR II is present in all but the smallest E1A 
protein; this region is required for transformation (Lillie 
e t  a l ., 1986; Moran e t  a l . ,  1986a) as well as induction of 
DNA synthesis (Howe e t  a l . ,  1990), but may be dispensable 
for transcriptional repression (Stein e t  a l ., 1990). CR III 
is unique to the 289R protein and is essential for the 
transactivating function of E1A (Moran e t  a l ., 1986b; Lillie 
e t  a l . ,  1987; Jelsma e t  a l . ,  1988), but dispensable for 
transformation and transcriptional repression (Zerler e t  
a l . ,  1986; Velcich and Ziff, 1985). The conserved regions 
of E1A appear to represent distinct functional domains which 
may act independently of other parts of the protein; a 49 
amino acid peptide including CR III efficiently activates an 
E1A inducible viral promoter upon coinjection into Hela 
cells (Lillie e t  a l . ,  1987).
1.2.3. Role of E1A proteins in regulation of transcription
E1A protein products regulate transcription from a number 
of viral and cellular promoters (for reviews of E1A trans­
activation see Berk, 1986b; Jones e t  a l . ,  1988; Nevins,
1989). In addition to the transactivating functions of the 
289R protein, E1A products can also repress transcription 
from various enhancer containing promoters (Borelli e t  a l . ,
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1984; Velcich and Ziff, 1985). The mechanism of E1A trans­
activation appears to be indirect, that is not involving an 
interaction between E1A proteins and specific DNA sequences 
within the activated promoter. A variety of studies indi­
cate that E1A mediates transcriptional regulation through 
cellular components. Activation of E1A dependent promoters 
can be mediated by another viral transactivating factor, the 
pseudorabies virus immediate early protein (Imperiale e t  
a l .  , 1983; Wu and Berk, 1988), as well as in a cell type
specific manner (Imperiale e t  a l . , 1984). Transcription of 
the gene for the cellular heat shock protein (hsp70) is 
activated in the presence of E1A (Nevins, 1982). F9 tera­
toma stem cells, which constitutivelv express hsp70, also 
allow early adenovirus gene expression in the absence of 
E1A; upon differentiation induced by retinoic acid early 
viral gene expression requires the E1A gene product and
there is a loss of hsp70 gene expression (Imperiale e t  a l . , 
1984). A great deal of effort from various laboratories has 
over the last few years led to the identification of a 
number of c i s  acting promoter sequences and t r a n s  acting 
cellular factors involved in E1A dependent promoter activa­
tion. Figure 3 shows a summary of the DNA-protein interac­
tions within the upstream promoter regions of the adenovirus 
early genes.
The Ad2 E1B promoter (see figure 3A) contains two 
elements essential for full activity i n  v i v o , a binding site 
for the Spl transcription factor (GC box) (Dynan and Tjian,
1983) and a TATA box (Wu e t  a l . ,  1987). Studies on other 
serotypes including the closely related Ad5 indicate that 
other upstream elements may be important for promoter 
activity (Bos and ten Wolde-Kraamwinkel, 1983; Parks e t  a l . ,  
1988; Parks and Spector, 1990). The organization of the E1B 
promoter will be described in detail in section 1.3.1. 
Mutations in the TATA box sequence but not the GC box affect 
activation of the E1B promoter by E1A, thus implicating the 
TATA box transcription factor (TFIID) in the process (Wu e t  
a l . ,  1987). however, Pei and Berk (1989) have shown that 
when the E4 TATA box is substituted for the E1B TATA box,
Figure 3: A) DNA-protein interactions within the upstream 
promoter region of the adenovirus early genes. The position 
of the binding sites and names of the factors are indicated. 
The arrowhead denotes the direction of transcription. The 
scale represents position relative to each cap site (+1). 
F o o t n o t e s :  1 Footprints protected by factors I-IV are as 
follows: I is TGGGCGTCGC, which may bind Spl; II is
GCTGTGGAATGT, which is identical to the GTII motif of the 
SV40 enhancer; III is CCCCAGGC., which may bind AP2; IV is 
TGTGGTTA. 2 This factor contains the same binding site as 
the E4F2 factor that binds at about -150 on the E4 promoter. 
B) DNA-protein interactions within the upstream region of 
the E1A gene. The scale represents the DNA genome (bp). 
(Modified from Jones e t  a l . , 1988).
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the promoter construct no longer responds to E1A
activation indicating specific sequence requirements for an 
E1A responsive TATA box. In the absence of upstream
sequences the presence of the E4 TATA box is not sufficient 
for E1A induction of the E4 promoter (Gilardi and 
Perricaudet, 1984; 1986).
The E2 early promoter has been extensively studied in 
terms of activation of transcription (see figure 3A).
Several elements within this promoter can respond to E1A 
transactivation. The E2 promoter contains a TATA-like
element (TAGA) (Zajckowski e t  a l . ,  1985) which is involved 
in E1A induction i n  v i v o  (Manohar e t  a l . ,  1990). Site
directed mutagenesis studies have identified three upstream 
promoter elements, two copies of a binding site for the
transcription factor E2F and one ATF binding site (Loeken 
and Brady, 1989). An additional E2F binding site is located 
further upstream, outside the minimal promoter region,
alongside a binding site for a factor termed E2aE-C3
(Jalinot e t  a l . ,  1988). A cellular factor Ca, distinct from
the E2F factor, has been reported to bind to sequences
overlapping the upstream and downstream E2F binding sites 
and may be involved in E1A induction (Jansen-Durr e t  a l . ,
1990). Several lines of evidence indicate that the E2F
factor plays a critical role in ElA-dependent regulation of 
transcription of the E2 early promoter. A segment of the E2 
promoter containing the two E2F binding sites can confer E1A 
inducibility onto a heterologous promoter (Kovesdi e t  a l . ,  
1987; Yee e t  a l . ,  1989) indicating a role for E2F in E1A
response. Furthermore, purified E2F protein specifically
activates transcription from promoters containing E2F
binding sites i n  v i t r o  (Yee e t  a l . ,  1989). The level of E2F 
binding activity increases during virus infection and 
increased binding stimulates E2A gene expression (Babiss,
1989). This increased binding activity is dependent on the 
presence of the E1A 289R protein and appears to occur in the 
absence of protein synthesis, leading to the suggestion of 
regulation by post translational modification (Reichel e t  
a l . ,  1988). This may involve phosphorylation of E2F (Bagchi
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e t  a l . ,  1989) possibly by an E1A induced cellular kinase. 
E1A dependent modification leads to the cooperative 
formation of stable complexes between two E2F molecules and 
their binding sites i n  v i t r o ,  but does not affect E2F 
binding to a single binding site (Jansen-Durr e t  a l . ,  
1989a). In addition to E1A, an E4 gene product is also
important for E2F activation and stimulation of E2
transcription (Babiss, 1989; Hardy e t  a l . , 1989; Reichel e t  
a l . , 1989). The E4 19.5K protein stimulates stable E2F 
binding to DNA by a direct complex formation between the 
19.5K protein and E2F {Huang and Hearing, 1989a; Neill e t  
a l . ,  1990; Raychaudhuri e t  a l . ,  1990). A scheme for 
combined action of E1A and E4 in the activation of E2F has
been proposed by Raychaudhuri e t  a l . ,  (1990). They suggest
that E1A acts to increase the levels of functional E2F 
independent of E4 functions, possibly by stimulating a 
cellular kinase or inactivating a phosphatase; E4 stimula­
tion of stable promoter binding of functional E2F could 
involve an alteration of E2F as a result of E4-protein 
interaction or alternatively the E4 protein may dimerize, 
bringing together the bound E2F molecules. This model 
accounts for independent activation seen in the presence of 
either the E1A 289R protein or the E4 19.5K protein and 
predicts the much greater effect seen when both are present. 
However, this contradicts the finding by Jansen-Durr e t  a l . , 
(1989a) that E1A does not affect the binding of E2F to a 
single site.
The ATF binding site in the E2 promoter is important for 
both uninduced and E1A induced promoter activity although
the promoter still responds to E1A in the absence of this 
element (Imperiale e t  a l . ,  1985). A family of related
cellular polypeptides interact with an ATF binding site (Hai 
e t  a l . ,  1988) and these bind to and mediate the tran­
scription of both E1A- and cyclic AMP (cAMP) inducible
promoters (Lee e t  a l . ,  1987; Lin and Green, 1988; Roesler e t  
a l . ,  1988; Hardy and Shenk, 1988; Pei and Berk, 1989; 
Muchardt e t  a l . ,  1990). Analysis of cDNA clones encoding 
factors binding to ATF binding sites and cAMP responsive
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elements (CRE) has revealed a family of cellular transcrip­
tion factors that possess homologous DNA binding domains 
(Hoeffler e t  a l . ,  1988; Hai e t  a l . , 1989), and are capable 
of forming DNA binding heterodimers (Hai e t  a l ., 1989). 
Dimerization involves a leucine zipper structure originally 
proposed by Landschulz e t  a l . ,  (1988). Liu and Green (1990) 
have suggested that E1A dependent activation of transcrip­
tion through an ATF binding site may involve an interaction 
between E1A and a DNA bound ATF factor. They used the
retinoblastoma susceptibility gene product (RB), which binds 
to E1A gene products (Whyte e t  a l . , 1988a), to demonstrate 
that when the E1A gene product is brought into the vicinity
of a promoter, transcription from that promoter is acti­
vated. A vector expressing a Gal4-RB fusion protein
including the Gal4 DNA binding domain and the RB E1A binding 
domain was cotransfected with an E1A expression vector and a 
reporter plasmid with Gal4 binding sites in the promoter. 
This resulted in transcriptional activity which was not seen 
in the absence of the Gal4 binding sites or E1A. Similarly 
the Gal4 polypeptide without RB did not support this 
activity. In a parallel experiment they demonstrated that a 
GAL-4-ATF-2 fusion protein similarly mediated E1A 
activation, probably by bringing the 289R E1A protein to the 
promoter. The ATF factors may be functionally distinguish­
able since another factor, ATF-1, did not support E1A 
response in this type of experiment (Liu and Green, 1990). 
Furthermore, ATF-2 is not inducible by cAMP (Liu and Green,
1990), while another ATF factor, CREB, does respond to cAMP 
activation (Hoeffler e t  a l . ,  1988; Gonzales e t  a l . ,  1989; 
Gonzales and Montminy, 1989). ATF-2 appears not to activate 
transcription in the absence of E1A (Liu and Green, 1990) so 
it is not clear if induction of transcription through an ATF 
binding site in the absence of E1A (Imperiale e t  a l . ,  1985) 
is mediated through another ATF factor. Liu and Green,
(1990) propose that ATF-2 has a role in transcriptional 
activation in uninfected cells; they suggest a possible 
activation of ATF-2 by modification such as phosphorylation. 
It is already known that CREB is activated by phosphorv-
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lation (Gonzales and Montminy, 1989). Alternatively a 
cellular counterpart of E1A may mediate transcriptional 
activation by ATF-2 (Liu and Green, 1990).
Several promoter elements have been mapped to the E3
promoter (see figure 3). Three of these, the TATA box, ATF 
site and API site are important for both basal and E1A 
induced gene expression (Garcia e t  a l . , 1987; Simon e t  a l . ,  
1988; Kornuc e t  a l . ,  1990). Factors LI and L2 are lymphoid
cell specific (see Jones e t  a l . ,  1988); binding of nuclear
factor I (NFI) has little effect on either basal or E1A 
induced gene expression (Garcia e t  a l . ,  1987; Kornuc e t  a l . ,
1990). A number of TATA box elements, including the E1B 
promoter, the cellular heat shock promoter (hsp70) and HIV 
LTR, as well as the E3 promoter element, are important for 
E1A activation of transcription (Wu e t  a l . , 1987; Simon e t  
a l .  , 1988; Kliewer e t  a l . ,  1989). However, unlike the other 
TATA elements, mutation or deletion of the E3 TATA box 
affects basal and induced transcription levels i n  v i t r o  only 
but not i n  v i v o  (Kornuc e t  a l . ,  1990).
The ATF and API binding sites are critical for E1A 
induction of the E3 promoter i n  v i v o ; the concentration and 
DNA binding activity of these factors appears not to be 
altered in the presence of E1A (Kornuc e t  a l . ,  1990). 
Possible mechanisms for E1A dependent activation of 
transcription through an ATF binding site were discussed 
above. An API binding site is similar although not identi­
cal to an ATF site (Angel e t  a l . ,  1987; Lee e t  a l . ,  1987b, 
1987c), and some factors can bind to both sites with 
different specificity (Hai e t  a l . ,  1989). A family of tran­
scription factors, including the c - j u n  and c - f o s  gene 
products interact with an API binding site (Bohmann e t  a l . ,  
1987; Angel e t  a l . ,  1988; Bos e t  a l . , 1988; Zerial e t  a l . ,  
1989; Hirai e t  a l . ,  1989). A functional DNA binding domain 
requires the formation of protein dimers that can be 
composed of either homologous or heterologous j u n and f o s  
subunits (Rauscher e t  a l . ,  1988; Turner and Tjian, 1989; 
Zerial e t  a l . ,  1989). Like the ATF factors, dimerization of 
API factors involves a leucine zipper motif (Landschutz e t
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a l .  , 1988; Sassone-Corci e t  a l . ,  1988; Turner and Tjian, 
1989; Gentz e t  a l . ,  1989). The role of an API binding site 
in regulation of transcription may involve competition for 
DNA binding by the various combinations of API dimers since 
different factors have different biological properties (Chiu 
e t  a l . , 1989; SchOtte e t  a l . ,  1989; Bohmann and Tjian, 
1989). Recent studies indicate that a cellular inhibitor 
may be involved in the regulation of c - j u n  transcriptional 
activity (Baichwal and Tjian, 1990). These authors suggest 
that API may communicate with the general transcriptional 
machinery through a coactivator (Lewin, 1990; Pugh and 
Tjian, 1990) and that activation may be regulated by the 
inhibitor and coactivator competing for the same binding 
site. However, the mechanism by which E1A regulates 
transcription through an API binding site remains unsolved.
DNA-protein interactions in the E4 upstream promoter 
region are shown in figure 3. The E4 gene is transcribed 
from the right hand end of the genome so upstream regions 
include the ITR, similar to the E1A promoter at the other 
end of the genome. The ITR includes two ATF binding sites 
and an NFI binding site, these sequences can be removed 
without much effect on expression from the E4 promoter when 
other promoter elements are intact (Gilardi and Perricaudet, 
1986; Hanaka e t  a l . ,  1987). It has been suggested that the 
repression of E4 transcription by the E2 DBP (Nevins and 
Winkler, 1980; Handa e t  a l . ,  1983), may result from inter­
ference of the DBP with factors bound to the ITR ( N e v i n s ,
1 9 8 9 ). Downstream of the ITR the E4 promoter contains three 
copies of an ATF binding site that is critical for tran­
scription and ElA-dependent t r a n s  activation (Lee and Green,
1987). Several protein factors have been shown to interact 
with this element (Raychaudhuri e t  a l . ,  1987; Lee e t  a l . ,  
1987a; Lee and Green, 1987; Cortes e t  a l . ,  1988; Leza and 
Hearing, 1988, 1989). ATF is in fact a family of transcrip­
tion factors (see above). A factor termed EIVF interacts 
with this site and similar to ATF the characteristics and 
amount of DNA binding activity appears to be unaffected by 
adenovirus infection (Cortes e t  al., 1988). The relation­
26
ship of this factor to ATF is not clear. Another factor 
that interacts with the ATF binding site, E4F, shows an 
increase in DNA binding activity after adenovirus infection, 
dependent on E1A function (Raychaudhuri e t  a l . ,  1987). This 
regulation of DNA binding activity involves phosphorylation 
(Raychaudhuri e t  a l . , 1989), suggesting a possible parallel 
with E1A regulation of E2F binding activity (Bagchi e t  a l . ,
1989). E4F may be a member of the ATF family since its DNA 
binding pattern is similar to that of ATF-3 (Rooney e t  a l . ,
1990). In addition, two other factors have been reported to 
bind to the E4 enhancer region. E4F2 binds to a site 
identical to the E2aE-C3 site described by Jalinot e t  a l . ,  
(1988) and another factor, E4TFI was reported to bind in the 
same region (see Jones e t  a l . , 1988). Lee et a l ., (1989)
have shown that there is not a simple correlation between 
the presence of an ATF site and E1A or cAMP inducibility;
ATF sites differ among themselves in a way that probably
involves flanking sequences. The E4 promoter may therefore 
be regulated in a complex manner involving several, possibly 
related, t r a n s acting factors and promoter elements with 
different protein binding specificities. Wada e t  a l . ,
(1991) have recently described different DNA binding
properties and transcriptional activation of ATF homodimers 
and heterodimers binding to the E4 promoter.
Early transcription from the major late promoter is
dependent on E1A (Nevins, 1981). The promoter region 
involved in E1A activation has been mapped between nt -66 
and +33 relative to the MLP cap site (Lewis and Manley, 
1985; Jansen-Durr e t  a l . ,  1988). This region overlaps the 
TATA box region which is identical to the E1A inducible E1B 
and hsp70 TATA elements (Wu e t  a l . ,  1987; Simon e t  a l . ,
1988) thus implicating the TATA-binding factor TFIID in the 
activation of the MLP by E1A. Furthermore, Leong e t  a l . ,  
(1988) have shown by using fractionated cell extracts that 
the fraction including TFIID stimulates transcription from 
the MLP several fold higher in infected cell extracts than 
extracts from mock infected cells.
E1A d e p e n d e n t  activation of transcription of viral genes
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extends to the RNA polymerase III transcribed VA RNA genes 
(Berger and Folk, 1985; Gaynor e t  a l . ,  1985; Hoeffler and 
Roeder, 1985; Yoshinaga e t  a l . ,  1986). Stimulation of VA 
RNA transcription by E1A involves the transcription factor 
TFIIIC (Yoshinaga e t  a l ., 1986), which recognizes and binds 
to the internal promoter element of polymerase-III tran­
scribed genes (Lassar e t  a l . ,  1983; Fuhrman e t  a l . , 1984). 
Expression of E1A may lead to an increase in phosphorylation 
of TFIIIC and thereby enhance functional complex formation 
at the promoter site (Hoeffler e t  a l ., 1988b).
Although the role of E1A in activation of transcription 
has been extensively studied the mechanism involved is by no 
means clear. However, a complex picture is emerging; E1A 
trans-activation may be obtained by several pathways
involving a number of c i s  acting sequences and t r a n s  acting 
factors. The picture is further complicated by the finding 
that several factors with different biological activities
can bind to the same E1A responsive promoter elements. 
There is evidence to suggest that in some cases the effect 
of E1A is stimulation of DNA binding activity, which may 
involve a change in phosphorylation of a transcription 
factor. A direct interaction between E1A and DNA-bound 
factors has been suggested in other cases, but so far there 
is no direct evidence for such interaction.
1.2.4. Enhancer repression by E1A proteins
Transcriptional repression may be an important mechanism 
for the regulation of eucaryotic gene expression (for a
review see Levine and Manley, 1989). E1A protein products 
can repress transcription dependent on either viral or
cellular enhancer sequences (Borelli e t  a l . ,  1984; Hen e t  
a l . ,  1985; Velich and Ziff, 1985; Hen e t  a l . , 1986; Stein
and Ziff, 1987; Stein and Whelan, 1989), including the E1A
enhancer (Tibbets e t  a l . ,  1986). Extensive mutational
analysis has revealed that the repression function is
distinct from E1A transactivation (Borelli et a l . ,  1984;
Velich and Ziff, 1985; Schneider e t  a l . ,  1987). There is
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some controversy over the role of conserved region II in 
transcriptional repression; mutations within this region 
have been found to have marked effect (Lillie e t  a l . ,  1986; 
Velich and Ziff, 1988) or little or no effect (Kuppuswamy 
and Chinnadurai, 1987; Schneider e t  a l . , 1987; Jelsma e t
a l . ,  1989; van Dam e t  a l . ,  1989; Rochette-Egly e t  a l . ,  1990; 
Stein e t  a l . , 1990) on repression activity. Sequences
within CRI are essential for repression (Lillie e t  a l .  , 
1987; Schneider e t  a l . , 1987; Jelsma e t  a l . , 1989; Stein e t  
a l . , 1990). In addition, sequences N-terminal to CRI are 
required for transcriptional repression functions (Jelsma e t  
a l . ,  1989; Stein e t  a l . ,  1990). There is strong correlation 
between enhancer repression activity and binding of a 300Kd 
cellular protein whose association with E1A requires 
sequences within the N-terminus (Egan e t  a l . , 1988; Whyte e t  
a l . , 1989), suggesting a possible role for this protein- 
protein infraction in enhancer repression (Jelsma e t  a l .  , 
1989; Stein e t  a l . ,  1990). The 300Kd protein has not been 
identified and its function is unknown.
1.2.5. Other functions of the E1A proteins
One of the features of the E1A proteins is their involve­
ment in oncogenic transformation (for reviews see Berk, 
1986a; Mak and Mak, 1986). E1A products can immortalize 
primary rodent cells in culture and cooperate with other 
oncogenes, such as the E1B gene products or an activated r a s  
gene, to produce fully transformed cells.
E1A proteins form stable complexes with three major 
cellular polypeptides with molecular weight around 105Kd, 
107Kd and 300Kd (Yee and Branton, 1985; Harlow e t  a l . ,
1986). Recent studies have shown that the binding sites for 
these cellular proteins lie within the region of E1A needed 
to cooperate with an activated r a s  gene for transformation, 
suggesting that these proteins may play a key role in
cellular transformation (Whyte e t  a l . ,  1988b; Egan e t  a l . ,  
1988; Whyte et  a l . ,  1989; Jelsma e t  a l . , 1989). The 105Kd
protein (pl05--RB) is the product of the retinoblastoma sus­
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ceptibility gene (Whyte e t  a l . ,  1988a, Egan e t  a l . ,  1989), 
an anti-oncogene that like other anti-oncogenes is thought 
to act in a pathway that restricts cell proliferation (for 
review see Klein, 1988; Hansen and Cavenee, 1988). pl05-RB 
has also been shown to complex with the SV40 large T antigen 
(DeCaprio e t  a l . , 1988; Ludlow e t  a l . ,  1989). Mutants of T 
antigen (DeCaprio e t  a l . ,  1988) as well as E1A (Egan e t  a l . ,  
1988; Jelsma e t  a l . ,  1989; Whyte e t  a l . ,  1989; Egan e t  a l . , 
1989) that fail to bind pl05-RB have drastically reduced 
transforming properties, leading to the suggestion that 
complex formation inactivates pl05-RB, thereby permitting 
the uninhibited growth associated with oncogenically trans­
formed cells.
This association is not the only event required for E1A 
mediated transformation since E1A products that bind pl05-RB 
but fail to bind the 300Kd protein are also defective for 
transformation (Egan e t  a l . ,  1988; Jelsma e t  a l . ,  1989; 
Whyte e t  a l . ,  1989; Stein e t  a l . ,  1990), indicating a possi­
ble role for the 300Kd protein in growth control as well. 
Furthermore, Stein e t  a l ., (1990) have shown that the 
ability of E1A to induce DNA synthesis in quiescent cells 
(Spindler e t  a l . , 1985) and repress enhancer-stimulated
transcription (see 1.2.4.) colocalize with N-terminal trans­
forming functions and correlate closely with binding of the 
300Kd protein. The binding of either the 300Kd protein or 
pl05-RB appears to be sufficient for the induction of DNA 
synthesis (Howe e t  a l . ,  1990) while binding of both is 
needed for transformation (Egan e t  a l . ,  1988; Jelsma e t  a l . ,  
1989). This suggests that the pathways by which pl05-RB and 
the 300Kd protein participate in the control of cell growth 
are more complex than those that control the onset of DNA 
synthesis (Howe e t  a l . ,  1990).
The role of the 107Kd protein is unknown; this protein 
and pi05-RB interact with overlapping sequences within CRII 
(Egan e t  a l . ,  1988; Whyte e t  a l . ,  1989) but the two 
polypeptides appear to be unrelated (Dyson e t  a l . ,  1989). 
The 107Kd protein also forms protein complexes with the 
large T antigens of SV40 and JC virus and may represent a
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further common component in transformation by E1A and large 
T antigen (Dyson e t  a l . ,  1989).
The transforming regions of the E1A proteins may be 
involved in induction of expression of some cellular 
proteins (Zerler et a l . , 1987; Simon e t  a l . ,  1987; Kaddurah- 
Daouk e t  a l . , 1990). The significance of this for the role 
of E1A in oncogenesis is not clear but Kaddurah-Daouk e t  
a l . ,  (1990) have suggested that the induction of an enzyme 
for cellular energy metabolism, by E1A, may be related to 
metabolic events that take place after oncogenic activation.
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1.3. Early region IB
Early region IB (E1B) together with the E1A region is 
involved in transformation by adenoviruses and this has led 
to a great interest in this gene complex. However, E1B gene 
products also have interesting properties in a lytic 
infection and this section will focus mainly on E1B in the 
lytic cycle.
1.3.1. General organization of the E1B region
The E1B region is located immediately downstream of the 
E1A region. The E1B DNA sequence is known for a number of 
serotypes (Ad2, Gingeras e t  a l .  , 1982; Ad5, Bos e t  a l . ,
1981; Ad7, Dijkema e t  a l . ,  1982; Adl2, Kimura e t  a l . ,  1981; 
Bos e t  a l . ,  1981; Ad40, van Loon e t  a l . ,  1987b; Ishino e t  
a l . , 1988; Ad41, van Loon e t  a l . ,  1987b; MAV-1, Ball e t  a l . , 
1988; 1989; Tupaia adenovirus, Flugel e t  a l . ,  1985). There 
is considerable sequence homology between the different 
serotypes both on the DNA and amino acid level (van Ormondt
and Hesper, 1983; Ishino e t  a l . ,  1988). Unlike the E1A
region, this homology is not limited to specific regions but 
is spread over most parts of the open reading frames. Two
large open reading frames are apparent from the DNA 
sequences (figure 4).
Transcription maps from the E1B region have been deter­
mined for several serotypes (Ad2, Berk and Sharp, 1978; Chow 
e t  a l . ,  1979; Perricaudet e t  a l . ,  1980; Virtanen and 
Petersson, 1985; Ad5, Bos e t  a l . ,  1981; Ad7, Yoshida and
Fujinaga, 1980; Dijkema e t  a l . ,  1982; Adl2, Bos e t  a l . ,  
1981; Virtanen e t  a l . ,  1982; for a comparison of Ad5, 7 and 
12 see van Ormondt and Hesper, 1983; Ad41 (transformed 
cells), van Loon e t  a l . , 1987b; MAV-1, Ball e t  a l . ,  1989).
Figure 4 shows the transcription maps and open reading 
frames for Ad2 and Adl2. The two major E1B transcripts in 
Ad2 are 22S and 13S coterminal mRNAs; they use different 
splice donor sites but share a splice acceptor site. Two 
minor species, 14S and 14.5S include the splice junction 
used in the 22S mRNA and in addition have the 13S splice
Figure 4: Structure of the Ad2 and Adl2 E1B mRNAs and open 
reading frames.
Sedimentation values (S) for Ad2 mRNAs and molecular weight 
(K) of Ad2 polypeptides are shown and the same nomenclature 
used for the Adl2 counterparts. Number of amino acid 
residues (R) for each protein product is indicated. Shades 
of hatched boxes denote different reading frames.
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donor site linked to different splice acceptors; the lid 
splice is in frame but the 14.5S splice changes the reading 
frame. A 9S mRNA encoding polypeptide IX is transcribed 
from a separate promoter within the E1B region. Adl2 also 
has a 22S mRNA and two transcripts corresponding to the Ad2 
14S mRNA, differing only in the use of different splice
acceptor sites in the 3' untranslated region, but no 13S
mRNA has been identified.
The other human serotypes have not been as extensively 
studied but appear to have a similar organization. The MAV- 
1 E1B region differs in only having two large transcripts, 
one corresponding to a 22S mRNA and another identical but 
with a splice removing most of the first open reading frame.
In addition to E1B transcripts from the E1B promoter, 
several authors have reported E1A-E1B cotranscripts which
encode E1B polypeptides. These have been detected in cells 
lytically infected or transformed with Ad2 (Berk and Sharp, 
1978; Kitchingman and Westphal, 1980; Hashimoto e t  a l .,
1984), Ad5 (van den Elsen e t  a l . ,  1983) or Adl2 (Sawada and 
Fujinaga, 1980; Saito e t  a l . ,  1983). The cotranscripts are 
relatively low in abundance, they have not been extensively 
analysed and cDNA sequences have not been determined. 
However, the Adl2 cotranscripts are reported to have 5 ’ ends 
and splice sites identical to those of the major E1A mRNAs 
and to extend to the 3' end of E1B, with a splice 
corresponding to the splice in E1B 22S mRNA. Berk and Sharp 
(1978), describe an Ad2 transcript consisting of fewer than 
50bp from the 5' end of E1A linked to a site near the 5 ’ end 
of E1B, resulting in a 22S type E1A-E1B cotranscript, but 
the precise structure of the E1A-E1B junction was not 
analysed. Hashimoto e t  a l . ,  (1984) report i n  v i t r o  transla­
tion of Ad2 E1A proteins from ElB-selected transcripts, 
indicating a different structure for E1A-E1B cotranscripts. 
They suggest that potential splice donor and acceptor 
sequences, spanning the E1A-E1B junction, may be utilized in 
these cotranscripts, but the usage of these splice sites has 
not so tar been demonstrated.
E1B mRNAs encode two major polypeptides in different
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reading frames, a 19Kd protein (19K) encoded by the first 
ORF and a 55Kd protein (55K) by the second ORF (Bos e t  a l . , 
1981; Anderson e t  a l . ,  1984) (see figure 4). The first ORF 
is present in all the E1B mRNA species while the whole of 
the second ORF is only present in the 22S mRNA. Polypep­
tides related to the 55K protein are encoded by the smaller 
E1B mRNAs (Green e t  a l . ,  1982; Lucher e t  a l . ,  1984; Lewis 
and Anderson, 1987). The Ad2 13S and 14.5S mRNAs encode 82 
residue (R) and 92R products respectively, both comprising 
the amino terminus of the 55K protein linked to a different 
ORF after the splice junction in the mRNA (Lewis and 
Anderson, 1987). Similarly, the 14S mRNA encodes a 155R 
(15K) protein which consists of the amino- and carboxy- 
termini of the 55K protein (Lewis and Anderson, 1987).
1.3.2. E1B transcription
E1B gene expression appears to be controlled in a complex 
manner on several different levels including regulation of 
initiation of transcription, splicing and mRNA stability. 
At early times in infection (3.5-9 hr p.i.) the 22S mRNA 
accumulates preferentially in the cytoplasm, while the 13S 
mRNA remains at low levels until 8 hr p.i. when it begins to 
increase in abundance, attaining a level comparable to that 
of. the 22S mRNA by 12 hr p.i. (Glenn and Ricciardi, 1988). 
The minor 14S and 14.5S mRNA species were not analysed in 
this experiment but Virtanen and Pettersson (1985) have 
shown that these are also differentially regulated. At 8 hr 
p.i. the 14.5S mRNA is 20 fold less abundant than the 14S 
mRNA while at late times they are present in approximately 
equal amounts. The differential accumulation of mRNA 
species from the same primary transcript is influenced by a 
change in relative cytoplasmic stability (Wilson and 
Darnell, 1981): The 72K DBP has been reported to cause
rapid turnover of early mRNA (Babich and Nevins, 1981). 
These authors suggest that at late times in infection the 
13S E1B mRNA accumulates since it is no longer destabilized 
by the DBP, but the 22S mRNA fails to accumulate because of
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specific degradation mediated by an unknown late viral 
function. However, the relative abundance of E1B mRNAs may 
also be regulated by a different mechanism. Montell e t  a l .  , 
(1984b) have shown that the relative concentrations of the 
13S to 22S nuclear mRNAs increased at late times during 
infection. Furthermore, an infection with a viral mutant 
with defect in the 13S splice donor site results in the use 
of cryptic splice donor sites near the original 13S site, 
specifically at a late time in infection. This evidence 
suggests that the temporal increase in the relative 
abundance of the 13S mRNA is at least partly due to an 
increased tendency to use the 13S splice donor site at late 
times in infection.
1.3.3. The E1B promoter
Like the other adenovirus early promoters the E1B 
promoter responds to transcriptional activation by E1A. The 
basic Ad2 E1B promoter is relatively simple, consisting only 
of a TATA box and a binding site for the cellular transcrip­
tion factor Spl (Wu e t  a l . ,  1987). These elements are 
conserved in other adenovirus serotypes (see figure 20, 
section 4.3.). Studies involving Adl2 have suggested that 
sequences upstream of these promoter elements may also be 
important for gene expression (Bos and ten Wolde- 
Kraamwinkel, 1983). In the Ad5 E1B promoter four protein 
binding sites have been identified upstream of the basic 
promoter (see figure 3 and figure legend for sequences of 
binding sites) (Parks e t  a l . ,  1988). Site IV, which 
resembles sequences found in analogous positions in other 
serotypes, is located downstream of the E1A ORF. Sites I, 
II and III are within E1A coding sequences; similar 
sequences have been identified in control regions of various 
viral and cellular genes. Parks e t  a l . ,  (1988) showed that 
in an i n  v i t r o  analysis increased transcriptional activity 
was seen in the presence of these upstream sequences only 
when the Spl binding site was absent. Wu e t  a l . ,  (1987) 
found that deletion of sequences upstream of the basic
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promoter had little effect on E1B transcription i n  v i v o , 
suggesting that these upstream elements are not important 
for E1B transcription. However, the possibility remains 
that these protein binding sites may be of importance under 
conditions not reflected in those experiments and perhaps 
different regulatory elements are important in different 
cell types.
The Spl binding site (Kadonaga e t  a l . , 1986) in the E1B 
promoter is essential for efficient transcription from that 
promoter (Wu and Berk, 1987; Parks e t  a l ., 1988). However, 
mutations of this site do not interfere with transactivation 
by the E1A protein or by the pseudorabies virus immediate 
early (IE) protein (Wu and Berk, 1987; 1988a). Transcrip­
tion factor Spl is a sequence specific DNA binding protein; 
it enhances transcription from several viral and cellular 
promoters that include at least one GC box (Kadonaga e t  a l . , 
1986). Spl binds to some but not all DNA sequences that 
contain the GGGCGG hexanacleotide, affinity is affected by 
flanking sequences; Spl binding sites are functional in 
either orientation (Kadonaga e t  a l . ,  1986). cDNA clones 
encoding this factor have been isolated and the DNA sequence 
determined (Kadonaga e t  a l . ,  1987; 1988). The protein binds 
to DNA via zinc finger motifs (Kadonaga e t  a l . ,  1987; 1988). 
Glutamine rich domains in the protein, outside the DNA 
binding region, are responsible for mediating transcrip­
tional activation (Courey and Tjian, 1988). Spl molecules 
activate transcription synergistically and the synergy 
appears to be at the level of transcriptional activation 
rather than DNA binding; that is, the protein-protein inter­
action appears to aid promoter activation by directly 
increasing the rate at which the general transcription 
machinary initiates transcription, rather than by stabiliz­
ing the protein-DNA complex (Courey e t  a l . ,  1989). Pugh and 
Tjian (1990) have suggested that Spl may activate transcrip­
tion by interacting with the general transcription 
apparatus, possibly TFIID, through specific coactivators. 
However, such coactivators have not so far been identified. 
Altered spacing between the Spl site and TATA box in the E1B
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promoter affects transcriptional activation by Spl (Wu and 
Berk, 1988b). This is consistent with protein-protein 
interaction between Spl and TFIID playing a role in tran­
scriptional activation. Spl binding does not affect the DNA 
binding activity of TFIID but instead appears to act by 
increasing the number of productive transcription complexes, 
possibly by increasing the binding activity of some other 
factor in the initiation complex (Schmidt e t  a l . ,  1989).
E1A transactivation of E1B is mediated through the TATA 
box and is not affected by Spl binding; the E1B TATA element 
is also a target for activation by the pseudorabies virus IE 
protein (Wu e t  a l ., 1987; Wu and Berk, 1988a,b). This
suggests that both these transactivating proteins can 
increase expression from the E1B promoter by stimulating the 
activity of the TATA binding factor TFIID. Studies with 
partially purified pseudorabies virus IE protein have shown 
that this protein stimulates transcription i n  v i t r o  by 
increasing the efficiency or rate of TFIID binding to the 
DNA template to form the preinitiation complex (Abmayr e t  
a l . ,  1988). Leong e t  a l . ,  (1988) have shown that the 
fraction including TFIID from adenovirus infected cell 
extracts has higher transcriptional activity than the 
parallel mock infected extract, consistent with the idea 
that E1A stimulates TFIID activity. The mechanism of such 
stimulation is still not well understood.
1.3.4. The 19K protein
The smaller E1B ORF is translated into a 19 kilodalton 
polypeptide (19K) which is located in the nuclear envelope 
and cytoplasmic membranes of infected and transformed cells 
(White e t  a l . ,  1984a; Mitchison e t  a l . ,  1990). Posttransla- 
tional acvlation may play a role in membrane association of 
the protein (McGlade e t  a l . ,  1987). A subset of the protein 
molecules are phosphorvlated but this appears to be 
nonessential for the function of the protein as shown by 
site-directed mutagenesis studies (McGlade e t  a l . ,  1989).
Several phenotypes have been associated with defects in
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19K expression. E1B 19K mutants show a host range phenotype 
for virus replication in human cells; replication in Hela 
cells is unaffected while replication in KB cells and WI38 
cells is defective and enhanced respectively (White e t  a l .  , 
1986; White and Stillman, 1987). Mutations can also cause 
enhanced cytopathic effect (c y t ) in infected Hela and KB 
cells (Takemori e t  a l . , 1968, 1984; Pilder e t  a l . r 1984;
Subramanian e t  a l . , 1984b; White e t  a l . , 1984b). This
phenotype is also associated with large plaque morphology 
( I p ) (Chinnadurai, 1983; Subramanian e t  a l . ,  1984b).
Furthermore, 19K mutants cause extensive degradation of
viral and cellular DNA (d e g ) in most cell lines (D'Halluin 
e t  a l . , 1979; Ezoe e t  a l . ,  1981; Lai Fatt and Mak, 1982; 
Pilder e t  a l . , 1984; Subramanian e t  a l ., 1984a; White e t
a l . , 1984b); therefore a major function of the 19K protein
appears to be to protect or stabilize viral and cellular DNA 
during infection. These phenotypes are all dependent on the 
expression of E1A 12S or 13S gene products, and cellular 
factors may also be involved since the phenotype is host 
cell dependent (White and Stillman, 1987). Mutants in the 
19K protein are defective for virion and DNA mediated trans­
formation (Chinnadurai, 1983; Babiss e t  a l . ,  1984; Fukui e t  
a l . ,  1984; White e t  a l . ,  1984b; Barker and Berk, 1987; 
Herbst e t  a l . ,  1988). The 19K protein also modulates viral 
gene expression. In the presence of E1A 13S or 12S gene
products it appears to have a negative effect on viral gene 
expression (White e t  a l . ,  1986; White and Stillman, 1987) 
while in the absence of E1A the 19K protein has a positive 
effect on the expression of viral genes (Herrmann e t  a l . ,  
1987; White e t  a l . , 1988a; Herrmann and Mathews, 1989). In 
cotransfection experiments, the presence of the 19K protein 
causes an increase in the level of gene expression from 
plasmids encoding viral or cellular proteins (Herrmann e t  
a l . ,  1987; Vales and Darnell, 1989; Herrmann and Mathews, 
1989; Shiroki e t  a l . ,  1990). The 19K protein has been shown 
to activate transcription indirectly by increasing the 
stability of plasmid and viral DNA (Herrmann and Mathews,
1989). This is consistent with the fact that the 19K
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protein is known to protect viral and chromosomal DNA from 
degradation during viral infection. The association of the 
19K protein with the nuclear lamina has been implicated in 
this function since this localization is disrupted in cells 
infected with deg mutants (White e t  a l .  , 1984a), leading to 
the suggestion that DNA stability is increased by altering 
its structure or distribution (Herrmann and Mathews, 1989). 
The 19K protein alters the structure and organization of the 
nuclear lamina and the intermediate filament network (White 
and Cipriani, 1989, 1990) and this may compartmentalize DNA 
or protect it from degradation by some unknown mechanism 
(Herrmann and Mathews, 1989). Disruption of the organiza­
tion of the intermediate filaments by the 19K protein has 
also been associated with the transformed cell phenotype 
(White and Cipriani, 1989, 1990). These authors have
suggested that this interference may promote transformation 
by modulating signal transduction, cell-cell interaction or 
chromatin structure.
1.3.5. The 55K protein and related polypeptides
The large E1B ORF is translated into a 55 kilodalton 
protein (55K) from the 22S mRNA (Bos e t  a l . ,  1981; Anderson 
e t  a l .  , 1984). Related proteins have been identified from 
Ad2 infected cells and i n  v i t r o  translated mRNA (Anderson e t  
a l .  , 1984; Lewis and Anderson, 1987). An 82R protein is a 
product of the 13S mRNA; it comprises the amino terminal 78 
codons of the large ORF. A 155R (15K) protein, amino- and 
carboxy-coterminal with the 55K protein is a product of the 
14S mRNA. These polypeptides have not been assigned a 
function and they are dispensable for virus growth and 
transformation in the presence of the 55K protein (Montell 
e t  a l . ,  1984b). A 92R predicted product of the 14.5S mRNA, 
sharing the amino-terminus with the 55K protein, has not so 
far been identified.
The 55K protein is modified by phosphorylation on 
threonine and serine residues (Malette e t  a l . ,  1983;
Spindler e t  a l . ,  1984; Schughart e t  a l . ,  1985). The impor-
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tance of this modification to the biological function of the 
protein is not known. Virus replication in most cell types 
is severely affected in the absence of a functional 55K 
protein. The E1B 55K protein plays a critical role in the 
selective expression of viral genes; unlike wild type adeno­
virus, viruses carrying mutations that impair production of 
the 55K protein do not induce inhibition of cellular protein 
synthesis or selective entry of viral mRNA into the 
cytoplasm (Babiss and Ginsberg, 1984; Babiss e t  a l ., 1985; 
Pilder e t  a l ., 1986; Williams e t  a l . ,  1986; Barker and Berk,
1987). A similar phenotype is observed with viruses 
defective for expression of the 34K protein encoded by ORF 6 
of the E4 region (see 1.1.2.2.) (Halbert e t  a l ., 1985; 
Weinberg and Ketner, 1986; Cutt e t  a l ., 1987). Sarnow e t  
a l ., (1984) have shown that the 55K protein and the E4 34K
protein form a complex in infected cells and they and others 
(Pilder e t  a l . ,  1986) have suggested that this complex is a 
functional unit involved in the mRNA accumulation process.
Further evidence for this comes from studies using double
mutants, lacking the ability to synthesize both proteins. 
Such double mutants have no more severe phenotype than 
single mutants carrying either mutation (Cutt e t  a l . , 1987; 
Bridge and Ketner, 1990).
In the absence of a functional 55K protein, no primary 
defect in transcription rate of late viral genes is seen,
and their RNAs are polyadenylated and spliced within the 
nucleus (Pilder e t  a l . ,  1986). Furthermore, these authors 
showed that a cDNA copy of a late gene produced unspliced 
mRNAs that failed to accumulate in the cytoplasm of E1B 55K 
mutant infected cells, confirming that the defect is not at 
the level of mRNA splicing. This led to the conclusion that 
the 55K protein regulates gene expression post-transcrip-
tionally, either at the level of RNA transport or by stabil­
izing viral mRNA upon entry into the cytoplasm. Leppard and 
Shenk (1989) looked at the site of action of the 55K protein 
by monitoring the movement of newly synthesized mRNA through 
a series of biochemically defined cellular subfractions. 
They found that in cells infected with a 55K deficient
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virus, late viral mRNA failed to accumulate efficiently 
within a specific nuclear compartment, where RNA was 
normally seen to accumulate after leaving the nuclear matrix 
and before associating with the nuclear envelope. This 
demonstrates that the 55K protein acts within the nucleus.
The absence of either or both of the 34K E4 protein and
the 55K protein results in a reduction of late viral mRNA in 
the nucleus as well as a defect in the transport of this 
nuclear mRNA (Sandler and Ketner, 1989; Bridge and Ketner, 
1990). This is consistent with the idea that the 55K/34K 
complex facilitates viral RNA metabolism at an intranuclear 
step, possibly by maintaining the stability of the pool of 
processed RNA molecules prior to translocation or perhaps 
facilitating the translocation step itself (Ornelles and
Shenk, 1991).
Although the 55K protein and E4 34K protein are found as 
a complex in infected cells (Sarnow et a l . ,  1984), large 
quantities of free proteins have also been detected (Cutt e t  
a l . ,  1987; Smiley e t  a l . ,  1990). Biochemical and immuno­
chemical studies have shown that the 55K protein is present 
at several locations in infected cells. By immunofluores- 
cent staining it is found in a diffused pattern within the 
cytoplasm and in an intensely stained fibrous body adjacent 
to the nucleus, while in the nucleus it is present in a 
granular, diffuse distribution and in local concentrations 
within and about the periphery of viral inclusion bodies
(Ornelles and Shenk, 1991). These bodies have been shown to 
be the site of viral DNA synthesis and accumulation (Moyne 
e t  a l . ,  1978; Brigati e t  a l . ,  1983; Voelkerding and Klessig,
1986) and may also be the sites of late viral RNA synthesis 
(Moyne et a l . ,  1978; Wolgemuth and Hsu, 1981). Smiley e t  
a l .  , (1990) examined the association of the 55K protein with
nuclear pore complexes. They found that although some of 
the nuclear 55K protein fractionated with the pore complex- 
lamina the protein does not form a stable complex with these 
organelles during the late phase of infection. This led 
them to conclude that the role of the 55K protein was not to 
modify the function of nuclear pore complexes but rather to
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affect some earlier step in the RNA transport process. This 
is consistent with the model for 55K function proposed by 
Ornelles and Shenk (1991). They suggest that the 55K/34K 
protein complex interacts with, and draws to the periphery 
of viral replication-transcription centres, a nuclear factor 
required for movement of mRNAs from their site of processing 
to the nuclear pores for transport to the cytoplasm. This 
would account for the ability of the complex to inhibit 
accumulation of RNAs transcribed from cellular locations as 
well as stimulating accumulation of viral transcripts. 
Studies using i n  v i t r o  transport systems have identified 
nuclear factors which could play such a role in RNA 
transport (Moffett and Webb, 1983; Subramaniam e t  a l . ,
1990).
Much of our current understanding of the functions of the 
E1B 55K protein comes from studies on viral mutants (see 
Williams, 1986 for a review; Barker and Berk, 1987; Byrd e t  
a l ., 1988; Breiding e t  a l . ,  1988; Mak and Mak, 1990; Yew e t  
a l . ,  1990; Kao e t  a l . ,  1990). Those studies have involved 
mutant viruses of subgroup A (Adl2) and C (Ad2, Ad5). While 
these mutants share the phenotype of a defect in late viral 
mRNA transport and lack of host cell protein synthesis shut 
off, some differences have been revealed between the two 
subgroups. Adl2 mutant viruses defective for the 55K E1B 
protein function are severely impaired for viral DNA 
synthesis (Shiroki e t  a l . ,  1986; Breiding e t  a l . ,  1988; Mak 
and Mak, 1990). This is in contrast with subgroup C where 
the 55K protein is not required for viral DNA replication 
(Lassam e t  a l . ,  1978; Babiss and Ginsberg, 1984; Williams e t  
a l . ,  1986). A further difference is seen in the host range 
characteristics of Adl2 and Ad5 E1B 55K mutants. While Ad5 
mutants with a growth defect on Hela cells grow to wild type 
levels on primary human embryo kidney cells (Harrison e t  
a l . ,  1977), Adl2 mutants do not grow efficiently upon these 
cells (Breiding e t  a l . ,  1988). The basis for this apparent 
difference in function between those two closely related 
polypeptides is not known.
hike oilier adenovirus El gene products the 55K protein
42
has been implicated in cellular transformation by adeno­
viruses. Transformation by viral infection appears to 
require the entire El region including the 55K protein 
coding sequences (Babiss e t  a l .  , 1984; Bernards e t  a l .  ,
1986; Barker and Berk, 1987; Byrd e t  a l . ,  1988). However, 
efficient DNA-mediated transformation using viral DNA carry­
ing mutations in the 55K ORF has been reported, suggesting 
that the 55K protein is non-essential for DNA-mediated 
transformation (Rowe and Graham, 1983; Babiss e t  a l . , 1984). 
Others have found that mutations in the 55K protein decrease 
or abolish transformation by plasmid or viral DNA (Bernards 
e t  a l .  , 1986; Barker and Berk, 1987). Studies on E1B 55K 
mutants are complicated by the fact that due to the overlap 
in the 55K and 19K E1B ORFs many of the mutants retain the 
ability to express a truncated protein from the 55K ORF. 
However, a mutant virus, dll520, constructed by Barker and 
Berk (1987), which does not express any truncated products 
from the 55K ORF or 55K related polypeptides, is unable to 
transform cells by infection or DNA transfection.
The role of the 55K protein in transformation has not 
been elucidated. The Ad5 55K protein is known to interact 
with a cellular protein p53 (Sarnow e t  a l ., 1982b) a
potential tumor suppressor gene product, and it has been 
suggested that this interaction inactivates p53 function 
(see Levine, 1990 for review). However, in Adl2 transformed 
cells p53 is not associated with the E1B 55K protein 
(Zanteina e t  a l . ,  1985) suggesting that this interaction is 
not necessary for the transformation process. Furthermore, 
mutational analysis revealed no correlation between the 
ability of Ad5 55K protein to bind p53 i n  v i t r o  and trans­
formation efficiency (Yew et. a l .  , 1990; Kao e t  a l . ,  1990).
Recently van den Heuvel e t  a l . ,  (1990) have shown that 
complex formation between p53 and the Ad5 E1B 55K protein 
reduces oncogenicity of transformed cells. This is consis­
tent with Adl2 transformed cells being more oncogenic than 
Ad5 transformed cells.
Mutational analysis of the Ad2 and Adl2 55K proteins have 
shown that while large parts of the 55K are needed for DNA-
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(Adl2) and virus-replication and transformation function, 
the two functions can be separated by mutation (Mak and Mak, 
1990; Yew e t  a l . ,  1990). This indicates that the role of 
the 55K protein in replication and transformation involves 
two different biological functions. However, the precise 
mechanism by which the 55K protein provides those functions 
awaits further studies.
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1.4. The enteric adenoviruses
Viral gastroenteritis in children can be caused by 
several different pathogens including adenovirus, which is 
second only to rotavirus as a causal agent (Estes e t  a l . ,  
1983; Uhnoo e t  a l . ,  1984; Brandt e t  a l . ,  1985). Although 
several adenovirus serotypes can be isolated from diarrhoeal 
stools most earlier epidemiological studies generally found 
as many adenovirus isolates in the stools of controls as 
from those with diarrhoea (Ramos-Alvares and Sabin, 1958). 
However, more recent studies have shown a close correlation 
between two distinct serotypes, designated Ad40 and Ad41 
(Uhnoo e t  a l . ,  1983; de Jong e t  a l . , 1983), and gastro­
enteritis (Brandt e t  a l . ,  1979; 1985; Yolken e t  a l . , 1982;
Chiba e t  a l . ,  1983; Uhnoo e t  a l . ,  1984; Leite e t  a l . ,  1985; 
Kidd e t  a l . ,  1986; Kotloff e t  a l . ,  1989). Accordingly those 
two serotypes are commonly referred to as the enteric adeno­
viruses (Jacobsson e t  a l . , 1979; Retter e t  a l . ,  1979). For 
a review of the enteric adenoviruses see Albert (1986).
1.4.1. Identification and classification
The enteric adenoviruses were first detected by electron 
microscopy on stool specimens from infants with acute 
gastroenteritis (Flewett e t  a l . ,  1975). It was found that 
they were excreted in large numbers but failed to grow in 
tissue culture. Further studies showed that while enteric 
adenoviruses did not grow in cells routinely used for the 
propagation of other adenoviruses such as human embryo 
kidney cells (HEK), KB, Hela, Hep-2 and WI-38, they grew 
readily in 293 cells (Takiff e t  a l . ,  1981), HEK cells trans­
formed with the Ad5 El region (Graham e t  a l . ,  1977). Kidd 
and Madeley (1981) showed that some but not all enteric 
adenovirus specimens could be passaged in Chang conjunctiva 
cells. Morover, their serological data (Johansson e t  a l . ,  
1980; Kidd and Madeley, 1981) indicated that irrespective of 
infectivity in Chang cell cultures, different isolates of 
enteric adenoviruses were antigenically related and distinct 
from the (then) 35 established adenovirus serotypes. The
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presence of two distinct serotypes of enteric adenoviruses 
was revealed by studies on large numbers of clinical iso­
lates (Uhnoo e t  a l . , 1983; de Jong e t  a l .  , 1983). The two 
types were indistinguishable in heamagglutination inhibition 
tests but neutralization tests distinguished between them. 
This data was further supported by restriction endonuclease 
analysis showing different DNA restriction patterns for the 
two new serotypes, Ad40 and Ad41 (Uhnoo e t  a l . , 1983; Takiff 
e t  a l .  , 1984). Those two serotypes are now classified as a 
separate subgroup, F, based on several criteria such as 
cross-reactivity in immunological studies, DNA homology and 
size of internal structural polypeptides (van Loon e t  a l . ,  
1985b; Wadell e t  a l . ,  1987; Hierholzer e t  a l . , 1988).
1.4.2. Epidemiology
Enteric adenoviruses have been detected in the stools of 
young children and infants with acute gastroenteritis in 
several studies conducted in industrialized and developing 
countries. These viruses are prevalent throughout the year 
with little seasonal variations, indicating that they may be 
endemic (de Jong e t  a l . ,  1983; Uhnoo e t  a l . ,  1984; Brandt e t  
a l . , 1985; Johansson e t  a l . ,  1985; Tiemessen e t  a l . ,  1989). 
In two one year studies conducted in Sweden, enteric adeno­
viruses were detected in 7-8% of children with diarrhoea 
(Uhnoo e t  a l . ,  1984; Johansson e t  a l . ,  1985). Two similar 
studies in South Africa found enteric adenoviruses in 6.5% 
and 13.2% of patients, although in the latter study it was 
the only pathogen in 6.2% of cases (Kidd e t  a l . ,  1986; 
Tiemessen e t  a l . ,  1989). A seven year study in the USA 
detected adenoviruses in feces of 5.1% of infants with acute 
gastroenteritis and concluded that most of them were 
causally associated with the disease (Brandt e t  a l . ,  1985). 
This rate of detection of enteric adenoviruses associated 
with disease (5-13%) suggests an important role in viral 
gastroenteritis second only to rotaviruses. Moreover, iso­
lation of enteric adenoviruses in as much as 52% of hospi­
talized children with diarrhoea has been reported in a short
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study in the USA (Yolken e t  a l . ,  1982). A recent one year 
study in a rural community in Guatemala monitored fecal 
excretion of Ad40 and Ad41 and rotaviruses in 194 children 
under the age of 3, as well as studying children hospital­
ized because of diarrhoea (Cruz e t  a l . , 1990). Half of the 
hospitalized children shed rotaviruses while over 30% shed 
Ad40 or Ad41. In the community, 22% of children excreted
Ad40 or Ad41 whereas 10% shed rotaviruses. Asymptomatic 
infections were found with both adenoviruses and rota­
viruses. Up to four Ad40 or Ad41 infections were observed 
in some children. Of 385 episodes of diarrhoea studied,
over 20% lasted more than 2 weeks; 25% of these were
associated with Ad40 or Ad41, 6% with rotaviruses. In a
community where 25% of mortality in preschool children is
caused by diarrhoea or dehydration (Cruz e t  a l ., 1990) this 
suggests a great clinical importance for the enteric adeno­
viruses as well as rotaviruses.
Ad40 and Ad41 have been isolated with approximately equal 
frequency in most studies which have distinguished between 
the two (de Jong e t  a l . ,  1983; Uhnoo e t  a l . ,  1982; Johansson 
e t  a l . ,  1985). They appear to cause disease mainly in 
infants and young children, with median age of patients
reported as 7-9 months (Brandt e t  a l . ,  1985; de Jong e t  a l . ,
1983) .
1.4.3. Pathogenesis
Clinical features of enteric adenovirus infection were 
studied by Uhnoo e t  a l . ,  (1984; 1986). After an incubation 
period of seven to eight days, infected children had a 
clinically moderate disease with diarrhoea and vomiting.
Elevated temperatures were rare and less than 20% of
patients had respiratory symptoms. The two serotypes caused 
similar symptoms although Ad41 infected children had more 
protracted diarrhoea (mean 12.2 days) than those infected 
with Ad40 (mean 8.6 days). These studies showed that the
enteric adenoviruses cause a more prolonged but milder 
infection with a lower frequency of vomiting and elevated
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temperatures than did rotaviruses. A study in the USA has 
shown that dehydration is as likely to develop in children 
with enteric adenovirus diarrhoea as among those with rota­
virus diarrhoea (Kotloff e t  a l . , 1989). Moreover, enteric
adenoviruses have been associated with a fatal disease. 
Ad41 virus particles were isolated from small intestinal 
mucosal cells in a fatal case of adenovirus gastroenteritis 
{Whitelaw e t  a l ., 1977; Johansson e t  a l . ,  1985). Upon
propagation in tissue culture this strain did not appear to 
be unusually virulent (Johansson e t  a l . ,  1985).
1.4.4. Propagation of Ad40 and Ad41 in tissue culture
A remarkable feature of the enteric adenoviruses is their 
growth restriction in cultured human cell lines, hence their 
late discovery as important pathogenic agents. The diffi­
culty in culturing clinical isolates of these viruses i n  
v i t r o  is not due to low virus concentrations since up to 
1011 virus particles can be detected per gram of diarrhoeal 
stool (Gary e t  a l . ,  1979; Retter e t  a l . ,  1979; Takiff and 
Straus, 1982). Isolates of enteric adenoviruses do not 
replicate in human embryonic kidney cells (HEK) (Kidd and 
Madeley, 1981; Takiff e t  a l . ,  1981; Takiff and Straus, 1982; 
de Jong e t  a l . ,  1983), which are routinely used for the 
isolation of other adenoviruses. Takiff e t  a l . , (1981)
reported efficient growth of enteric adenovirus isolates in 
293 cells, HEK cells transformed with the Ad5 El region, and 
suggested that the early Ad5 gene functions expressed in 
those cells might be providing helper functions to permit 
virus replication. However, while successful growth of Ad40 
in 293 cells has been reported (de Jong e t  a l . ,  1983; Brown
e t  a l . ,  1984), others have failed to detect Ad40 replication
in these cells (Chiba e t  a l . ,  1983; Uhnoo e t  a l . ,  1983).
This may reflect differences between virus isolates or 
variations between laboratories.
A detailed study on the growth characteristics of around 
200 isolates of enteric adenoviruses in different cell lines 
was conducted by de Jong et al., (1983). They report
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difficulties in growing both Ad40 and Ad41 and although both 
serotypes propagated in 293 cells and tertiary cynomologus 
monkey kidney cells (tCMK) they found in general that growth 
depended on virus strain, cell type, subline and batch and 
other unknown factors. This may explain conflicting results 
obtained by others attempting to propagate enteric adeno­
viruses in several cell lines. Uhnoo e t  a l . ,  (1983) used 
clinical isolates to infect A549, HT29 and 293 cells and 
found that while Ad41 isolates grew in HT29 and 293 cells 
all the cell lines were nonpermissive for Ad40. Different 
results were obtained by Witt and Bousquet (1988) investiga­
ting the growth properties of purified Ad40 and Ad41 
virions. Both serotypes were infectious for A549 and 293 
cells as well as Chang conjunctiva and KB cells whereas Hela 
cells were only permissive for Ad41. Virus harvest of all 
permissive cells was infectious on A549 cells. These 
authors suggest that the increased host range of enteric 
adenoviruses seen in this study compared to previous studies 
may reflect the difference between using purified virions as 
opposed to clinical material. They propose that other 
viruses present in virus isolates may partly explain the 
host cell restriction of enteric adenoviruses from clinical 
isolates. However, this would not account for the differ­
ences in host range between the enteric and other adeno­
viruses in clinical specimens. Although Witt and Bousquet 
observed virus replication with both Ad40 and Ad41, 
infectious titers obtained, as determined by an indirect 
irnmunofluorescent assay, were relatively low for both sero­
types and Ad40 in particular, in all the cell lines. This 
indicates that these cell lines are only semipermissive for 
the enteric adenoviruses and their propagation is restricted 
in tissue culture compared to an i n  v i v o infection.
An interesting observation reported by Witt and Bousquet
(1988) is that when high concentrations of Ad40 were used in 
an infection, virus replication was not observed, while at a 
lower multiplicity of infection Ad40 did replicate in the 
same cell lines. This might suggest the presence of 
defective virus particles in the virus stock, interfering
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with infection by nondefective virus particles. Indeed it
has been shown that while the production of Ad40 virions is
3-10-fold lower that that observed for other adenoviruses, 
the yield of infectious virus is 100-1000-fold less (Brown, 
1985). However, this inhibitory effect of using high input 
of Ad40 virions may be cell type specific since Witt and 
Bousquet did not see such inhibition in KB cells and 
similarly this effect has not been detected in KB derived 
cell lines (Nancy Mackay, personal communication).
The ability of the enteric adenoviru^s to propagate in
293 cells (Takiff e t  a l .  , 1981) implicated the El region in
the growth restriction of these viruses. Further studies 
led several authors to suggest that a malfunction of the E1A 
region was at least partly responsible for the host range 
phenotype. Although both Ad40 and Ad41 E1A gene products 
are capable of inducing expression from the Ad2 E4 promoter 
in transient transfection assays, the level of transactiva­
tion is considerably lower than by the Ad5 E1A gene product 
(van Loon e t  a l . ,  1987a). Similarly, Ishino e t  a l . ,  (1988) 
found that the Ad40 E1A gene product is a weaker transacti­
vator than either Ad5 or Adl2 E1A; they also demonstrated 
that the Ad40 E1A gene has a weaker cis-acting promoter than 
Adl2. Other evidence suggests a lack of E1B functions in 
the enteric adenoviruses. Plasmids containing the El region 
of either Ad40 or Ad41 are capable of transforming baby rat 
kidney cells (van Loon e t  a l . ,  1985a) whereas these
serotypes are not capable of virion mediated transformation
(Takiff and Straus, 1982). Similar phenotypes have been 
reported for E1B 55K mutant viruses (Rowe and Graham, 1983; 
Babiss et a l . ,  1984; see section 1.3.5.). More direct 
evidence for the involvement of the E1B region in the growth 
restriction of Ad40 comes from studies by Mautner e t  a l . ,
(1989). By using a series of KB cell lines expressing
either one or both of the Ad2 E1A and E1B regions it was
shown that Ad40 grows equally well on cells expressing the 
whole of the El region and cells expressing only the E1B 
region, as determined by the yield of virion DNA. Cells
expressing only E1A gene products are no more permissive
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than KB cells without any adenovirus sequences. This indi­
cates that a lack of E1B but not E1A functions may be 
involved in the growth restriction of Ad40. This is 
supported by the finding that in coinfection assays there is 
reciprocal complementation between Ad40 and the Ad5 E1A 
mutant dl312 while complementation of Ad40 by mutants 
lacking the E1B region or defective for the E1B 55K protein 
is hardly detectable (Mautner e t  a l . ,  1989; this thesis).
The growth defect of Ad40 in tissue culture is more 
severe than that of Ad41 as seen by the lack of Ad40 growth 
in several cell lines that are permissive for Ad41 (de Jong 
e t  a l .  , 1983; Uhnoo e t  a l . ,  1983; 1984; van Loon e t  a l . ,
1985b). It is therefore possible that the basis for the 
host range may differ between the two serotypes. Several 
recent studies have focused on the growth restriction of 
Ad41 in tissue culture. Tiemessen and Kidd (1988) assayed 
for complementation of Ad41 growth by Ad2 on the semi- 
permissive Chang conjunctiva cells (Kidd and Madeley, 1981) 
and non-permissive human embryo fibroblasts (HEF) (de Jong 
e t  a l . ,  1983). They determined the effect of Ad2 infection, 
before, after or together with Ad41, on late antigen 
production. Ad2 provided a helper function for Ad41 in HEF 
cells and the complementation was most effective when cells 
were preinfected with Ad2. In Chang conjunctiva cells, Ad41 
late antigen synthesis was enhanced in the presence of Ad2; 
the degree of complementation was dependent on Ad2 input 
concentration in both cell types. Although these results 
show that Ad41 propagation in non-permissive and semi- 
permissive cells is enhanced in the presence of Ad2 they do 
not give any indication as to which gene products may be 
involved in the complementation. In double infection 
experiments on HEF cells interference of Ad41 on Ad2 repli­
cation was detected, dependent on the relative time of 
infection by each serotype (Tiemessen and Kidd, 1988). This 
is consistent with a hierarchy of dominance between 
different adenovirus serotypes which has been attributed to 
the transcriptional repression function of E1A gene products 
(Leite e t  a l . ,  1986; Tibbetts et  a l . ,  1986; Larsen and
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Tibbetts, 1987) .
Further studies on the growth kinetics of Ad41 on HEF and 
Chang conjunctiva cells in the absence and presence of Ad2 
and on 293 cells, were performed by Tiemessen and Kidd,
(1990). Several different patterns emerged. Namely, on 293 
cells Ad41 showed infectivity with one-hit kinetics, i.e. 
infectivity was directly proportional to input virus concen­
tration, while in Ad2-Ad41 double infections on HEF and 
Chang conjunctiva cells the infectivity followed a pattern 
of two-hit kinetics. An Ad41 single infection on the semi- 
permissive Chang conjunctiva cells showed multiple-hit 
kinetics. This indicates that while in 293 cells a single 
Ad41 particle is capable of a productive infection, in Chang 
conjunctiva cells several virus particles are needed to 
infect a cell productively. As a way of explaining this 
finding Tiemessen and Kidd (1990) propose that the virus 
stock contains a homogeneous population of virus particles, 
each particle having an equal probability of initiating
infection but a low probability of continuing infection to
late antigen synthesis, perhaps due to a limiting concentra­
tion of some essential product. This limitation would then
be overcome by multiple infecting genomes, the possibility 
of a successful cellular infection increasing markedly with 
increasing concentration of input virus. According to this 
model the limiting product would most likely be an El gene 
product since the need for a multiple infection is overcome 
in 293 cells, expressing the Ad5 El region, as well as in a 
coinfection with Ad2. Furthermore, the need for this 
product would have to be cell type dependent since HEF cells 
are non-permissive for Ad41 in the absence of a complement­
ing Ad2 infection while Chang conjunctiva cells are semi-
permissive for Ad41.
It is not clear if this model could apply to the growth 
properties of Ad40 since it has been reported that a high 
multiplicity of Ad40 infection can inhibit virus replication 
in some cell lines (Witt and Bousquet, 1988; see above).
Moreover, this may be an over simplification of the basis
for AcM.1 growth restriction. Pieniazek, D. e t  a l . ,  (1990a)
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have recently reported that in their hands Ad41 loses 
infectivity rapidly upon passaging on 293 cells, while 
propagation on HEp-2, Int407 and Hela cells is successful. 
Comparison of yields of complete and incomplete Ad41 
particles showed that in 293 cells 62% of virus particles 
were incomplete and in HEp-2 cells incomplete particles made 
up 40% of the total virus particles. This implies that Ad41 
virus stocks include a high proportion of defective virus 
particles and is in contrast to the prediction by Tiemessen 
and Kidd (1990) that Ad41 virus stocks are homogeneous. The 
loss of Ad41 infectivity upon passaging in 293 cells was 
found to be related to a deficiency of the core protein V in 
virus particles, probably due to a defect in the assembly of 
Ad41 virions in 293 cells (Pieniazek, D. e t  a l . ,  1990a). 
The basis for this selective loss of infectivity is not 
clear and contradicts previous reports where Ad41 has 
successfully been passaged in 293 cells (de Jong e t  a l .,
1983; Uhnoo e t  a l . ,  1983).
One of the factors that can influence Ad41 propagation is 
serum concentration. The growth restriction of Ad41 on HEK 
cells, previously reported to be non-permissive (Takiff e t
a l . , 1981; Kidd and Madeley, 1981), and other primary cell 
lines, can be overcome by keeping a low serum concentration 
(0.2-1%) in the infection medium (Pieniazek, D. e t  a l . ,
1990b). Although this results in accumulation of viral DNA 
and virus particles similar to that seen in permissive 
cells, no CPE is seen on the human primary cells. The lack 
of CPE suggests that the primary cells produce lower amounts 
of penton protein since appearance of CPE is linked to the 
amount of penton present in the infected cells (Pettersson, 
1984). The serum effect was found exclusively in primary
cells and not seen for continuous cell lines such as HEp-2 
and 293 cells. In primary cells the accumulation of Ad5 DNA
is not related to serum concentration (Pieniazek, D. e t  a l . ,
1990b) . Thus it appears that some factor present in serum
may selectively inhibit Ad41 DNA replication in primary
cells, possibly by affecting interaction between viral and 
cellular factors in those cells. Another example of a
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selective replicative block in a particular cell type is 
that of Adl2 in primary hamster cells which are permissive 
for Ad2 and Ad5 replication (Klimkait and Doerfler, 1987). 
Pieniazek, D. e t  a l . , (1990b) suggest that this growth
restriction of Ad41 and Adl2 in certain primary cells may be 
related to the fact that both serotypes infect cells of the 
gastrointestinal tract i n  v i v o and may as such have specific 
growth requirepents. It is of interest that the replicative 
block of Adl2 in primary hamster cells can be overcome in a 
double infection with Ad2 or Ad5 and in cells expressing the 
Ad2 or Ad5 El region (Klimkait and Doerfler, 1985). More­
over the E1A mutant dl312 provides helper functions for Adl2 
DNA replication in a double infection whereas the E1B mutant 
dl313 does not (Klimkait and Doerfler, 1987). This is 
analogous to the complementation of Ad40 growth on KB cell 
lines and by E1A but not E1B mutant viruses (Mautner e t  a l . ,  
1989) and further implicates the E1B region in the host 
range of adenoviruses.
1.4.5. The molecular biology of the enteric adenoviruses
Detailed studies of adenovirus serotypes 2 and 5 and to a 
lesser extent Adl2 have created a vast amount of information 
some of which may apply to adenoviruses in general. As a 
result, a comparison with those well characterized serotypes 
is a useful approch to studying the enteric adenoviruses. 
Conversely, such a comparison can add to the perception of 
general adenovirus biology.
The overall DNA homology, as determined by liquid phase 
hybridization, is 62-69% between Ad40 and Ad41, while the 
DNA from both serotypes is 15-22% homologous to Ad2 DNA (van 
Loon e t  a l . ,  1985b). The homology within subgroup F is 
lower than seen within subgroups B-E but similar to subgroup 
A; the intersubgroup homology is in the same range as seen 
for other subgroups (see table 1). A direct DNA sequence 
comparison has also been used to study the relationship 
between the enteric adenoviruses and other serotypes. The 
DNA sequence of the Ad40 ITR shows a closer relation to that
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of Ad5 than to viruses of any of the other subgroups, but it 
is one of the longest of the known ITRs of human adeno­
viruses and resembles subgroup A in that respect (Ishino e t  
a l .  , 1987). The nucleotide sequence of several genes is 
also known for Ad40 (El region, van Loon e t  a l . , 1987b; 
Ishino e t  a l . ,  1988; DBP and 23K protease, Vos e t  a l . ,  1988; 
fibre, Kidd and Erasmus, 1989; hexon, Toogood e t  a l . ,  1989) 
and Ad41 (El region, van Loon e t  a l .  , 1987b; Allard and
Wadell, 1988; DBP and 23K protease, Vos e t  a l . ,  1988; 100K 
and 33K proteins, Slemenda e t  a l . , 1990; pVIII and the E3
promoter, Pieniazek e t  a l . ,  1989b; fibre, Pieniazek, N.J. e t  
a l . , 1989a, 1990; Kidd e t  a l . ,  1990; hexon, Toogood and Hay,
1988) .
According to the DNA sequence data available so far the 
genome organization of the enteric adenoviruses corresponds 
to that of other human adenoviruses. However, an intriguing 
difference is that the Ad41 genome contains two adjacent 
fibre genes (Pieniazek, N.J. e t  a l . , 1989a, 1990). This may 
be analogous to avian adenoviruses which have two fibre 
proteins of different size (Laver e t  a l . ,  1971). The 
corresponding Ad40 sequence has not been analysed in detail 
although the DNA sequence of one fibre gene has been 
determined (Kidd and Erasmus, 1989). The predicted Ad40 and 
Ad41 fibre polypeptides fit the secondary structure model 
predicted by Green e t  a l . ,  (1983) which proposes a shaft 
made up of pseudorepeat units approximately 15 amino acids 
long. Like Ad5 and Ad2, one of the Ad41 fibre proteins has 
22 such repeats whereas the other one has 12 (Pieniazek, 
N.J. e t  a l . ,  1989a, 1990; Kidd e t  a l . ,  1990). Ad40 has a
pattern of 21 repeats in the shaft region (Kidd and Erasmus,
1989). The Ad40 fibre gene is highly homologous (95.6%) to 
the larger of the Ad41 fibre genes, excluding a 45bp region 
present only in the Ad41 gene which accounts for one 15
amino acid repeat (Kidd e t  a l . ,  1990). The overall homology 
with Ad2 fibre is only 33% on the amino acid level although 
regions of higher homology can be identified. The fibre is 
responsible for cellular attachment of the virus and it is 
in feres ting to speculate that differences in host cell
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specificity may be reflected in the divergence of the 
fibres. However, the replicative block of the enteric 
adenoviruses in tissue culture is after entry into cells 
(Takiff and Straus, 1982), thus making this an unlikely 
explanation for the growth restriction of these viruses in 
cells permissive for Ad2.
Analysis of hexon sequences reveals 88% overall amino 
acid sequence homology between Ad40 and Ad41 (Toogood e t  
a l .  , 1989 . Regions of low homology correspond to regions 
that are variable between Ad2 and Ad5 indicating that those 
are areas of type specific antigen determinants as pre­
viously suggested by Kinloch e t  a l . , (1984). A comparison
between these four serotypes also reveals other regions, 
conserved within a subgroup but variable between subgroups, 
probably representing group specific antigens (Toogood e t  
a l ., 1989). The hexon amino acid sequence is 77% homologous 
between Ad41 and Ad2 (Toogood and Hay, 1988), which is
considerably higher conservation than seen for the fibre. 
This mav reflect more structural constraints on hexon"  A
sequences.
Vos e t  a l . ,  (1988) determined the nucleotide sequence of 
the DBP gene of Ad40 and Ad41 as well as the 23K protease 
gene and parts of the hexon and 100K protein genes. They 
found that the overall sequence organization in that region 
is extremely compact and contains large deletions with
respect to Ad2, both within promoters and protein coding 
sequences. The amino acid sequence of the 23K protease is 
very well conserved between the two serotypes (90%) whereas 
a homology of 72% for the DBP is only slightly higher than 
between either serotype and Adl2 (69%).
The El region of the enteric adenoviruses has been most 
extensively studied, partly because it has been implicated 
in the fastidious growth of these viruses. The DNA sequence 
of this region of both serotypes was determined by van Loon 
e t  a l . ,  (1987b) and found to be 85% homologous to each other 
and to share 52% homology with the corresponding Ad5 region. 
The organization of the region is similar to that found for 
other serotypes and strategic sequences essental for the
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propagation of all human adenoviruses are present in both 
serotypes. Open reading frames were identified corre­
sponding to the E1A and E1B regions of other serotypes. 
Comparable results were obtained by Ishino e t  a l .  , (1988)
who sequenced the El region of a different strain of Ad40 
and Allard and Wadell (1988) who analysed the E1A region of 
a different Ad41 strain. Ishino e t  a l . ,  (1988) compared the 
amino acid sequence o f  E1A proteins and E1B 19K and 55K 
proteins to that of the corresponding Ad2 and Adl2 polypep­
tides. While Ad40 E1A proteins share a similar homology 
with Ad2 and Adl2 (40% and 39% respectively) both the E1B 
19K and 55K proteins share a higher homology with Adl2 (48% 
and 53% respectively) than with Ad2 (44% and 47% respec­
tively) .
For RNA analysis, rat cells transformed with Ad40 or Ad41 
El containing plasmids were used as a source of total RNA 
because of the inability to projjgate the fastidious viruses 
in conventional cell lines (van Loon e t  a l ., 1987b). The El 
transcription maps as determined by SI analysis are shown in 
figure 5. Three Ad40 E1A mRNA species were detected, corre­
sponding to the Ad2 9S, 12S and 13S mRNAs. However,
although the intact Ad40 E1B region was present in those 
cells (van Loon e t  a l ., 1985a) no E1B mRNA was detected
either by SI analysis or Northern blotting. In Ad41 
transformed cells an E1A 13S mRNA was identified as well as 
an E1B transcript corresponding to the Ad2 22S mRNA. Van 
Loon e t  a l . ,  (1987b) postulate that the absence of Ad40 E1B 
rnRNA may be due to low transactivation of the E1B promoter 
by Ad40 E1A and that this may be the basis for the replica­
tive block of Ad40 in tissue culture. The same argument may 
apply to Ad41 but the presence of multiple copies of El 
sequences in transformed cells may overcome this low
expression level. These authors (van Loon e t  a l . ,  1987a) 
and others (Ishino e t  a l . ,  1988) have shown that the Ad40
and Ad41 E1A products are weaker transactivators than the
Ad5 ElA products (see 1.4.4.). However, efficient growth of 
Ad4 0 in KB cells expressing the Ad2 E1B region and not in 
the parallel cell line expressing the E1A region (Mautner e t
Figure 5: Virus specific mRNAs present in cells transformed 
with the Ad40 or Ad41 El region.
Transcripts were mapped by SI nuclease analysis. The mRNAs 
transcribed from the Ad40 E1A region are indicated by roman 
numerals. The dashed carets represent intron sequences. 
Start and stop (bars) codons and ORFs have been denoted. 
ORFs in mRNAs transcribed from the viral sequences are 
indicated by black boxes, while ORFs in the E1B region of 
Ad40 and the polypeptide IX coding region of Ad41 are 
indicated by striped boxes. Scales are in nt. (Reproduced 
from van Loon e t  a l ., 1987b).
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a l . ,  1989) disputes this conclusion since the presence of 
Ad2 E1A would be expected to complement for low transacti­
vation by Ad40 E1A.
The three conserved regions within the E1A region 
(Kimelman e t  a l . ,  1985; see 1.2.2.) have also been 
identified in Ad40 and Ad41 (van Loon e t  a l . ,  1987b; Ishino
e t  a l . ,  1988; Allard and Wadell, 1988). However, while the
homology of the conserved regions of Ad7, Adl2 and SAV-7 
with the corresponding Ad5 regions is over 60%, the Ad40 and 
Ad41 conserved regions share only 51% and 45% homology with 
Ad5 respectively (van Loon e t  a l . ,  1987b). CR I is least
well conserved (Allard and Wadell, 1988; Ishino e t  a l . ,
1988) but CR II and CR III also share lower homology with 
Ad5 than do other serotypes. CR III is the trans-activating 
domain of the E1A protein and differences in this sequence
may account for the low trans-activating function of Ad40 
and Ad41 E1A compared to E1A products of Ad5 and Adl2.
Although this may partly explain the restrictive growth of
the enteric adenoviruses in tissue culture other factors are 
likely to be involved as well. A comparison of E1B protein 
sequences shows that both Ad40 E1B ORFs share a higher
homology with Ad5 and particularly Adl2 than the
coresponding E1A ORFs (Ishino e t  a l . , 1988). No strictly
conserved domains have been identified in the E1B proteins 
so the relevance of any sequence differences are difficult 
to assess. Studies on other adenoviruses have shown that 
mutations in both the 19K and 55K E1B proteins affect the
host range of those viruses (see 1.3.4. and 1.3.5.) making 
this region a likely candidate for having a role in the host 
range of the enteric adenoviruses.
1.4.6. The aims of the project
The aim of the work presented in this thesis was to 
investigate the molecular basis for the growth restriction 
of enteric adenovirus 40 in tissue culture. This virus is 
S0verely restricted for grow t. h in most tissue culture 
svstenis. Successful propagation of the viius in KB cell
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lines expressing the El region or only the E1B region of Ad2 
facilitated i n  v i t r o  studies of the virus which had 
previously been limited. This also implicated the E1B 
region of Ad40 in the fastidious growth. Initial studies 
using complementation assays with Ad5/2 and Adl2 El virus 
mutants were consistent with a lack of Ad40 E1B function. A 
study of the Ad40 E1B region was thus undertaken with the 
aim of understanding the basis for the apparant E1B 
deficiency. This involved the analysis of E1B transcription 
and detailed transcription mapping in order to determine if 
the kinetics of E1B transcription or splicing patterns of 
E1B transcripts differed from that of other serotypes. 
Moreover, the activity of the E1B promoter and response to 
E1A trans-activation was investigated. In addition several 
cell lines were tested for their ability to support Ad40 
replication in the absence of a complementing adenovirus 
function in order to provide a system more analogous to the 
i n  v i v o  growth of the virus.
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2. MATERIALS
2.1. Viruses
Adenovirus 40 strain Dugan was obtained from Dr. J. de 
Jong as a low passage seed stock (de Jong e t  a l . , 1983). It 
was propagated in KB16 cells (see 2.2.); preliminary 
experiments were done using passage 3-5 virus stocks while 
later experiments used p9 of the virus.
Table 2 lists Ad5, Ad2 and Adl2 El mutants used. The 
mutations in dl309 are also present in the Ad5 El mutants 
and Ad2 E1B mutants. Adl2 mutant viruses and wild type were 
obtained from Dr. Phil Gallimore (Breiding e t  a l . ,  1988; 
Byrd e t  a l . ,  1988; Edbauer e t  a l . , 1988):
Table 2
Type Mutant Mutation Protein Reference
Ad 5 dl309 Lacks Xbal sites 
at 29 and 79 mu. 
83-85 mu. deleted
E3 proteins 
deleted
(1)
Ad 5 dl312 nt 448-1349 
deleted
E1A proteins 
not made
(1),(2)
Ad 5 dl313 nt 1334-3639 
deleted
E1B and ppIX 
not made, E1A 
truncated
(1) , (2)
Ad2/5 pm 17 2 2 G4A at nt 1722 E1B 19K not 
made, 55K ORF 
not affected
(3)
Ad2/5 dll520 C->T at nt 2022 
nt 2496-3323 
deleted
E1B 55K&15K not 
made, 19K ORF 
not affected
(3)
Adi 2 hr700 G4A at nt 949 E1A 12S and 13S 
products Asp 
Asn in CR III
(4)
Adl2 in602 Insertion of 8bp at 
nt 2247, frameshift.
E1B 55K trunc­
ated
(4)
Adi 2 dl620 nt 2127-2823 deleted 
inframe.
E1B 55K altered (4)
Ad 12 pm700 ATG4ATC at nt 154 3 E1B 19K not 
made
(5)
(1) Jones and Shenk (1979).
(2) Ross e t  a l . ,  (1980).
(3) Barker and Berk (1987).
(4) Breiding e t  a l . , (1988)
(5) Edbauer e t  a l . ,  (1988).
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2.2. Cells
- KB16 cells, expressing Ad2 E1A and E1B products (Babiss e t
a l ., 1983) were used for the propagation of Ad40. They
will be referred to here as KBa+b cells.
- 293 cells, expressing Ad5 E1A and E1B products (Graham e t
a l .  t 1977) were used for the propagation of Ad2/5 and 12
El mutants.
- Hela cells, a current laboratory stock was used for virus
infections.
- WS Hela cells (originally from Dr. W. Schaffner, Zurich),
were used for transient assays.
- Tera-2 C13: cloned human teratoma cells (Thompson e t  a l .,
1984), obtained from Dr. R. Everett.
- E J : Human bladder carcinoma cells, obtained from J. Lang,
the Beatson Institute.
- HT29: Human colon adenocarcinoma cells, obtained from Dr.
C. Parasceva, Bristol.
- Human pancreatic carcinoma cells were obtained from A.
Grant, St. Georges Hospital (Grant e t  a l ., 1979).
- A549: Human lung carcinoma cells, obtained from the
European Collection of Animal Cell Cultures (ECACC).
- Int407: Human embryonic intestinal cells, epithelial,
obtained from the ECACC.
- A431: Human squamous carcinoma cells, obtained from Dr. J.
Jaukroger, Glasgow Vet. School.
2.3. Bacteria
The following strains of E.  c o l i  K12 were used:
- DH1 [recAl, endAl, thi-1, hsdR17, supE44, gyrA96, (Nalr ),
relAl] (Hanahan 1983) , was used as a host for CAT gene 
plasmid constructs.
- GM4 8 [dam-6, dam-3, galT22, dral4, lacyl, thr-1, leu-6,
tonA31, tsxA78, supE44], (Marinus, 1973), was used as a 
host to prepare unmethylated plasmid DNA.
- JM109 [F ', traD36, proA+ , proB+ , laclq , lacZSMl5/recAl,
endAl, gyrA96, (Nalr ), hsdR17, supE44, relAl, 6(lac- 
proAB), micA], (Yanisch Perron e t  a l . ,  1985), was used as
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a host for all other plasmids throughout this work.
- NM522 [recA* (supE, thi, 6(lac-proAB), hsd5, {F', proAB, 
lacl0 , lacZ5M15})], (Gough and Murray, 1983), was the 
host strain used for M13 bacteriophage.
2.4. Cloning vectors
- pUC8 (Vieira and Messing, 1982) was used for cloning of 
double stranded cDNA.
- M13 bacteriophage vectors (Messing and Vieira, 1982) 
were used for the production of single stranded DNA for 
sequencing. PCR amplified cDNA was cloned into the double 
stranded replicative form of M13mp8 (obtained from A. 
Dolan).
2.5. Plasmids
The following plasmid constructs were generously provided 
by N. Mackay; the Ad40 El plasmids were all derived from 
pAA12 (van Loon e t  a l . ,  1985) which consists of the ClalB 
fragment of Ad40 (nt. 1-3933), by subcloning into pTZ18
vectors (Mautner e t  a l . , 1989, 1990):
- pNM80: Ad40 E1A, nt 1-1643
- pNM81: Ad40 E1B, nt 1643-3933
- pNM82: Ad40 El, nt 1-3933
- pNM83: Ad40 E1A, nt 1-1211
- pNM86: Ad40 E1B 3'end, nt 2857-3928
- pNM87: Ad40 E1B 5'end, nt 1643-2857
- pNM90: Ad2 E1A, nt 1-1569
- pNM92: Ad2 E1B, nt 1569-3322
- pAscl0.3: Adl2 El (SallC. fragment) was obtained from 
Dr. P.J. Byrd (Byrd e t  a l . ,  1982).
The following plasmids were a gift from Dr. C. Herrmann, 
Cold Spring Harbor:
- pLElA: Ad5 E1A, nt 1-1704 in pAT153 vector (Dery e t
a l . ,  1987)
0 5
pMT'.L 3S E1A 13S cDNA sequences under the control of the 
mouse metal lothionein-1 promoter in pAT'153 vector (Zerler e t
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a l . ,  1986)
- pElB-CAT: Ad5 E1B promoter, nt 1336-1702, upstream of 
the CAT gene in a pXf3 derived plasmid vector (Dery e t  a l . ,
1987).
2.6. Oligonucleotides
The oligonucleotides described below were used in this 
study. They all include Ad40 DNA sequences and were made by 
reference to the DNA sequence published by van Loon e t  a l .  
(1987). The nucleotide numbers refer to that sequence; R 
and L refer to the rightward and leftward reading strands; 
lower case sequences are linker sequences including cloning 
sites. Oligonucleotides were synthesised by Dr. J. 
McLauchlan on a Biosearch 8600 DNA Synthesiser by trityl-on 
synthesis and purified on OPC cartridges.
Table 3
Oligo n t . str. Sequence
VS1 1548-1528 L 5'CTCCTTAGCTCTATAGATTAC3'
VS4 3287-3267 L 5 ’CGGGTTGTCAGATATGGGCTA3'
VS5 3380-3400 L 5'CCGACGATCCAATAGTGGCGT3*
VS6 3000-3020 R 5'GAGTCAAAGGTTCGTTGTCGC 3'
VS9 1368-1385 R 5 1ctgcagctcgaGTGGGTATATAAGCAGGT3’
VS10 1352-1369 R 5'ctgcagctcgagTTTCTTGGGCGTGTTTGT3*
VS11 1298-1315 R 5'ctgcagctcgagCCAAGTGCTCCTGAGATC3'
VS12 1056-1074 R 5 ’ctgcagctcgagAACAAGAGTTAACGACTT3’
VS13 1411-1395 L 5 ’ctgcagaagcttGAATAAACTAACACTAA3'
VM40 567-586 R 5'TTCCCTGAACCTTCTGAGGC3’
RU3 1719-1736 R 5'gggctgcagatetATGGAGCGCCCAAACTCA3’
RU4 3129-3149 L 5'gggctgcagatctTTAATCCTCATCGCTGGATTC3
2.7. Reagents
Most chemicals were purchased from BDH Chemicals, UK or
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Sigma Chemical Co. and were of analytical grade. Otherwise, 
Bio-Rad Laboratories supplied ammonium persulphate and
TEMED; Koch-Light Laboratories supplied acrylamide and boric 
acid; Melford Laboratories supplied caesium chloride; 
Amersham supplied Hybond-N nylon membranes, and Zeta probe 
blotting membranes were obtained from Bio-Rad. Ultrapure 
dNTPs, T7 DNA sequencing kit and Oligolabelling kit were 
purchased from Pharmacia. DOTMA (transfection reagent) was 
supplied by Boehringer-Mannheim; RNasin (ribonuclease 
inhibitor) was purchased from Promega; RNA ladder (molecular 
weight marker) and Diethylpyrocarbonate (DEPC) were
purchased from Bethesda Research Laboratories (BRL). Wacker 
Chemical Co. supplied Wacker Silane GF38; NuSieve GTG 
agarose was supplied by FMC Bioproducts; Formamide and
formaldehyde were supplied by Fluka; Methylmercury was from 
Alpha Products (W. Germany). TMPD and Xylenes were supplied 
by Aldrich Chemical Co. OPC cartridges were purchased from 
Applied Biosystems.
2.8. Radiochemicals
Radioisotopes were supplied by Amersham at the following 
specific activities;
- 5 ’[a-32P]dNTPs, 3000 Ci/mmol (10pCi/ul)
- 5' [ /-3 2 P]ATP, 5000 Ci/mmol (10pCi/ul)
- 14 C Chloramphenicol, 45 mCi/mmol, was obtained from NEN 
DuPont
2.9. Enzymes
Restriction enzymes were supplied by Bethesda Research 
Laboratories (BRL), Boehringer-Mannheim and Northumbrian 
Biologicals Ltd. (NBL). Klenow fragment DNA polymerase 
(LFP), Poll DNA polymerase, SI nuclease, T4 ligase and MMLV 
reverse transcriptase were obtained from BRL; AMV reverse 
transcriptase was from Life Sciences; RNase free DNase was 
purchased from Promega; AmpliTaq DNA polymerase was obtained 
from Pei: kin Elmer Cetus; Calf Intestinal Phosphatase (CIP)
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was supplied by Boehringer-Mannheim and T4 kinase by NBL.
2.10. Tissue culture media
Most cell types were grown in Dulbecco's modified eagle 
medium (DMEM), without sodium pyruvate, with 4500 mg/1 
glucose (Gibco). Medium was supplemented with lOOIU/ml 
penicillin, 100 pg/ml streptomycin, 4mM L-glutamine and 5% 
foetal calf serum (FCS) for Hela cells and KBa+b cells or 
10% FCS for other cell types.
WS Hela cells were grown in DMEM, with sodium pyruvate, 
with 1000mg/l glucose, supplemented with lOOIU/ml penicil­
lin, 100 ug/ml streptomycin, 4mM L-glutamine and 5% FCS.
Pancreatic carcinoma cells were grown in Ham's F-12 
medium (Flow Laboratories), supplemented with lOOIU/ml peni­
cillin, lOOpg/ml streptomycin, 4mM L-glutamine and 10% FCS.
2.11. Bacterial culture media
NM522 cells were grown in 2YT broth, all other strains 
were grown in L-broth. Media was supplemented with 
ampicillin (50yg/ml) and chloramphenicol (200jig/ml) where 
appropriate. Agar plates contained 1.5% (w/v) agar in L-
broth.
- L-broth: 177mM NaCl, 10g/l Difco Bactopeptone, 5g/l 
yeast extract (pH7.5 prior to sterilization).
- 2YT broth: 85mM NaCl, 10g/l Difco Bactotryptone, 10g/l 
yeast extract.
- Top agar: 1% (w/v) agar in water.
2.12. Solutions
- lOxBlunt end kinase buffer: 500mM Tris-HCl pH9.5, lOOmM
MgCl2 , 50mM DTT, 50% glycerol
- 50xDenhardt's solution: 1% (w/v) BSA, 1% (w/v) Ficoll, 1%
(w/v) Polyvinyl pyrollidine
- IOx EM buffer: 50mM Sodium borate, lOOmM Sodium sulphate,
lOmM EDTA, J50mM Boric acid
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- Formaldehyde loading buffer: 50% glycerol, ImM EDTA pH8.0,
0.25% (w/v) Bromophenol blue, 0.25% (w/v) Xylene
cyanol
- Formamide dyes: 98% (v/v) formamide, 2% (v/v) 0.5M EDTA
pH8.0, 0.1% (w/v) Xylene cyanol, 0.1% (w/v)
Bromophenol blue
- GSCN buffer: 4M Guanidinium thiocyanate, 5mg/ml Sarcosine,
0.1M 3~mercaptoethanol, 0.33% (v/v) Antifoam A, 50mM 
Tris-HCl pH7.5, 2mM EDTA pH8.0
- Hirt buffer: lOmM Tris-HCl pH7.9, lOmM EDTA, 0.6% (w/v)
SDS
- Hybridization buffer: 80% (v/v) formamide, 400mM NaCl,
40mM Pipes pH6.4, ImM EDTA
- 5xKinase buffer: 350mM Tris-HCl pH7.5, 50mM MgCl2 , 25mM
DTT
- 5xLigase buffer: 250mM Tris-HCl pH7.6, 50mM MgCl2 , 5mM
DTT, 5mM ATP, 25% (w/v) polyethylene glycol-8000
- Lysis buffer: 50mM Tris-HCl pH8.0, lOOmM NaCl, 5mM MgCl2 ,
0.5% (v/v) Nonidet P-40
- lOxMOPS: 180mM MOPS [3-(N-morpholino)-propanesulfonic
acid] pH7.0, 50mM sodium acetate, lOmM EDTA pH8.0
- IOxNT buffer: 500mM Tris-HCl pH7.8, 50mM MgCl2 , lOmM DTT
- PBS: 137mM NaCl, 2.7mM KC1, 4.3mM Na2HPO< , 1.4mM KH2PO<
(pH "7.3),.
- IOx PCR buffer: lOOmM Tris-HCl pH8.3, 500mM KC1, 15mM
MgCl2 , 0.01% (w/v) gelatin
- Phenol/chloroform: 1:1 mixture of phenol equilibrated in
TE, and chloroform
- Potassium acetate solution: 3M Potassium acetate, 11.5%
(v/v) Acetic acid
- IOx RT buffer: 500mM Tris-HCl pH8.0, 50mM MgCl2 , 50mM DTT,
500mM KC1, 500 pg/ml BSA
- SI buffer: 250mM NaCl, 30mM Sodium acetate pH4.6, ImM
ZnS04
- Sample buffer: 50% (w/v) Sucrose, 0.1M EDTA pH8.0, 0.2%
(w/v) Bromophenol blue
- SOB: 2% (w/v) Bactotryptone, 0.5% (w/v) yeast extract,
iOrnM NaCl, 2. 5rnM KC1, lOrnM MgCl2 , 1 OmM MgSO«
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SOC: 20mM glucose in SOB
20xSSC: 3M NaCl, 0.3M tri-Sodium citrate (pH7.0)
20xSSPE: 3M NaCl, 0. 2M NaH2 P04 , 0.02M EDTA (pH7.4)
TBE: 90mM Tris, 90mM Boric acid, ImM EDTA (pH8.3)
TE: lOmM Tris-HCl pH8.0, ImM EDTA 
TEN: lOOmM NaCl, 50mM Tris-HCl pH7.5, lOmM EDTA 
TFB: lOmM MES, lOOmM RbCl, 45mM MnCla, lOmM CaCl2 , 3mM 
hexamine cobaltic chloride 
TS: 140mM NaCl, 30mM KC1, 280mM Na2HP04 , lmg/1 glucose, 
0.001% (w/v) phenol red, 25mM Tris-HCl pH7.4,
lOOU/ml penicillin, lOOpg/ml streptomycin 
Versene: 0.6mM EDTA in PBS, 0.002% (w/v) phenol red
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3. METHODS
3.1. Eucarvotic cell culture
Cells were routinely passaged at 80% confluency in 80cm2 
or 175cm2 flasks (Nunclon). They were harvested by washing
twice in versene, resuspended in fresh medium and incubated 
in an atmosphere of 95% air/5% CO2 at 37°C. For storage, 
cells were resuspended at approximately 107 cells/ml in
storage medium (70% growth medium, 10% glycerol, 20% FCS), 
and aliquots frozen slowly to -140° C. For recovery, cells 
were thawed at 37°C and resuspended in growth medium.
3.2. Virus preparation
Ad40 seed stocks were prepared by infecting subconfluent 
monolayers of KBa+b cells on 50mm plates with 0.1ml of a 
1/10 - 1/40 dilution of virus stock in T S . Virus was 
allowed to absorb for 1 hr at 37°C before the addition of 
infection medium (5ml DMEM/0.5% FCS per plate). Plates were 
incubated 3-5 days at 37°C until cpe was apparent. Cells 
were harvested by scraping into the medium, pelleted at
l,000rpm/5 min in an MSE coolspin centrifuge and resuspended 
in 0.2ml TS/plate. Virus was released by three rounds of 
freezing and thawing (-70°C/37°C) , followed by centrifuga­
tion (2,000rpm/10 min) to remove cell debris. The superna­
tant, containing the virus, was stored at -20°C. Seed 
stocks of other serotypes were prepared in the same way by 
infecting 293 cells with O.lpfu/cell; stocks were titrated 
by a plaque assay on 293 cells (Williams, 1970). Ad40 does 
not form plaques under any conditions tested so far; yield 
of Ad40 virus stocks was estimated by restriction digest 
analysis of viral DNA.
3.3. Preparation of viral DNA
DNA was prepared from crude harvested virus by incubating 
virus suspension 2 hr/37°C in the presence of Proteinase K 
at lOOpg/ml and 0.1% (w/v) SDS. The reaction mix was then
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extracted with an equal volume of phenol/chloroform, 
followed by a chloroform extraction. Finally, the DNA was 
concentrated by ethanol precipitation in the presence of 
0.3M sodium acetate pH5.5 and lyg tRNA carrier.
3.4. Preparation of whole cell RNA
Total RNA was harvested by a modification of the 
guanidinium thiocyanate method (Chomczynski e t  a l . ,  1987), 
from cell monolayers on 50mm plates. Medium was removed and 
cell monolayers lysed directly by adding 200ul GSCN buffer 
onto the plates. The harvest was transferred to Eppendorf 
tubes and sequentially 1/10 vol. water saturated phenol and 
1/5 vol. chloroform/isoamyl alcohol (49:1) were added to the 
cell lysate with thorough mixing after the addition of each 
reagent. The final mixture was incubated on ice for 15 min 
and centrifuged 12,000rpm/10 min. The aqueous phase was 
precipitated with an equal volume of isopropanol 1 hr/-20°C, 
centrifuged, the pellet resuspended in GSCN buffer and the 
isopropanol precipitation repeated. After centrifugation 
the pellet was resuspended in 0.3M sodium acetate pH7.0 and 
ethanol precipitated. Prior to analysis the RNA was pel­
leted by centrifugation 12,000rpm/10 min and resuspended in 
water. The concentration of RNA was determined by spectro­
photometry (see 3.7.).
3.5. Preparation of cytoplasmic RNA
Cytoplasmic RNA was isolated from cell monolayers on 50mm 
plates as described (Ausubel e t  a l ., 1987). Reagents were 
either treated with DEPC or made up in DEPC. treated water to 
prevent RNase activity, and cells and reagents were kept on 
ice. Monolayers were washed three times with PBS, cells 
harvested into 1ml PBS, the harvest from 3 plates pooled, 
pelleted by centrifuging l,000rpm/5 min/4°C (Sorvall 
benchtop centrifuge) and resuspended in 375pl lysis buffer 
(see 2.12.). After incubation on ice for 5 min nuclei were 
pelleted 12.000rpm/2 min/4°C and frozen at -70°C. The
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supernatant was made 0.2% in SDS and extracted twice with 
phenol/chloroform/isoamyl alcohol (25:24:1) and once with 
chloroform/isoamyl alcohol (24:1) prior to ethanol precipi­
tation. Before analysis, the RNA was pelleted by centri­
fugation 12,000rpm/15 min/4°C, washed with 75% ethanol/25% 
0.1M sodium acetate and resuspended in DEPC treated water. 
RNA concentration was determined by spectrophotometry.
3.. 6. Preparation of intranuclear viral DNA
Nuclei were isolated as described above (see 3.5) and DNA 
was extracted by a modification of the Hirt procedure (Hirt
1967). The nuclear pellet was resuspended in 40yl TE, 20
volumes Hirt buffer added and incubated 10 min at room 
temperature, 1/5 vol 5M NaCl was added, mixed and left on 
ice at 4° C overnight. Lysed nuclei were spun 15,000rpin/30 
min in SS34 rotor and the supernatant incubated with 0.1 
mg/ml RNase A for 1 hr/37°C and 0.1 mg/ml Proteinase K for 3
hrs/37°C. The lysate was subsequently extracted with
phenol/chloroform and chloroform and concentrated by ethanol 
precipitation.
3.7. Quantitation of nucleic acids
The concentration of nucleic acids was determined by the 
optical density (OD) at 260nm using a Beckman DU-62 spec­
trophotometer .
Values used:
OD2 6 0 of 1 = 50yg/ml - for double stranded DNA 
40yg/ml - for RNA 
20yg/ml - for oligonucleotides 
The purity of a nucleic acid preparation was assessed 
from the ratio of absorbance at 260nm/280nm, a pure DNA 
preparation having a ratio of 1.8 and a pure RNA sample 
having a ratio of 2.
The molar concentration of oligonucleotides was deter­
mined directly as OD2 6 0 /EM (molar extinction coefficient)
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Em = A(16,000) + 0(12,000) + C(7,000) + T(9,600)
Em is the optical density of a 1M solution of the oligomer 
determined at 260nm (Tullis e t  a l . , 1989).
3.8. Radioactive labelling of DNA
3.8.1. Nick translation:
100-200ug plasmid DNA was radiolabelled (Rigby et al., 
1977) in IxNT buffer with 40ug/ml gelatin, two dNTPs at 40mM 
and 25yCi [a32P]dNTP of the other two. The reaction mix was 
incubated at 37°C for 10 min with DNasel (0.2yg/ml) and sub­
sequently 2U E.  c o l i  DNA Poll was added and incubated at 
14°C/2 hrs. Labelled DNA was separated from unincorporated 
nucleotides by fractionation on a 5ml G-50 Sephadex column, 
after the addition of 1/5 vol sample buffer. Probes 
prepared by this method generally had a specific activity of 
Ixl07_lxl08 cpm/yg.
3.8.2. 5'end labelling:
In order to prepare 5'end labelled probes for SI mapping, 
the appropriate restriction fragments were isolated and 
20pmol DNA termini treated with 0.5U calf intestinal phos­
phatase (CIP) in lOOyl final volume of 20mM Tris-HCl pH8.0, 
ImM MgCl2 and ImM ZnSCL at 37°C/30 min. The phosphatase was 
removed by phenol/chloroform and chloroform extraction, the 
sample ethanol precipitated and resuspended in water at 
lpmol/yl. A labelling reaction contained 15yl of lxkinase 
buffer, lOOyCi [^-32P]ATP, lpmol DNA and 5U T4 poly­
nucleotide kinase. After incubation, 37°C/45 min, the 
reaction mix was ethanol precipitated with lyg tRNA carrier 
in the presence of 2M ammonium acetate, and reprecipitated 
in 0.3M sodium acetate. The final pellet was washed with 
70% ethanol and resuspended in 20yl H*0.
Oligonucleotides were 5 ’end labelled in the same way 
using 25yCi [tf-32P]ATP/25ng oligonucleotide, without a prior 
phosphatase treatment. Alternatively, lOpmol oligonucleo­
tide was 5 ’end labelled in 20yl Ixblunt end buffer, 50yCi
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[l(-32 P] ATP and 10U T4 kinase at 37° C/2 hrs. The reaction 
was precipitated in the presence of 4M ammonium acetate for 
30 min on ice and pelleted at 12,000rpm/20 min. The pellet 
was washed in 70% ethanol and resuspended in water.
3.8.3. 3'end labelling:
DNA was 3' end labelled by the method of Ausubel e t  a l . ,  
(1987). Restriction fragments with overhanging 5 * ends were 
isolated and 3'end labelled for use as probes in SI mapping. 
For each restriction site to be labelled, the base comple­
mentary to the first unpaired base was added on using Klenow 
fragment DNA polymerase. The 10yl reaction mix included 
200ng DNA restriction fragment, 50mM Tris-HCl pH8.0, lOmM
MgCl2 , 50mM NaCl, 40yCi of the appropriate [a-32P]dNTP and
1U Klenow. After incubation 15 min/30°C the reaction was
stopped by adding lyl 0.5M EDTA and precipitated as 
described for 5 ’ end labelled fragments.
3.8.4. Random priming:
An oligolabelling kit from Pharmacia was used to make 
specific probes by the random priming method (Feinberg and 
Vogelstein, 1983). Restriction fragments (50ng), isolated 
from NuSieve agarose gels (see 3.10), were denatured by
boiling and flash cooling and incubated with the reagent mix 
provided, 50pCi [a-32P]dCTP and 1U Klenow in 50pl at 37°C/1 
hr. The reaction mix was made up to lOOpl in TE, loaded 
onto a 1ml G-50 spun column and centrifuged at 2.000rpm/10 
min. The flowthrough, containing labelled probe was 
collected, while unincorporated 32PdCTP remained on the 
column. The specific activity of probes prepared by this 
method was generally around lxlO8cpm/pg.
3.9. Gel electrophoresis
3.9.1. Agarose gels:
For the separation of DNA fragments agarose gels were run 
in BRL gel electrophoresis kits at 150 volts, submerged in
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lxTBE buffer at room temperature. A 100ml gel slab contained 
0.8 - 2% (w/v) agarose, lxTBE buffer and 0.5yg/ml ethidium 
bromide. One tenth volume of sample buffer was added to 
samples prior to electrophoresis. For the isolation of DNA 
fragments NuSieve GTG agarose was used at a concentration of 
2 -4% (w/v).
Formaldehyde gels for the separation of RNA contained 
1.2% agarose in lxMOPS and 3% (v/v) of 37% formaldehyde.
RNA samples in 50% formamide, 17.5% (v/v) 37% formaldehyde 
and lxMOPS were incubated at 55°C/15 min and 1/5 vol formal­
dehyde loading buffer added to each sample prior to loading 
on gel. Gels were run submerged in lxMOPS at 120 volts for 
2V2 hrs in a fume hood.
Methyl mercury gels for RNA analysis contained 1% agarose 
and 5mM methyl mercury in 100ml lxEM buffer. Prior to
electrophoreses, samples were mixed with an equal volume of
2x RNA sample buffer (20% glycerol, 0.05% (w/v) bromophenol 
blue, in 2xEM buffer) and a 1/10 vol of 0.1M methyl mercury. 
Gels were run in a fume hood, nonsubmerged at 80 volts with 
lxEM buffer recycled from the catjode to the anode.
3.9.2. Denaturing acrylamide gels:
For separation of DNA fragments from SI analysis and 
primer extension assays 5% gels were made from a 30% stock 
of 29:1 acrylamide / N ,N 1-methylene-bis-acrylamide, with 7M 
urea in lxTBE buffer. They were polymerized by adding TEMED 
(0.7pl/ml) and 1/150 volume 10% ammonium persulphate (APS).
For DNA sequence analysis 6% gels were made from a 40% 
stock of 19:1 acrylamide / bis-acrylamide, with 9M urea in 
0.5xTBE buffer. They were polymerized by the addition of 
TEMED (1.7yl/ml) and 1/600 volume 25% APS.
The gels (0.35mm x 230mm x 450mm) were prerun at 40W for 
1 hr prior to loading samples. Samples were denatured by 
boiling in 0.3-lx formamide dyes and run at 40W in lx or 
0.5xTBE for the appropriate length of time. After electro­
phoresis, gels were either fixed in 10% acetic acid/45% 
methanol for 30 min and dried for 2 hrs/80°C or wet gels
were exposed directely to XS film at -70°C for autoradi-
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ography. For drying gels one gel plate was pretreated with 
0.1% (v/v) Waker silane GF38/0.3% (v/v) acetic acid in
ethanol to allow adhesion of the gel to the plate.
3.10. Recovery of DNA from agarose gels
Agarose gels containing 0.5 pg/ul ethidium bromide were 
briefly exposed to long wave UV light to visualize DNA and a 
small slice containing the DNA fragment of interest cut out 
of the gel. The DNA was electroeluted onto dialysis 
membrane in 0.5xTBE buffer for 2 hrs at 100 volts, recovered 
by washing the membrane in buffer and concentrated by 
ethanol precipitation. DNA was retrieved from NuSieve GTG 
agarose gel slices by hot phenol extraction. 2x (v/w) TE 
was added to the gel slice and melted at 65°C/10 min. One 
volume phenol at 65°C was added, vortexed lmin and spun 
12,000rpm/5 min. Phenol extraction was repeated, followed 
by a chloroform extraction and ethanol precipitation.
3.11. Cloning of DNA fragments
DNA fragments made by the polymerase chain reaction (see 
3.18.) were used for cloning. Where restriction sites were 
included in the primers comprising the ends of the DNA 
fragments, these were used as cloning sites. Fragments 
without restriction sites were cloned by blunt end ligation.
3.11.1. PCR products without restriction sites were cloned 
into M13mp8 RF for sequencing. DNA fragments were isolated 
from a NuSieve agarose gel by hot phenol extraction (see
3.10. above), kinased in lxkinase buffer, ImM ATP and 20U T4 
kinase for 1 hr/37°C, phenol/chloroform and chloroform
extracted and ethanol precipitated. The M13 vector was 
digested with Smal in the presence of CIP. A lOpl ligation 
mix consisted of lxligase buffer, 1U T4 ligase, 20ng 
Smal/CIP treated M13 and approximately 25ng PCR product 
(1/10 of isolated fragment). The reaction was incubated at 
15°C overnight and 5pl used to transform NM522 bacteria.
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3.11.2. PCR products containing PstI cloning sites were 
cloned into pUC8. Fragments were isolated as before and 
digested with PstI, and pUC8 was digested with PstI in the
presence of CIP. Samples were extracted with phenol/-
chloroform and chloroform and ethanol precipitated after 
restriction digest. Ligations were carried out as above 
with a 20pl ligation mix containing 1/5 of isolated PCR 
product and 20ng Pstl/CIP treated pUC8, and the total 20pl 
was used to transform JM109 bacteria.
3.11.3. PCR products containing Hindlll and Xhol restriction 
sites were cloned into the Hindlll and Xhol sites of pElB- 
CAT (see 4.3.1.). The plasmid was digested with Hindlll and 
Xhol in the presence of CIP to remove the original insert, 
and the backbone isolated from NuSieve agarose gel as
described above. The PCR reaction mix was diluted 1 in 5 in
lx restriction-buffer b (Boehringer-Mannheim), digested with 
Hindlll and Xhol, phenol/chloroform extracted and ethanol 
precipitated. Ligations were carried out as before in 20pl 
lxligase buffer with 1U T4 ligase, 1/10 PCR product and 
lOOng E1B-CAT backbone. Half of the ligation mix was used 
to transform DH1 cells.
3.12.Transformation of E.  c o l i  with plasmid DNA
3.12.1. Calcium chloride method (Cohen e t  a l ., 1973):
An overnight culture of bacteria (1ml) was diluted into 
50ml L-broth and shaken at 37°C until an ODe30 of 0.3-0.4 
had been reached. The bacteria were then pelleted at 
2,000rpm/10 min/4°C, resuspended in 50mls ice cold 30mM 
CaCl2 , pelleted, resuspended again in 50mls 30mM CaCl2 and 
left on ice for 20 min. After further centrifugation the 
pellet was resuspended in 1ml 30mM CaCl2 . A ligation mix 
(or lOOng plasmid DNA) was incubated with 200pl cell 
suspension on ice for 30 min. Cells were heat shocked at 
42°C/2 min and incubated shaking at 37°C/1-2 hrs after the
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addition of 800pl L-broth. The bacteria were then plated 
out on L-broth agar plates (containing ampicillin where 
appropriate) and incubated overnight at 37°C.
3.12.2. Hanahan method (Hanahan, 1983):
50yl overnight culture of bacteria was incubated with 
6.5ml SOB at 37°C until an ODs30 of 0.4 was reached. After 
standing on ice for 15 min the bacteria were pelleted at
2,500rpm/12.5 min/4°C, resuspended in 2ml TFB, on ice for 15
min and the centrifugation repeated. The pellet was taken
up in 0.5ml TFB with sequential addition of 17.5pl DMSO (5 
min on ice), 17.5pl 2.25M DTT in 40mM MES pH6.2, (10 min on
ice), 17.5pl DMSO, (5 min on ice). A ligation mix (or lOOng 
plasmid DNA) was incubated with 200pl cell suspension on
ice/30 min, heat shocked 42°C/90 sec, incubated 37°C/1 hr
after the addition of 800pl SOC and plated out as before.
3.13. Small scale plasmid DNA preparation
Miniprep DNA for the analysis of bacterial colonies was 
prepared by alkaline lysis. A single bacterial colony in
5ml L-broth was allowed to grow to saturation. 1.5ml cell 
suspension was centrifuged 12,000rpm/20 sec in a microfuge, 
pellet resuspended in lOOpl TE at room temperature for 5 
min, followed by the addition of 200ul 0.2N NaOH/1% SDS and 
incubation on ice for 5 min. After the addition of 150pl 
potassium acetate solution (see 2.12) the mix was vortexed
for 2 sec, placed on ice for 5 min and centrifuged 
12,000rpm/l min to pellet cell debris and chromosomal DNA.
Plasmid DNA was precipitated by adding 0.9ml 100% ethanol to
the supernatant and incubating for 2 min at room tempera­
ture. After centrifugation 12,000rpm/l min the pellet was 
washed with 70% ethanol, resuspended in 20pl TE and 5pl used 
for further analysis by restriction enzyme digest.
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3.14. Large scale preparation and purification of plasmid 
DNA
A 10ml overnight culture of bacteria was diluted to 
400ml in L-broth containing the appropriate antibiotic and 
incubated shaking at 37°C ur il the ODe30 was between 0.6 
and 0.8. An aliquot was taken at this stage for storage as 
glycerol stock. A glycerol stock was made by diluting an 
aliquot of culture 1:1 in 60% L-broth/40% glycerol, and 
stored at -70°C. To the rest of the culture chloramphenicol 
was added to a final concentration of 2 0 0 pg/ml and the
culture incubated shaking overnight. The cell suspension 
was pelleted (Sorvall GS3 rotor) 7,000rpm/10 min, drained
and resuspended in 2ml sucrose solution (250mM sucrose, 2mM
MgCl2 , 50mM Tris-HCl pH8.0) and lysozyme added to 4pg/ml 
final concentration. After leaving at room temperature for 
30 min, 800pl of 0.25M EDTA pH8.0 and 3.2ml Triton solution 
(0.5% Triton, 62,5mM EDTA pH 8 .0, 50mM Tris-HCl pH8.0) were 
added and left at room temperature for a further 15 min. 
The suspension was centrifuged 17,000rpm/40 min/4°C (Sorvall 
SS34 rotor) and the supernatant subjected to equilibrium 
centrifugation on a caesium chloride gradient. A 6ml sample 
consisted of 3.5ml DNA supernatant, 250pl ethidiurn bromide 
(lOmg/ml) and 4.5g CSCI2 , made up to 9.3g in TE. After 
centrifugation at 40.000rpm/18 hr/15°C (Dupont TV865 rotor), 
the lower band on the gradient, containing the banded
plasmid DNA, was isolated and extracted with isopropanol to 
remove ethidiurn bromide, dialysed vs TE for 2 hr/4°C and
incubated with RNase A (lOOpg/ml) 1 hr/37°C and Proteinase K 
(lOOpg/ml)/1% SDS, 1 hr/37°C. After one phenol/chloroform
and two chloroform extractions the DNA was concentrated by 
ethanol precipitation.
3.15. Transformation of bacteria with M13 phage
For the propagation and isolation of M13 recombinant 
phage M13 replicative form (RF) was introduced into NM522
cells by the method of Bankier e t  a l ., 1987. A single
colony of bacteria was incubated in 100ml 2YT broth until
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OD6 3 0 reached 0.3-0.4, when cells where pelleted at 
2,000rpm/10 min/4°C and resuspended in 2.5ml TFB. The 
suspension was left on ice for 15 min followed by the 
sequential addition of lOOyl DMSO (5 min on ice), lOOyl 
2.25M DTT/0.04M potassium acetate pH6.0 (10 min on ice) and
lOOyl DMSO (5 min on ice). The ligation mix was incubated 
with 200yl cell suspension on ice for 45 min, heat shocked 
at 42°C/3 min, mixed with 3ml top agar and plated onto L- 
broth agar plates. Top agar included 50yl X-gal (2% 5- 
bromo-4-chloro-3-indolyl-3~galactoside in DMF) and 50yl IPTG 
(2.5% isopropyl-3~D-thiogalactopyranoside in H2 O) for 
identification of recombinant M13 by colour. Cells 
containing self ligated M13 will produce p-galactosidase 
which in the presence of IPTG hydrolyses X-gal thus produc­
ing blue plaques, while plaques containing recombinant M13 
remain colourless. After incubation overnight, white plaques 
Were picked for further analysis.
3.16. Preparation of single stranded DNA from M13 recombi­
nant phage
White plaques were picked into 1.5ml of diluted NM522 
overnight culture (1/100 in 2YT) and shaken vigorously at 
37°C/5% hr. Cells were pelleted at 12,000rpm/5 min and 
0.2ml of 20% (w/v) polyethylene glycol/2.5M NaCl added to 
the supernatant to precipitate phage. After leaving 30
min at room temperature, and spinning 12,000rpm/5 min, the 
pellet was resuspended in TE, extracted with phenol and 
ethanol precipitated in the presence of 0.4M sodium acetate. 
The DNA pellet was washed with 70% ethanol and finally 
dissolved in 50yl 0.2xTE, and 4yl used for a sequencing 
reaction.
3.17. DNA sequencing
DNA was sequenced by the dideoxy-chain termination method 
(Sanger e t  a l ., 1977) using a T7 DNA polymerase sequencing 
kit from Pharmacia according to the producers standard
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protocol. Plasmid DNA was denatured prior to sequence
analysis by incubating 5 min at room temperature with 0. 2M 
NaOH in TE, followed by ethanol precipitation in the
presence of 2M ammonium acetate. Denatured plasmid DNA
(2pg) or single stranded M13 DNA (see above) was incubated 
with 1-10 pmol of the appropriate primer at 37°C/20 min in 
annealing buffer. Subsequently, labelling mix (including 
dGTP, dCTP and dTTP), 5pCi [a-32P]dATP and 3U T7 polymerase 
were added to the reaction and left 3-5 min at room 
temperature. 4. 5pl aliquots were then added to four 2.5yl 
stop solutions, each including one ddNTP, and reaction 
allowed to continue at 37°C/5 min. After the addition of 
5ul formamide dye mix the reactions were denatured by
boiling for 1 min and 4yl analysed on 6% denaturing
acrylamide gels.
3.18. Polymerase chain reaction (PC.R)
3.18.1. Automated PCR (Saiki e t  a l . , 1985, Mullis e t  a l .,
1986, Mullis and Faloona, 1987) was used to amplify specific
fragments from a DNA template. A pair of template specific
primers are extended using a thermostable DNA polymerase 
(Saiki e t  a l . ,  1988) in successive rounds of template 
denaturation, annealing of primers and extension, resulting 
in a theoretical 106-107 fold amplification of a DNA 
fragment. A typical 50pl reaction mix consisted of 200pM 
dNTPs, 1U AmpliTaq DNA polymerase, 0.2pM each primer and
template DNA (various amounts, see results) in lxPCR buffer. 
In a 1.5ml eppendorf tube the reaction mix was overlaid with 
50pl liquid paraffin and amplification performed on a Cambio 
thermal cycler. Initial denaturation at 94°C/5-7 min was 
followed by 30 cycles of 94°C denaturation, annealing of 
primers at the appropriate temperature and 72°C extension. 
Reaction times were varied (see results), annealing 
temperature was usually 5-10°C below the Tm of the primers, 
where Tm - 2 [AT] + 4[GC]. Prior to analysis the paraffin
was removed by chloroform extraction and subsequently 1/5 of
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a reaction mix was run on a 1.5-2% agarose gel with 123 
ladder (BRL) as a size marker.
3.18.2. cDNA-PCR
A combination of cDNA synthesis and PCR amplification was 
used for the analysis of splice junctions in cytoplasmic RNA 
essentially as described by Kawasaki and Wang, (1989). Prior 
to cDNA synthesis cytoplasmic RNA was treated with RNase 
free DNase, extracted twice with phenol/chloroform, once 
with chloroform and ethanol precipitated in order to remove 
any residual DNA that might act as a template in a 
subsequent PCR reaction. 5pg cytoplasmic RNA were incubated 
with lyM "downstream" primer, ImM each dNTP, 10U RNasin and 
10U AMV reverse transcriptase in 10pl lxPCR buffer, for 10 
min at room temperature followed by 15-30 min/42°C. The 
reaction mix was boiled 5 min, quickly chilled on ice and 
half or all of the reaction mix used for a PCR reaction. A 
50yl PCR mix included 5-lOpl cDNA reaction mix, 0.2pM 
"upstream" primer, an additional 0.2pM of downstream primer 
and 1U AmpliTaq polymerase in lxPCR buffer, and amplifi­
cation was performed as described above (3.18.1.). A cDNA- 
PCR reaction without RNA template and a PCR reaction on DNA 
template were performed in parallel as controls. All 
reagents were made up and aliquoted using positive displace­
ment pipettes and kept separate from PCR products in order 
to avoid contaminating the reaction mix with amplified DNA 
template.
3.19. SI mapping
SI nuclease analysis was carried out by a modification of 
the method of Berk and Sharp (1977). Restriction fragments 
were isolated by electroelution (see 3.10.) and 3' or 5' end 
labelled (see 3.8) for use as probes. The probes are listed 
in table 4. Both strands on each double stranded fragment 
will be labelled. Approximately 5xl04 cpm probe was freeze 
dried with 50pg total or cytoplasmic RNA from mock infected 
or Ad40 Infected KBa+b cells. The pellet was resuspended in
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20yl hybridization buffer, denatured at 68°C/10 min and 
transferred directly to 55°C/3 hr. Samples were diluted 
tenfold in ice cold SI buffer including 166U SI nuclease 
(BRL) and incubated 42°C/30 min. After ethanol precipita­
tion, protected fragments were resuspended in formamide dye 
mix, denatured by boiling and analysed on 5% acrylamide gels 
using 3' end labelled Hpall fragments of pBR322 as molecular 
weight markers.
Table 4. Restriction fragments used for SI analysis
Size Restr. fraq. Nt. End label Source
579bp Hpal-Bcll 1064-1647 5' pNM82
1022bp BamHI-EcoRI 1849-2857 3' pNM87
475bp Aval-PstI 2938-3410 5' or 3' pNM86
565bp Taql-TaqI 3366-3690 3 ' pNM86
3.20. Primer extension analysis
Primer extension anaysis of RNA from mock infected or 
Ad40 infected cells was performed by the method described by 
Ausubel e t  a l . ,  (1987). Oligonucleotides were 5 ’ end 
labelled and approximately lng annealed to 50yg of total RNA 
at 30°C overnight in 30ul hybridization buffer. The follow­
ing day samples were ethanol precipitated and resuspended in 
reaction mix. A 12.5pl reaction mix including 10U AMV 
reverse transcriptase contained 0.5mM dNTPs and 25U RNasin 
(ribonuclease inhibitor) in lx RT buffer. Alternatively, 
Moloney Murine Leukemia Virus (MMLV) reverse transcriptase 
was used according to the manufacturer's specifications. A 
20yl reaction mix including 200U MMLV reverse transcriptase 
was lOmM DTT and 0.5mM dNTPs in lx buffer (50mM Tris-HCl 
pH8.3, 75mM KC1, 3mM MgCl2 ). Primer extension was carried 
out at 42°C/1-1.5 hr and stopped by the addition of 0.5M 
EDTA followed by treatment with O.lmg/ml RNase A at 37°C for 
30 min. After increasing the volume to 125pl with 2.5M 
ammonium acetate, samples were extracted with phenol/chloro­
form/isoamyl alcohol (25:24:1) and ethanol precipitated. 
Extended products were analysed on 5% denaturing acrylamide 
gels with 3 ’ end labelled pBR322 Hpall fragments as markers,
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or on 6% gels alongside the appropriate sequencing ladders 
(see results).
3.21. Northern blot analysis
3.21.1 Methyl mercury gels
RNA samples were run on methyl mercury gels as described 
(see 3.9.1.) and directly after electrophoresis the RNA was 
blotted onto a Hybond-N membrane in 20xSSC overnight. After 
fixing the blot by exposing to short wave UV light for 4 
min, prehybridization (3-5 hr) and hybridization (overnight) 
were carried out in 50% formamide, SxSSPE, 5xDenhardt's 
solution, 0.5% SDS and O.lmg/ml denatured salmon sperm DNA, 
by incubating at 42° C- in a shaking waterbath. Denatured DNA 
probe, labelled by the random priming method, was included 
in the hybridization mix. Blots were washed at room
temperature in 2xSSC/0.1% SDS for 2x30 min and O.lxSSC- 
/0.1%SDS for 2x30 min and exposed to flashed film with
intensifying screen at -70°C.
3.21.2. Formaldehyde gels
Following electrophoresis (see 3.9.1.), formaldehyde gels 
were equilibrated in 0.5xTBE for 2x10 min and electroblotted 
onto Zeta Probe membrane in 0.5xTBE using a Mini Trans-blot
(Bio-Rad) at 80V/1 hr. The membrane was dried at 80°C under
vacuum and prehybridized and hybridized as described above 
in 50% formamide, 4xSSPE, 1%SDS, 5xDenhardt’s and 0.5mg/ml 
salmon sperm DNA, with nick translated probe included in the 
hybridization mix. Blots were washed at room temperature 
for 15 min in each of the following solutions: 2xSSC/0.1% 
SDS; 0.5xSSC/0.1% SDS; 0.1xSSC/0.1% SDS, and exposed to 
flashed film with intensifying screen.
3.22. Slot blot / Dot blot analysis
DNA was applied directly to Hybond-N using a dot blot or 
a slot blot (Schleicher and Schuell) apparatus. Samples
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were either denatured with 1 vol 1M NaOH (10 min/room tem­
perature) and neutralized with 2 vol 2M ammonium acetate, or 
by boiling for 3 min in 6xSSC and cooling on ice. Membrane 
was presoaked in 1M ammonium acetate or 6xSSC and samples 
applied under vacuum and the wells washed through with 200yl 
presoak solution. Filters were air dried and fixed by 
exposing to short wave UV light for 4 min, and prehybridized 
and hybridized in 50% formamide, 5xSSC, lxDenhardt's and 
lOOug/ml salmon sperm DNA at 42°C. A 32P labelled DNA probe 
was included in the hybridization mix. After hybridization 
blots were washed at room temperature in 2xSSC/0.1% SDS for 
2x30 min and 0.1xSSC/0.1% SDS for 2x30 min and exposed to 
flashed film with intensifying screen at -70°C. DNA 
concentrations were determined from the autoradiographs by 
densitometric analysis using the data system for the Hoefer 
GS-360 scanning densitometer. Within the ranges used there 
was a linear relationship between the amount of DNA present 
and the area under the peak corresponding to the DNA slot/- 
dot on the autoradiograph.
3.23. Transfection of DNA into eucaryotic cells
Plasmid DNA was introduced into WS Hela cells for the 
detection of gene expression from a CAT reporter plasmid by 
CAT assays. WS Hela cells were seeded at a low density on
50mm plates and the next day the subconfluent monolayers
were transfected using DOTMA (N-[1-(2,3-Dioleyloxy)propyl]- 
N , N , N-trimethylarnmonium chloride), a liposome mediated 
transfection-reagent. For each transfection assay, 4yg of
the CAT reporter plasmid were cotransfected with 4yg of
inducer plasmid or pUC8. Plasmid DNA was mixed with 1.5ml 
tissue culture medium and separately 40pl DOTMA was added to 
1.5ml medium. The two solutions were mixed, added to
drained cell plates and the cells incubated at 37°C/6 hr.
Transfection medium was then removed by suction, replaced by
fresh growth medium and incubated for a further 48 hr. The
cells were harvested into 3ml TEN after washing once in PBS, 
pelleted at 2,000rpm/l min/4°C, drained and resuspended in
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75pl 0.25M Tris-HCl pH8.0. After sonication cell extracts 
were cleared by centrifugation 12,000rpm/2 min and the 
supernatant used directly for CAT-assays or stored at -20°C.
3.24. CAT assays
Cell extracts from transfected cells were assayed for 
chloramphenicol acetyl transferase (CAT) activity by the 
method of Seed and Sheen (1988). This assay exploits the 
relatively low specificity of CAT for the acyl donor, which 
allows butyryl CoA to be substituted for acetyl CoA. The 
greater hydrophobicity of butyrylated chloramphenicol allows 
an effective discrimination between free and acylated chlor­
amphenicol by a simple phase extraction (Seed and Sheen,
1988) . A reaction mix contained 25pl cell extract (see 
above), lpl 25mM butyryl CoA, 0.5pl t14C]chloramphenicol 
stock and 18.5pl H2 O. After incubation at 37°C/1 hr the 
reaction mix was extracted with 180yl of TMPD (tetramethyl- 
pentadecan)/Xylenes 2:1, followed by centrifugation for 1 
min in a microfuge. Subsequently, 150pl of the organic 
(top) phase was removed to a scintillation vial and counted 
by scintillation counting in 4ml ecoscint as a measure of 
the CAT enzyme activity in each cell extract.
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4 .  RESULTS
The aim of the work described in this thesis was to 
investigate the properties involved in the growth restric­
tion of Ad40 in tissue culture as compared to other 
adenovirus serotypes. It has been shown previously that 
Ad40 can grow on 293 cells, expressing the El region of Ad5 
(Takiff e t  a l .  , 1981; de Jong e t  a l . ,  1983), although others 
have failed to detect Ad40 replication in those cells (Chiba 
e t  a l . , 1983; Uhnoo e t  a l . ,  1983). In this laboratory it 
was established that Ad40 will grow on KB cell lines 
expressing the Ad2 El region or the E1B region alone but not 
on cells expressing only the E1A region (Mautner e t  a l . ,
1989). This suggests that the growth restriction of Ad40 in 
tissue culture can be overcome by supplying Ad2 E1B gene 
products i n  t r a n s  but not by providing only the Ad2 E1A gene 
products. These results indicate that the low transacti- 
vating function of Ad40 E1A gene products and the weak c i s -  
activity of the E1A promoter (van Loon e t  a l . ,  1987a; Ishino 
e t  a l . , 1988) are not a major cause of the restrictive 
growth of Ad40 in tissue culture. Moreover, this implies 
that one or more Ad40 E1B gene products are not expressed in 
a functional form in KB cells or alternatively they are 
functionally different from their Ad2 counterparts. Studies 
on other adenovirus serotypes have shown that mutations in 
either the E1B 19K or the 55K proteins can affect the host 
range of these viruses. Hence the Ad40 E1B region is a 
potential candidate for having a role in the host range of 
the virus. In order to better understand the involvement of 
the E1B region in the restricted growth a study of the Ad40 
E1B region was undertaken.
4.1. Virus complementation
The ability of Ad40 to complement Ad2/5 and Adl2 El 
mutant viruses was tested using a coinfection assay. This 
was done in order to see if Ad40 could provide functions 
lacking in viruses defective for E1A or E1B protein func­
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tions, thus indicating the presence or absence of those 
functions in Ad40. Further, if coinfection with wild type 
virus enhances Ad40 replication, this assay should indicate 
which El mutations affect the ability of those serotypes to 
complement Ad40 growth.
4.1.1. Coinfection of Ad5/2 El mutants with Ad40:
Ad2/5 mutant viruses used in this study are described in 
table 2 (section 2.1.). Ad5 mutants dl309, dl312 and dl313 
were isolated by Jones and Shenk (1979). Briefly, dl309 is 
an Ad5 virus that lacks three Xbal sites and has a large 
deletion within the E3 region, but grows as well as wild 
type in tissue culture. This is the background for a large 
deletion in the E1A region in dl312 and a deletion of the 
E1B region in dl313; both viruses are defective for growth 
on Hela cells but complement each other in a double infec­
tion (Jones and Shenk, 1979) . Gene specific E1B mutants
were constructed by Barker and Berk (1987) by recombining 
altered Ad2 E1B sequences into a dl309 background. A mutant 
virus, pml722 specifically lacking the E1B 19K product was 
created by introducing a stop codon after the first 3 
residues of the 19K ORF. This mutant replicates as well as 
wild type in Hela cells. The mutant dll520 specifically 
lacking the E1B 55K protein and related products has a point 
mutation creating a stop codon after the second residue of 
the 55K ORF but not affecting the overlapping 19K ORF, and a 
827bp deletion downstream of the 19K ORF. Replication of 
this virus is defective on Hela cells but like dl312 and 
dl313 the defect is less marked at a high multiplicity of 
infection.
In coinfection assays a p3 stock of Ad40 was used diluted 
1/10 in TS in the absence of a suitable quantitation method 
for Ad40. The virus does not form plaques on KBa+b cell or 
293 cells and attempts to enhance plaque formation have so 
far been unsuccessful. Ad5/2 mutant viruses were used at a 
multiplicity of 3pfu/cell. Single and double infections 
were used to assess reciprocal complementation between each
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of these mutant viruses and Ad40. Hela cells on 50mm plates 
were infected with lOOpl virus dilution in a single 
infection and lOOjil of each virus in double infections.
Single infections on KBa+b cells were performed in parallel. 
Cells were harvested at 72 hr.p.i., virus released by 
freezing and thawing and virion DNA extracted as described 
(see 3.2. and 3.3.). DNA obtained by this method resides 
within virus particles since DNasel treatment prior to DNA 
extraction does not alter the yield (Mautner e t  a l . ,  1989). 
Dilutions of virion DNA were applied in duplicate to Hybond- 
N on a dot blot apparatus and probed with a mixture of E1A 
and E1B containing plasmids of the appropriate serotype
(pNM80/pNM81 and pNM90/pNM92 for Ad40 and Ad5/2 respective­
ly) . Autoradiographs were quantitated by densitometry.
The autoradiographs are shown in figure 6. In the 
absence of Ad40, dl312 and dl313 DNA was not detectable in 
Hela cell extracts. However, in the presence of Ad40, dl312
DNA was detected at the highest dilution, indicating a sub­
stantial increase in the level of virion DNA, whereas dl313 
DNA was not detected. Moreover, coinfection with dl312 
resulted in a 2-fold increase in Ad40 yield while in the 
presence of dl313 the Ad40 yield was even less than for a 
single infection. The E1B 55K mutant dll520 replicated 
poorly on Hela cells but the yield of virion DNA was 
increased around 2-fold in the presence of Ad40. However, 
the coinfection with dll520 only resulted in a 30% increase 
in the yield of Ad40 compared to a single infection. Both 
dl309 and pml722 replicated efficiently in a single infec­
tion in Hela cells as expected. In the double infection the 
yield of pml722 was somewhat reduced while nearly a 2-fold 
increase was seen in dl309 virion DNA. Both viruses however, 
increased the yield of Ad40 around 3-fold in a double infec­
tion relative to a single Ad40 infection. While the 
mutation in dll520 was efficiently complemented in KBa+b 
cells, dl312 and dl313 grew poorly in those cells. Better 
yields of those mutants were obtained from 293 cells which
were used for preparation of virus stocks; this finding was
also noted by Nancy Mackay (personal communication). The
Figure 6: Coinfection of Ad5/2 with Ad40
KBa+b cells and Hela cells were infected with 3 pfu/cell 
of Ad5 or Ad2 mutant and lOOyl of 1:10 diluted p3 stock of 
-Ad40. Virus was harvested at 72 hr p.i. and virion packaged 
DNA was extracted. Dilutions (1/40, 3/400 and 1/400) were
applied to nylon filters and probed with a mixture of E1A 
and E1B containing plasmids (lOOng of each) of the appro­
priate serotype (pNM80/pNM81 and pNM90/pNM92 for Ad40 and 
Ad5/2 respectively). The top left panel shows the yield of 
Ad5/2 viruses in a single infection on KBa+b cells and Hela 
cells. The yield of Ad5/2 viruses and Ad40 in a double 
infection on Hela cells is shown on the right. The lower 
panel on the left shows the yield of Ad40 in a single 
infection on KBa+b cells and Hela cells. Plasmid controls 
are shown on the right. The lack of cross-reaction between 
Ad40 and Ad5 sequences was established by probing dl309 with 
the Ad40 probe and Ad40 with the Ad5 probe (not shown).
Single infection Double infection
cells: KBa+b Hela Hela Hela
Mock 
dl312 
d!313 
pm1722 
dl1520 
d!309
probe: Ad2 Ad2 Ad2 Ad40
Mock • BM
Ad40 • •  • < • 5  1 0.1 5 1 0.1ng
probe: Ad40 Ad40
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basis for this difference is not known.
4.1.2. Coinfection of Adl2 El mutants with Ad40:
The Adl2 mutant viruses used in this study are described 
in table 2 (section 2.1.). Gene specific El mutants of Adl2 
were constructed by Breiding e t  a l . ,  (1988) and Edbauer e t  
a l . ,  (1988). The E1A mutant hr700 has a point mutation 
resulting in altered amino acid sequence in conserved region 
3 of the 266R and 235R E1A proteins. Replication of this 
virus is restricted in Hela cells (Breiding e t  a l . , 1988). 
A point mutation in pm700 changes the AUG initiation codon 
of the E1B 19K ORF to AUG. In in602 a frameshift in the E1B 
55K ORF leads to a termination codon after 148 residues, and 
dl620 has a 696bp in frame deletion in the 55K ORF. Both 
viruses retain the coding potential for the 19K E1B protein 
and they are defective for growth on Hela cells (Breiding e t  
a l . ,  1988).
Single and double infections on Hela cells were carried 
out as described above and single infections on KBa+b cells 
were carried out in the same way. Dilutions of virion DNA 
were analysed on dot blots by probing with an Ad40 El 
containing plasmid (pNM82) or an Adl2 El containing plasmid 
(pAsclO.3).
The results are shown in figure 7. The efficient growth 
of the E1A mutant hr700 in Hela cells was unexpected. A 
contamination of the virus stock by wild type virus or a 
reversion of the point mutation can not be excluded as an 
explanation. A reduced yield was seen when coinfected with 
Ad40, while the yield of Ad40 was increased nearly 2-fold 
compared to a single infection. The two E1B 55K mutants 
(in602 and dl620) did not replicate on Hela cells in a 
single infection, but in the presence of Ad40, both were 
detectable. They had little effect on the Ad40 yield, 
although a slight decrease was seen in the presence of in602 
relative to a single Ad40 infection. Replication of pm700 
and 12wt was not affected by the presence of Ad40 but they 
increased the yield of Ad40 6- and 4-fold respectively in
Figure 7: Coinfection of Adl2 with Ad40
KBa+b cells and Hela cells were infected with 3pfu/cell 
of Adl2 viruses and lOOjal of 1:10 diluted Ad40 p4 stock. 
Virus was harvested at 72 hr p.i. and virion DNA applied to 
dot blots (diluted 1/40, 3/400 and 1/400) and probed with El 
containing plasmids (pNM82 and pAscl0.3) of Ad40 and Adl2. 
The top left panel shows the yield of Adl2 viruses in a 
single infection on KBa+b cells and Hela cells. The yield 
of Adl2 viruses and Ad40 in a double infection on Hela cells 
is shown on the right. The lower panel on the left shows
the yield of Ad40 in a single infection on KBa+b cells and 
Hela cells. Plasmid controls are shown on the right. The 
lack of cross-reaction between Ad40 and Adl2 sequences was 
established by probing Ad40 with the Adl2 probe and Adl2wt 
with the Ad40 probe (not shown).
Single infection Double infection
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the double Infection.
4.1.3. Summary
The results described above show that Ad40 growth on Hela 
cells can be complemented by coinfecting with Ad2/5 or Adl2 
viruses that replicate well on Hela cells. Furthermore, 
Ad40 and dl312, an Ad5 E1A mutant which does not grow on 
Hela cells in a single infection, can complement each other, 
resulting in increased replication of both viruses on this 
cell line. On the other hand, Ad40 does not complement 
dl313, an E1B negative virus. All the E1B 55K mutants show 
an increased yield in a double infection relative to a 
single infection but interestingly this effect is one sided 
in all cases, since the yield of Ad40 is not increased.
These results are consistent with the observation that 
Ad40 can grow on cells expressing the E1B region of Ad2 
(Mautner e t  a l . ,  1989) and suggest that Ad40 expresses a 
functional E1A protein capable of acting i n  t r a n s  to 
complement an Ad5 E1A mutant. The results also indicate that 
expression of the E1B 55K protein is essential for 
complementation of Ad40 since the mutant viruses that do not 
increase the yield of Ad40 in a double infection are the E1B 
negative virus (dl313) and the E1B 55K mutants of both Ad5/2 
and Adl2. However, Ad40 may not be completely devoid of 
functional E1B 55K protein since it can provide some helper 
function for the 55K mutants. Alternatively, an increase in 
the levels of some other viral products in the presence of 
Ad40 may account for the increased replication of mutant 
viruses in double infections. This would be analogous to 
the permissive growth of many El mutant viruses at a high 
multiplicity of infection and could apply to both E1A and 
E1B mutant viruses. However, the complementation of Ad40 by 
an E1A mutant (d!312) but not by any of the E1B mutant 
viruses implies that the growth restriction of Ad40 in Hela 
cells is related to the lack of an E1B 55K protein function. 
The E1B 19K protein is not essential in tissue culture and 
the 19K mutant. viruses grow like wild type, so these
89
experiments do not address the question whether or not Ad40 
has a functional E1B 19K protein.
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4.2. Analysis of RNA transcribed from the El region of Ad40
The DNA sequence of the El region of Ad40 shows similar 
organization of transcription signals and open reading 
frames to that of other human serotypes (van Loon e t  a l . , 
1987b, Ishino e t  a l . ,  1988; see figure 5). Van Loon e t  a l .  
used baby rat kidney cells transformed with an Ad40 El 
containing plasmid as a source of El RNA in Northern 
blotting and SI mapping experiments. They identified 9S, 
12S and 13S E1A mRNAs but did not detect any E1B transcripts 
despite the fact that the intact E1B region was present in 
those cells (van Loon et a l . , 1985a). However, Ad40 El tran­
scripts have not previously been identified from a lytic 
infection. If transcription of the E1B region in infected 
cells is as incompetent as it appears to be in transformed 
cells this could account for the E1B 55K deficiency of Ad40, 
suggested by the virus complementation experiments described 
above and by complementing cell line experiments (Mautner e t  
a l . ,  1989), In order to address this question, Ad40 El 
transcription in Ad40 infected KBa+b cells was investigated 
in several different ways. A timecourse of El transcription 
was studied by Northern blotting and after establishing the 
presence of E1B mRNAs the structure of these transcripts was 
analysed in detail by nuclease protection and primer 
extension assays, PCR analysis and partial cDNA sequencing 
and by Northern blotting.
4.2.1. Timecourse of El transcription
RNA transcripts mapping to the El region were analysed by 
Northern blotting of cytoplasmic RNA from Ad40 infected 
KBa+b cells harvested at various times after infection. 
Cells on 50mm plates were infected with lOOyl of a 1/10 
dilution of Ad40 p9. Following incubation at 37°C two plates 
were harvested at each timepoint and cytoplasmic RNA 
extracted as described (see 3.5.). Duplicate samples were 
run on 1.2% agarose/formaldehyde gels and blotted onto Zeta 
probe membranes. Blots were probed with pNM83 and pNM81 for
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E1A and E1B respectively. In figure 8A E1A mRNAs are first 
seen at 24 hr p.i.f and they increase in abundance up to 42 
hr p.i. The higher band corresponds to E1A 12S and 13S 
mRNAs which would not be separated under these conditions, 
and the lower band corresponds to the 9S mRNA. This is 
consistent with the E1A transcripts mapped by van Loon et 
a l .  , (1987b; figure 5). In figure 8B bands detected by the
E1B probe can first be seen at 24 hr p.i. albeit at a low 
intensity, and they increase in abundance up to 42 hr p.i. 
On a longer exposure all the bands seen at 30 hr p.i. are 
seen clearly at 24 hr p.i. but none of them are seen at 12 
hr p.i. Three major bands are apparent on this gel. The 
probe, pNM81, extends beyond the 3' end of the E1B region 
and the top band is most likely a transcript from the IVa2 
region downstream of E1B (see Mautner et al., 1990; section 
4.2.2.I.V.). From analogy with other adenoviruses a 22S 
mRNA would also be expected but the presence of such a band 
may be obscured by the IVa2 mRNA. The middle band could 
correspond to a 13-14S E1B mRNA and the third band is most 
likely the 9S mRNA for polypeptide IX. It is notable that 
the late ppIX mRNA appears at the same time as the presumed 
early 13-14S mRNA although the possibility that the 13-14S 
mRNA is transcribed first cannot be ruled out at this stage 
in the absence of a timepoint between 12 and 24 hr p.i. The 
late appearance of the early transcripts was somewhat 
unexpected. However, the relationship between early tran­
scription and DNA replication was not determined in this 
experiment. Mautner et a l . ,  (1990) found that E1B mRNA was 
not detected until after the onset of DNA replication (see 
also 4.2.3.). Moreover, they showed that in the presence of 
a cytosine arabinoside block of DNA replication E1B tran­
scripts were not detectable.
Figure 8: A timecourse of El transcription in KBa+b cells
Cytoplasmic RNA was harvested from mock infected and Ad40 
(p9) infected KBa+b cells at the times indicated post
infection. Duplicate samples were separated on 1.2%
agarose/formaldehyde gels and blotted onto Zeta probe
membranes. The harvest from one 50mm plate was loaded per 
lane. The migration of the 18S ribosomal RNA is indicated.
A) E1A RNA. The blot was probed with a nick translated Ad40 
E1A containing plasmid, pNM83 (nt 1-1211). B) E1B RNA. The 
blot was probed with a nick translated Ad40 E1B containing 
plasmid, pNM81 (nt 1643-3933). Blots were exposed for 3
days.
M 12 24 30 36 42 hr
■18S
B
M 12 24 30 36 42 hr
-18S
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4.2.2. Mapping of E1B mRNA
In order to determine the protein coding capacity of E1B 
mRNAs a transcription map of the Ad40 E1B region was obtain­
ed using RNA from Ad40 infected KBa+b cells harvested at 42 
hours post infection. This timepoint was chosen with refer­
ence to the Northern blotting experiment described above, 
where all E1B mRNAs appear to increase in abundance at least 
up to 42 hr p.i. Those Northern blots and the following 
mapping experiments all used RNA from cells infected with 
Ad40 p9. Initial experiments were performed using a p4 
stock of Ad40. Although E1B RNA was detectable on Northern 
blots it was low in abundance compared to a p9 infection; SI 
mapping experiments on that material were not successful 
most likely due to the low abundance. The p9 virus was more 
concentrated than the p4 stock (as seen from a comparison of 
virion DNA), hence using the p9 stock at a 1/10 dilution 
resulted in a higher multiplicity of infection which could 
account for the increase in E1B transcription. However, in 
the absence of a plaque assay or other reliable titration 
method a comparison between different virus stocks is not 
feasible.
Several methods were applied to obtain a transcription 
map of the E1B region. SI nuclease mapping and primer 
extension analysis were used to locate 5' ends, 3' ends and 
spl ice sites. Restriction fragments and oligonucleotides 
used in this analysis were chosen by reference to the DNA 
sequence and the mRNA structure predicted from analogy with 
other adenovirus serotypes. Further details of mRNA 
structure were determined by PCR mapping, partial cDNA 
sequencing and Northern blotting. Figure 9A shows the 
transcription map obtained by the above methods. Also shown 
are locations of oligonucleotides used for primer extension 
and PCR analysis (figure 9B), and end labelled restriction 
fragments used in SI analysis (figure 9 0 .  Nucleotide 
numbers indicate transcription initiation sites, splice 
sites and polyadenylation sites. Open reading frames were 
predicted from the published sequence (van Loon e t  e l . , 
1987b; Ishino e t  a l . ,  1988) and from the mRNA structure.
Figure 9: Ad40 E1B transcription map.
The transcription map was determined by SI nuclease 
mapping, primer extension analysis, PCR mapping partial cDNA 
sequencing and Northern blotting. See text for details. A) 
mRNA structure and location of open reading frames. Exons 
are represented by bold lines, and carets indicate introns. 
Hatched boxes denote ORFs for the predicted E1B proteins and 
polypeptide IX. The 15K ORF is composed of the first 73 and 
last 29 amino acids of the 55K ORF. A 41 residue E1A ORF is 
indicated by an open box on the E1A-E1B cotranscripts. 
Positions of 5' ends, 3' ends and junctions are indicated. 
RNA and protein sizes are designated by analogy with Ad2.
B) Oligonucleotides used in primer extension and PCR 
analysis. The oligonucleotide sequences are shown in table 
3. C) Restriction endonuclease fragments used in SI 
analysis. The bold number refers to the fragment size and 
the number in italics to the position of the label. Only 
labelling of L strand is indicated except for the 565bp 
fragment where 3 ’ end labelling of both strands is indi­
cated. 579 is a Hpal-Bcll fragment from pNM82, 1022 is a 
BamHI-EcoRI fragment of pNM87, 475 is an Aval-PstI fragment 
from pNM86 and 565 is a TaqI fragment of pNM86. The line at 
the bottom represents the DNA genome; end labelled 
restriction sites are indicated.
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4.2.2.1 SI nuclease analysis and primer extension assays
SI nuclease analysis was performed by the method of Berk 
and Sharp (1977) as described (section 3.19). Briefly, 
double stranded restriction fragments (see figure 9C and 
table 4) were either 5' or 3' end labelled and after 
denaturation allowed to hybridize to total or cytoplasmic 
RNA from Ad40 infected or mock infected cells. Following 
digestion of single stranded DNA with SI nuclease, protected 
DNA fragments were analysed on a 5% acrylamide gel. Primer 
extension analysis (section 3.20) used 5' end labelled 
oligonucleotides (see figure 9B and table 3) which after 
hybridization to total RNA were extended by reverse tran­
scription. The products were analysed on acrylamide gels as 
above.
i) 5 ’ end of E1B mRNA
In order to determine the 5' end of E1B mRNAs, a 579 nt 
fragment (figure 9C) 5' end labelled at nt 1647 was used in 
SI nuclease assay on infected and mock infected cell 
extracts (figure 10). Protected fragments of 170 and 240 nt 
were obtained from infected cell extracts, which correspond 
to 5' ends or splice acceptor sites at nts 1480 and 1408 
approximately. From the nucleotide sequence and by analogy 
with Ad2 the site at 1408 is likely to be the cap site. 
Primer extension analysis was used to determine the precise 
location of the cap site: A primer (VS1) 5' labelled at 1548 
was extended using RNA template from mock infected or 
infected cells (figure 11A, lanes 1 and 2). Unique bands of 
137 and 142 nt were obtained, and these were precisely 
located on the genome by running alongside a sequencing 
ladder (figure 11B). This identifies a T residue at nt 1412 
and an A residue at nt 1403 as 5' ends. A 5' end around nt 
1480, a possibility raised by the SI analysis, would have 
resulted in a band of 60-70 nt, but nothing was seen in this 
region of the gel (figure 11A, lane 2). The possibility of 
a splice acceptor site around nt 1480 can not be excluded;
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Figure 10: SI nuclease analysis of the 5'end of E1B mRNA
A restriction fragment spanning nt 1064-1647 of Ad40 was
5 ’end labelled and used in SI nuclease assay on whole cell 
RNA obtained from Ad40 infected (I) and mock-infected (M)
KBa+b cells at 42 hr p.i. Hybridization and SI nuclease
digestion were done at 55° and 42° respectively. The 
molecular weight marker (C) is a Hpall digest of pBR322, the 
size of the fragments (bp) is indicated. Arrows show the 
positions of protected fragments obtained.
Figure 11: Primer extension analysis of E1B and ppIX mRNAs. 
Ad40 infected and mock infected KBa+b cells were harvested 
at 42hr p.i. Hybridization of oligonucleotide primers and 
reverse transcription were performed at 30° and 42° 
respectively. A) Primer VS1, 5' end labelled at nt 1548 was 
used to analyse E1B mRNA 5' end (lanes 1 and 2). Primers 
VS4 and VS5, 5' end labelled at nt 3287 and 3400 
respectively, were used to analyse ppIX mRNA 5' end (lanes 
3-6). Reactions used AMV reverse transcriptase. Samples 
were run on 5% denaturing acrylamide gels. A Hpall digest of 
pBR322 was used as molecular weight marker (lane 7). The 
filled circles mark unique products from infected cells. 
The diagram indicates predicted mRNA structure, location of 
primers and extended products. B) Primers VS1 and VS4 were 
extended using MMLV reverse transcriptase and run on 6% 
denaturing acrylamide gels. Sequencing reactions using the 
same primers on a pNM82 plasmid template were run alongside. 
Arrows point to the bands seen in A here precisely located 
alongside sequencing ladders. Other bands seen with VS1 in 
lane I were consistently obtained on mock infected cell 
extracts as well using the MMLV reverse transcriptase (not 
shown) although not seen on this gel; the top band corre­
sponds to the band seen at 180 in lanes 1 and 2 in A. For 
precise location and sequence of oligonucleotide primers, 
see table 3.
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the sequence CTTCTGCCAG/A (nt 1472-1482) may have such a 
role. There were indeed bands of approximately 330 nt and 
420 nt, obtained by extension of primer VS1 (figure 11A lane
2) which suggests that some E1B transcripts may extend 
beyond the predicted E1B 5' end. This possibility was 
addressed by cDNA analysis (see 4.2.2.2.). A 175 nt
fragment was obtained from mock infected as well as infected 
cell RNA (figure 11A lanes 1 and 2). This most likely 
results from the primer annealing to cellular RNA, possibly 
endogenous Ad2 mRNA.
ii) Splice donor site 1
A splice donor site corresponding to the Ad2 E1B 13S 
splice donor site was mapped by SI analysis using a 1022 nt 
fragment 3' labelled at nt 1849 as probe (figure 9C). A 
ladder of protected fragments was obtained, the largest one 
corresponding to a 90 nt protected fragment (figure 12) 
locates a splice donor site at nt 1938, where there is a 
splice donor consensus sequence (AGG/GTACTA, nt 1936-1944). 
No other splice donor sites were detected using this probe
in the region between nt 1849 and 2870. The ladders of bands 
(seen on a lower exposure) 
in the figure/\can “be- explained as resulting from hetero­
geneous 3' labelling of the BamHI site in the probe. A 
likely reason for the heterogeneity is as follows. The 
BamHI site has the sequence 5 'GATCCA/t G/c T/a G/c C/g A/t G/c .., 
(letters in subscripts denote the 3 ’ end). The only dNTP 
added to the labelling reaction was [a32p]dGTP. In some 
cases the 3'-5’ exonuclease activity of the Klenow 
polymerase may degrade the double stranded DNA back to the 
C/c (bold) and add a labelled G in that position. These 
molecules may then have a variable number of bases added 
back to the 3' end. In addition, other molecules will have 
labelled G paired directly to the single stranded C residues 
and again these may have a variable number of bases added to 
the 3' end. This could account for the two sets of ladders 
where the sequence indicates a single splice donor site. No 
convenient alternative restriction site was available to 
make a different probe for the detection of this splice
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Figure 12: SI nuclease analysis of splice donor site 1
A restriction fragment spanning nt 1849-2857 of Ad40 was 
3'end labelled and used in SI nuclease assay on cytoplasmic 
RNA obtained from Ad40 infected (I) and mock-infected (M) 
KBa+b cells at 42 hr p.i. Hybridization and SI nuclease 
digestion were done at 55° and 42° respectively. The 
molecular weight marker (C) is a Hpall digest of pBR322, the 
size of the fragments (bp) is indicated. The arrow indi­
cates the size of the protected fragment obtained. The 
multiple bands are the result of a heterogeneous 3'end 
labelling of the probe (see text).
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donor site by SI analysis and another fragment including the 
same BamHI site also produced the same ladders. The use of 
this site was independently confirmed by cDNA sequencing 
(see 4 . 2 . 2 . 2 .) .
iii) Splice donor site 2
A second splice donor site, corresponding to the Ad2 E1B 
22S splice donor site, was mapped using a 475 nt fragment 3' 
labelled at nt 2938 as a probe in SI nuclease assay (figure 
9C). In figure 13 a 214 nt band corresponds to a splice 
donor site at nt 3151 which is immediately after the termi­
nation signal of the large open reading frame (TAAGG/GTAAGG, 
nt 3147-3157). The two smaller bands in figure 13, 147 and 
151 nt, map to a region which includes a potential splice 
donor consensus sequence (nt 3085-3089). However, attempts 
to identify a use of this potential site were not successful 
(see 4.2.2.2.). In addition faint bands of unknown origin 
were seen on the gel between 170-190 nt.
iv) Splice acceptor site and 5' end of ppIX mRNA
In order to look for a splice acceptor site and the 5' 
end of polypeptide IX mRNA, the same 475 nt fragment was 5' 
end labelled at nt 3410 and used in SI analysis. This 
resulted in two protected fragments, 204 and 189 nt long
(figure 14) corresponding to ends at nt 3207 and 3222 
respectively. Primer extension analysis resolved that there 
is a 5 ’ end at nt 3207; figure 11A, lanes 4 and 6, show
extended products from VS4 and VS5 5' labelled at nt 3287
and 3400 respectively. A 194 nt band (lane 6) and a hetero­
geneous (see below) 86-87 nt band (lane 4) identify a 5' end 
at nt 3207-8. This was further confirmed by running primer 
extended products against a sequencing ladder (figure 11B)
demonstrating the major 5' end at nt 3207. According to the
DNA sequence, the 3222 site is a splice acceptor
(AAGTTACAAAATGAG/TG, nt 3207-3223). This is analogous to
the situation in Ad2 where the cap site for polypeptide IX 
mRNA is located within the intron of the E1B mRNAs. Primers 
VS4 and VS5 would also be expected to be extended to the 5*
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Figure 13: SI nuclease analysis of splice donor site 2
A restriction fragment spanning nt 2938-3410 of Ad40 was 
3 ’end labelled and used in SI nuclease assay on whole cell 
RNA obtained from Ad40 infected (I) and mock-infected (M) 
KBa + b cells at 42 hr p.i. Hybridization and SI nuclease 
digestion were done at 55° and 42° respectively. The mole­
cular weight marker (C) is a Hpall digest of pBR322, the 
size of the fragments (bp) is indicated. Arrows show the 
positions of protected fragments obtained.
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Figure 14: SI nuclease analysis of a splice acceptor site 
and the 5 1 end of ppIX mRNA
A restriction fragment spanning nt 2938-3410 of Ad40 was 
5'end labelled and used in SI nuclease assay on cytoplasmic 
RNA obtained from Ad40 infected (I) and mock-infected (M) 
KBa+b cells at 42 hr p.i. Hybridization and SI nuclease 
digestion were done at 55° and 42° respectively. The mole­
cular weight marker (C) is a Hpall digest of pBR322, the 
size of the fragments (bp) is indicated. Arrows show the 
positions of protected fragments obtained.
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end of E1B mRNA templates. No such products were observed 
most likely because long extended products are not made 
efficiently.
v) 3' ends of E1B, ppIX and IVa2 mRNAs
A common 3' end for E1B and ppIX transcripts was 
identified using a 565 nt 3'end labelled fragment (figure 
9C) in SI nuclease assay. This is a TaqI fragment where
both strands are labelled. Figure 15 shows that two bands, 
of 268 and 298 nt, were obtained using this fragment; the 
268 nt protected fragment corresponds to a 3' end around nt 
3633, downstream of the polyadenylation signal at nt 3614- 
3619. This is the only poly A signal on the R strand in this 
region and thus maps the poly A site for E1B mRNAs and ppIX 
mRNA. There is a poly A signal on the other strand which, 
by analogy with Ad2, corresponds to the poly A signal of a 
IVa2 transcript. The 298 nt fragment maps the 3' end of the 
IVa2 transcript also around nt 3633, downstream of the 
sequence AAATAAATAAA (nt 3659-3649).
4.2.2.2. Analysis of cDNA by PCR amplification, cloning and 
sequencing
The mapping data described above indicated that the 
structure of Ad40 E1B late mRNA was analogous to the major 
transcripts found in other serotypes. The transcription map 
did thus not appear to offer any explanation as to the 
apparent lack of E1B 55K protein function. However, due to 
the lack of convenient restriction sites, some parts of the 
E1B region were not analysed in the experiments described 
above. In particular a site corresponding to the 1st splice 
acceptor site utilized in the 14S and 14.5S mRNAs of Ad2 and 
Ad12 (see figure 4) would not be identified by the restric­
tion fragments used. In addition, the mapping data left
some unanswered questions; the possibility of a splice 
acceptor site around nt 1480 raised by SI analysis (figure
10) and the identity of 3-400 nt fragments produced by
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Figure 15: SI nuclease analysis of the 3 1 ends of E1B, ppIX 
and IVa2 mRNAs
A restriction fragment spanning nt 3366-3690 of Ad40 was 
5'end labelled and used in SI nuclease assay on whole cell 
RNA obtained from Ad40 infected (I) and mock-infected (M) 
KBa+b cells at 42 hr p.i. Hybridization and SI nuclease 
digestion were done at 55° and 42° respectively. The mole- 
culai weight marker (C) is a Hpall digest of pBR322, the 
size of the fragments (bp) is indicated. Arrows show the 
positions of protected fragments obtained.
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extending primer VS1 (figure 11A) remained unsolved. Also, 
protected fragments seen in SI analysis (see figure 13) and 
described in 4.2.2.1.iii, were not accounted for.
In order to extend the the analysis of E1B transcripts, 
RNA was subjected to cDNA-PCR mapping. The procedure is 
outlined in figure 16. After DNase treating a cytoplasmic 
RNA preparation in order to remove residual DNA which would 
interfere with a PCR reaction, cDNA was made using a single 
oligonucleotide primer. Prior to analysis, the cDNA was 
amplified using a pair of primers in a PCR reaction, making 
an amplified double stranded cDNA copy. PCR products were 
analysed on agarose gels and for further analysis amplified 
cDNA fragments were isolated, cloned and sequenced.
A cDNA-PCR assay using oligonucleotides RU4 and RU3 (see 
table 3 and figure 9B) was expected to amplify a 1457bp 
fragment from a cDNA copy of 22S mRNA. In addition these 
primers span a potential splice junction corresponding to 
the 1st splice junction in 14S and 14.5S mRNAs of other 
serotypes. Thus this experiment should determine if such 
transcripts are made in Ad40. The results are shown in 
figure 17A. When RNA from mock infected cells was used as a 
template no products were made (lane 5) whereas infected 
cell RNA gave a 334bp amplified product (lane 6). The 
absence of a 1457bp band corresponding to a 22S mRNA 
template can most likely be explained by incomplete reverse 
transcription of a long template since other evidence (SI 
analysis and Northern blotting, see 4.2.2.3.) indicates the 
presence of 22S mRNA. A parallel PCR reaction using cloned 
viral DNA as template gave a 1457bp product (lane 7). For 
further analysis the 334bp cDNA fragment was isolated and 
cloned into the PstI site of pUC8 via PstI sites near the 5 ’ 
end of each primer. The cloned fragment was sequenced 
(figure 17B), and the cDNA sequence found to correspond to 
nt 1719-1938 and 3061-3149 of the genomic DNA sequence 
(figure 17C). This confirms the splice donor site mapped to 
nt 1938 by SI analysis, and reveals a hitherto undetected 
splice acceptor site at nt 3061 (TTAGGTTATATCCAG/C, nt 3046- 
3061). This corresponds to the splice acceptor used in the
Figure 16: cDNA-PCR procedure
The flow chart outlines the procedure employed for the 
production of cDNA and amplification by the polymerase chain 
reaction followed by cloning and sequencing of the amplified 
product. See 3.18.2, 3.10. and 3.11. for details of
methods.
DNase treated RNA
Reverse transcribed in PCR  
buffer using primer A
I
5‘ 3‘ RNA
—  5 ‘ 
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3 ‘
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ligated into Smal site of M13 ligated into PstI site of pUC8
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Figure 17: PCR amplification and sequence analysis of cDNA.
A) 5ug DNase 1 treated cytoplasmic RNA from mock infected 
(lanes 2 and 5) or Ad40 infected (lanes 3 and 6) KBa+b cells 
harvested at 42 hr p.i. was reverse transcribed and ampli­
fied in a PCR reaction as described (3.18.2.) .  ^ lOng pNM82 
(Ad40 El) was amplified in parallel. One tenth of each PCR 
reaction was run on a 2% agarose gel. The size marker 
(lanes 1 and 8) is a 123bp DNA ladder (BRL). cDNA was made 
using oligonucleotide primers VS1 (lanes 2 and 3) and RU4 
(lanes 5 and 6). Primer pairs VS1-VM40 (lanes 2-4) and RU4- 
RU3 (lanes 5-7) were used for PCR amplification (see table 3 
for primer sequences and locations). Sizes of PCR products, 
in base pairs, are indicated on either side of the gel.
B) The 179bp VS1-VM40 cDNA fragment was cloned into M13 
and sequenced using an M13 primer. The left panel shows the 
sequence around the E1A-E1B junction. The 334bp RU4-RU3 
cDNA fragment was cloned into pUC8 and sequenced using RU4 
as primer. The sequence at the splice junction is shown in 
the right panel.
C) E1A and predicted E1B mRNA structure. Locations of 
primers used in PCR analysis is indicated by arrows, and 
cDNA sequences are represented by bold solid lines and 
intron sequences by broken lines. The DNA sequence around 
the splice junction of each cDNA is shown with upper case 
for exon and lower case for intron sequences. The residues 
underlined in the VM40-VS1 sequence denote (from left to 
right) the E1B cap site a, the E1A ORF stop codon TGA, and 
the initiation codon ATG for the first E1B ORF.
1>Conditions used for PCR reactions were as follows: Initial 
denaturation 94°C (7min) was followed by 30 cycles of 94°C 
denaturation (lmin), 55°C annealing (lmin) and 72°C 
elongation (3min).
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Ad2 14S mRNA, creating an in frame splice in the 55K ORF in 
both serotypes. Thus a 14S mRNA is transcribed from the E1B 
region of Ad40. Oligonucleotides RU3 and RU4 include the 
translation initiation and termination codons respectively 
of the E1B large open reading frame. The RU3-RU4 cDNA clone 
(pVSl) therefore includes the whole coding region for a 
protein comprising the amino- and carboxy-termini of the 
predicted E1B 55K protein, the counterpart of the Ad2 E1B 
15K protein (figure 4).
SI analysis indicated a potential splice acceptor site 
around nt 1480, and extension of primer VS1 (located near 
the 5' end of E1B) produced fragments of approximately 330 
and 420 nt in addition to the smaller products which defined 
the E1B 5' end. These results implied that some E1B tran­
scripts have a 5' end further upstream, ie within the E1A
region. A pair of oligonucleotides, VM40 and VS1 (see table 
3 and figure 9B), spanning the region between nt 567-1548, 
were used in a cDNA-PCR reaction to look for E1A-E1B cotran­
scripts. The results are shown in figure 17A. A 179bp cDNA 
product was consistently amplified in this reaction using 
infected cell RNA as template, (lane 3) whereas using viral 
DNA as template a 982bp fragment was obtained (lane 4). No 
product was obtained from mock infected cell RNA template 
(lane 2). The 179bp cDNA product was isolated and in the 
absence of restriction sites in the primers, cloned into 
the Smal site of M13 and sequenced (figure 17B). The 
sequence corresponded to nt 567-604 and 1408-1548 of the 
genomic DNA sequence (figure 17C). The 5' side of the 
junction (GCT/TCATGA, nt 602-610) bears no resemblance to a 
splice donor site and is located upstream of all the E1A 
splice sites mapped by van Loon e t  a l . ,  (1987b). The 3' 
side of the junction maps between the E1B mRNA cap sites
defined by primer extension analysis, and the sequence
(TTTTAGTGTTAGTTT/A, nt 1393-1408) lacks a splice acceptor 
consensus. Five clones of the 179bp fragment obtained from 
two different RNA preparations gave an identical sequence 
and a fragment of this size was consistently obtained in 
numerous independent PCR reactions. This indicates that
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this unconventional RNA junction is not an artefactual 
result of the PCR reaction but represents a real junction in 
E1A-E1B cotranscripts. Assuming that these transcripts 
share a 5 ’ end with E1A mRNAs they contain the first 40 
codons of the E1A ORF linked to E1B. No new ORFs are
created by the junction and the E1A ORF terminates with one
codon added after the junction. The nature of these cotran­
scripts was further investigated by Northern blotting (see
4.2.2.3.).
A cDNA-PCR reaction was used to analyse the splice 
junction in the 22S mRNA. This was done in order to clarify 
if the potential splice donor site indicated by SI analysis 
around nt 3088 (figure 13; see 4.2.2.1.iii) as well as the
predicted site at nt 3151 was utilized in the 22S mRNA.
Oligonucleotides VS4 and VS6 (table 3; figure 9B), spanning 
nt 3000-3287 amplified a single spliced product (not shown). 
The size of this fragment (217bp) was consistent with the 
use of a splice donor at nt 3151 and a splice acceptor at nt 
3222. This indicated that the potential splice donor sites 
mapped by SI analysis around nt 3088 (figure 13) are not 
used in the 22S mRNA. Primer VS6 lies upstream of the 
splice acceptor site used in the 14S mRNA and thus this PCR 
product is not amplified from a 14S template. Moreover, the 
14S cDNA (described above) was amplified using primer RU4 
demonstrating that this mRNA species is not spliced at nt 
3088 either. The formal possibility remains that an mRNA 
species exists which uses the splice acceptor at nt 3061, a 
splice donor around nt 3088 and the splice acceptor site at 
nt 3222, which would account for the 147 and 151nt bands 
detected by SI analysis in figure 13. A more likely 
explanation is that those bands are artefactual and the site 
at nt 3151 is the only splice donor site in this region (see 
figure 9A).
In order to distinguish between a 14S mRNA structure, 
identified above, and a possible 13S mRNA structure 
analogous to the Ad2 E1B 13S mRNA, several attempts were 
made to amplify cDNA using primers from the first and the 
last ElB exons. A seemingly ideal primer pair was VS4-RU3
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(see figure 9B). However, using VS4 in primer extension 
analysis resulted in extended products from mock infected as 
well as infected cells (Hela as well as KBa+b), and these 
products were amplified using RU3-VS4 in a PCR reaction, 
even under stringent conditions. From the primer extension 
data it was clear that these products were much more 
abundant than products extended from E1B mRNA template 
(similar in abundance to products from ppIX mRNA template, 
not shown). This would explain why they appeared to be 
preferentially amplified over E1B cDNA template in a PCR 
reaction. Consequently no E1B specific products were 
identified by this method. Using RU3-VS5 as a primer pair 
in this reaction did not give reproducible results. Thus 
this apprqjbh did not clarify if the Ad40 E1B region is tran­
scribed into a 13S mRNA as in Ad2 or if such a transcript is 
absent as is the case in Adl2.
4.2.2.3. Northern blot analysis of El transcripts
From the primer extension analysis it was clear that the 
E1B cap site is used, while evidence from the cDNA analysis 
showed that some E1B transcripts are linked to a
fragment from the 5' end of E1A. As an approach to deter­
mine which types of E1B transcripts have an E1A 5 ’ end and 
to further resolve the structure of El transcripts, total 
RNA harvested at 42 hr p.i. was separated on a methyl 
mercury gel. This gel system was chosen in order to get a 
better resolution of mRNA species than that obtained on the 
formaldehyde gels used previously (figure 8). RNA was 
blotted onto a nylon membrane and blots probed with selected 
restriction fragments from the El region. Based on the cDNA 
sequence data, one E1A probe was selected that would not 
detect the predicted E1A-E1B cotranscripts and another one 
chosen that would hybridize to the E1A sequences in such 
transcripts. In addition the E1B probe that was used was a 
fragment near the 3 ’ end of E1B that should recognize all 
ElB transcripts and ppIX mRNA but not IVa2 mRNA.
When the RNA was probed with the E1A fragment nt 709-1211
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(figure 18, lane 2) two bands were observed, corresponding 
to E1A 12S and 13S transcripts. However, when the adjacent 
fragment nt 1-709, comprising the 5 ’ end of E1A, was used 
(figure 18, lane 1) two additional bands were seen. Those 
bands comigrated with the 22S and 14S bands detected by the 
E1B probe, nt 2857-3410 (figure 18, lane 3). This shows 
that the E1A-E1B cotranscripts identified by cDNA analysis 
exist as two types, having 22S and 14S E1B structure. The 
band migrating below the 14S cotranscript in lane 3 is 
likely to be the E1B 14S mRNA which would differ from its 
cotranscript counterpart by 180nt and should thus be 
separated in this part of the gel (the E1A 12S and 13S 
differ by 84nt). On the other hand the 22S cotranscript 
would not be separated from its E1B counterpart on this type 
of gel. The intensity of the 14S cotranscript bands in lane 
1 and 3 demonstrates that the specific activity of the 
probes is similar. The increased intensity of the E1B 22S 
signal as compared to the corresponding E1A signal thus 
indicates that the E1B band is heterogeneous, containing 
22S type transcripts from both the ElA and the E1B promoter. 
The E1B probe also gave a strong 9S band, corresponding to 
the predicted mRNA encoding structural polypeptide IX. A 
potential E1B 13S mRNA is predicted to be 90nt smaller than 
the 14S mRNA. The absence of a band between the 14S and 
ppIX mRNAs (lane 3) thus implies that a 13S mRNA is not
produced from the Ad40 E1B region.
4.2.2.4. Summary
The Ad40 E1B transcription map was determined from RNA 
produced at late times in infected KBa+b cells. The results 
are shown in figure 9A. E1B transcripts corresponding to
Ad2 14S 22S and 9S mRNA were identified but no 13S mRNA
equivalent was detected, a pattern similar to that seen in 
the Adl2 transcription map. The coding potential for E1B 
19K, 55K and 15K proteins and for polypeptide IX is retained 
in the Ad40 transcripts. In addition novel E1A-E1B cotran­
script counterparts of the 14S and 22S mRNAs were detected.
E1A E1B
5‘ 3‘ 3‘
22 S - 
14 S -  
13 S -  
12 S -
9 S -
1 2 3
Figure 18: Northern blot of El mRNA
Total RNA from Ad40 infected KBa+b cells harvested at 
42 hr p.i. was separated on a 1% agarose/methyl mercury gel 
and analysed on a Northern blot. The blot was probed with 
ElA (lanes 1 and 2) and E1B (lane 3) DNA restriction frag­
ments and exposed overnight. The E1A 5' probe (lane 1) is a 
PstI fragment of pNM82 (nt 1-709), the E1A 3' probe (lane 2) 
is a Pstl-AccI fragment of pNM82 (nt709-1211), and the E1B 
3' probe is an EcoRI-PstI fragment of pNM86 (nt 2857-3410). 
Numbers on the right are the sizes of the RNA marker (9.5-kb 
RNA ladder, BRL). Numbers on the left are S values as
referred to in the text, but do not signify specific S 
values for these mRNA species (note that E1B 14S comigrates 
with ElA 13S).
- 4.4 kb
- 2.4 kb
k
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These are predicted to be 5' coterminal with E1A transcripts 
and contain the first 40 codons of the E1A first exon linked 
to a site 4-5 nt downstream of the E1B cap site, retaining 
all the coding potential of the E1B mRNAs. No new open
reading frames are created by the junction, and the E1A ORF 
terminates with one codon added after the junction. The 
E1A-E1B junction is unusual in that it does not conform to 
splice consensus sequences and thus may not be generated by 
a conventional splicing mechanism.
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4.2.3. A timecourse of El transcription and DNA replication 
in Ad40 infected Kba+b cells and Hela cells
The mapping of E1B mRNA led to the unexpected observation 
of E1A-E1B cotranscripts. Although these transcripts do not 
appear to be formed by conventional splicing mechanism they
may be the product of a primary transcript extending from
the El cap site to the E1B poly A site. Such a transcript
would be made by a read through of the E1B promoter, and if
it was made early in infection it could interfere with tran­
scription from the E1B promoter.
The experiments described below were performed to address 
several questions. Firstly, to see if E1A-E1B cotranscripts 
could be detected at early times in infection, before tran­
scripts from the E1B promoter are detectable; Secondly, to 
look at a timecourse of DNA replication in parallel with a 
timecourse of transcription in order to see if E1B tran­
scripts can be detected before the onset of DNA replication; 
Thirdly to compare the pattern of transcription and repli­
cation in the permissive KBa+b cells with that seen in Hela 
cells, which are only semi-permissive (see 4.4.).
KBa+b cells and Hela cells on 50mm plates were infected 
with lOOyl of a 1/10 dilution of Ad40 p9 and harvested at 
various times post infection. After incubation at 37°C two 
plates of each cell type were pooled and harvested at each 
timepoint. Cytoplasmic RNA was extracted and DNA was 
recovered from the nuclei by Hirt extraction. Subsequently 
the RNA was run on three 1% agarose/5mM methyl mercury gels 
(1/4 harvest of a 50mm plate/lane) and blotted onto Hybond-N 
membranes. Blots were probed with three different DNA 
fragments from the El region, selected to distinguish 
between E1A and E1B mRNAs and cotranscripts, labelled by the 
random priming method. Hirt DNA (1/4 of a 50mm plate) was 
applied to Hybond-N on a slot blot and probed with a nick 
translated Ad40 El plasmid (pNM82).
The results are shown in figure 19. Panel A shows a time­
course of Ad40 infected Hela cell and KBa+b cell RNA probed 
with an E1A fragment (nt 709-1211). This probe does not 
overlap E1A sequences found in the E1A-E1B cotranscripts
Figure 19: A timecourse of El transcription and DNA replica­
tion in Hela cells and KBa+b cells
Cytoplasmic RNA was harvested from mock infected and Ad40 
infected Hela cells and KBa+b cells at the times indicated 
post infection. DNA was harvested from the nuclei in 
parallel by Hirt extraction. Aliquots of RNA were separated 
on three 1% agarose/5mM methyl mercury gels (1/4 harvest of 
a 50mm plate/lane) and blotted onto nylon membranes. Hirt 
DNA (1/4 harvest of a 50mm plate) was applied to a nylon 
membrane on a slot blot.
A) A Northern blot probed with an E1A restriction
fragment (nt 709-1211) which does not overlap the E1A-E1B 
cotranscripts, labelled by the random priming method. The 
blot was exposed for 7 days.
B) A Northern blot probed with an E1A restriction
fragment (nt 1-709) overlapping the E1A-E1B cotranscripts, 
labelled by the random priming method. The blot was exposed 
for 7 days.
C) A Northern blot probed with an E1B restriction
fragment (nt 2857-3410) which overlaps all ElB mRNAs but not 
IVa2. The fragment was labelled by the random priming 
method and the blot exposed for 3 days. A longer exposure 
did not reveal E1B mRNA at earlier timepoints than seen 
here.
D) A slot blot of Hirt DNA was probed with a nick trans­
lated plasmid from the Ad40 El region (pNM82) and exposed 
for 5 days. On the original autoradiograph the levels seen 
in the timecourse on Hela cells up to 24 hr are similar to 
that seen in mock infected KBa+b cells.
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mapped previously. Panel B is a parallel blot probed with
an adjacent E1A fragment (nt 1-709) which should identify 
the E1A-E1B cotranscripts as well as E1A transcripts. The 
blot in panel C was probed with an E1B fragment (nt 2857- 
3410) which detects all E1B mRNAs as well as the E1A-E1B 
cotranscripts. A parallel timecourse of nuclear DNA in 
both cell types is shown in panel D. Panel C shows that the 
E1A-E1B cotranscripts appear at the same time as E1B mRNAs 
and are not seen at early times in infection. Therefore 
they are not likely to be the cause of a lack of early E1B 
transcription by promoter occlusion, although the
possibility remains that they are made early but in 
undetectable amounts or that they are unstable. In KBa+b 
cells the 12S E1A mRNA is first seen at 18 hr p.i. and all 
other El mRNAs, including E1A-E1B cotranscripts, appear 
between 18 and 24 hr p.i. The first increase in viral DNA 
levels in KBa+b cell nuclei is also seen at 24 hr p.i. In
Hela cells El mRNAs become detectable even later and DNA
replication is more delayed, E1A 12S and 13S mRNAs are seen 
at 24 hr p.i. while E1B mRNAs and E1A-E1B cotranscripts 
appear between 24 and 30 hr p.i. A slight increase in DNA 
levels is seen at 30 hr p.i. with a further increase between 
36 and 42 hr p.i. Thus the pattern of transcription and 
replication appears to be similar in KBa+b cells and Hela 
cells. E1A mRNA appears first and six hours later the E1B 
22S, 14S and ppIX transcripts as well as the E1A-E1B cotran­
scripts are detectable along with a slight increase in DNA 
levels. Over the following six hours RNA levels increase 
but change in DNA levels is not detectable. After a further 
six hours DNA levels have risen and increase rapidly after 
that in KBa+b cells. This procedure begins later in Hela 
cells than in KBa+b cells and increase in DNA replication is 
less dramatic at least up to 42 hr p.i.
These experiments are not conclusive as to whether E1B 
mRNA is made before the onset of DNA replication. Mautner 
e t  a l . ,  (1990) found that they could not detect E1B mRNA 
until 30 hr p.i, after the onset of DNA replication at 18-24 
hr p.i. in KBa+b cells and they did not see accumulation of
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RNA in the presence of a replicative block up to 42 hr p.i. 
Furthermore, they did not detect any E1B mRNA up to 42 hr 
p.i. in Hela cells but saw an increase in DNA levels at 30 
hr p.i. Differences in extraction methods and sensitivity 
of probes may at least partly explain this discrepancy. 
Moreover, their experiment used a different virus stock, 
thus the multiplicity of infection may differ between the 
experiments. A higher multiplicity of infection in the 
experiment described here would account for an increase in 
transcription. The onset of DNA replication is detected at 
the same time in both experiments but they detected E1B mRNA 
at later times than seen in this experiment. However, the 
results described here are in agreement with an RNA time­
course described in section 4.2.1., thus supporting this 
data.
The onset of DNA replication and E1B transcription around 
the same time may suggest that one is dependent on the 
other. It has been shown previously that the E1B 55K 
protein is required for DNA replication in Adl2 (Shiroki e t  
a l ., 1986) but not in Ad5 (Babiss and Ginsberg, 1984). In 
Ad40 E1B mRNA does not accumulate when DNA replication is 
blocked (Mautner e t  a l . ,  1990). The reason for this could 
be that in Ad40, DNA replication is inefficient in the 
absence of the E1B 55K protein and that the E1B region is 
only transcribed on newly replicated DNA. This would be 
consistent with the small increase in DNA level seen 24-30 
hr p.i. followed by the detection of E1B RNA and later 
increased DNA replication. It would also explain the 
finding that E1B mRNA does not accumulate under a replica­
tive block. An alternative explanation could be that E1B 
transcription is inefficient and therefore not detectable 
until after DNA replication when an increase in template 
results in a detectable transcription level.
The Ad40 El transcription pattern is remarkably different 
from that seen in an Ad5 infection on Hela cells at a 
moderate multiplicity of infection (Glenn and Ricciardi, 
1988). Ad 5 El A transcripts were detectable at 2 hr p.i., 
ElB 22S at 3.5 hr p.i. and low levels of ElB 13S were seen
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early with an increase after 8 hr p.i. In addition the ppIX 
9S mRNA was detectable after 8 hr p.i. with a rapid increase 
at 10-12 hr p.i., and a IVa2 mRNA was seen at 9.5 hr p.i. 
The onset of DNA replication was not determined in this 
study. Not only is the whole transcription process severely 
delayed in Ad40 as compared to Ad5 but also the time lag 
between early and late transcription appears absent, since 
E1B transcripts are not seen before the ppIX mRNA. It is 
however notable that the time lag between the onset of E1A 
and E1B transcription is seen, suggesting that Ad40 E1B 
transcription may be activated in the presence of E1A and 
that the delay is due to a delay in transcription of E1A. 
Although this may partly explain the late onset of E1B 
transcription it can not be the only reason since providing 
E1A by coinfecting with an E1B mutant virus or using a cell 
line expressing E1A does not result in complementation of 
Ad40 growth.
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4.3. The Ad40 E1B promoter
E1B transcripts were not detectable before the onset of
DNA replication in KBa+b cells and Hela cells (see above). 
This implies that the E1B promoter may be inactive at early 
times in infection. The E1B promoter region is discussed in 
detail in section 1.3.2. The Ad2 E1B promoter is a simple 
promoter, consisting of a TATA box and an Spl binding site 
(GC box) (Wu e t  a l . ,  1987). Only mutations in the TATA box 
interfere with E1A transactivation, suggesting that E1A 
activation of E1B is mediated through the TATA box. Parks 
e t  a l . ,  (1988) identified four protein binding sites in the 
upstream region of the Ad5 E1B promoter (see figure 3) and 
suggested that they might be involved in stimulation of 
transcription in the absence of a functional GC box. Figure 
20 shows a comparison between the E1B promoter sequences of 
Ad40 and other adenovirus serotypes of different subgroups. 
The sequences have been lined up with respect to the E1A 
termination codon, E1A poly-adenylation signal, Spl binding 
site, TATA box and the initiation codon for the 19K ORF. 
The TATA box sequence of Ad40 is identical to that of Ad2, 4 
and 7 and is in a similar position relative to the cap site. 
The consensus sequence for an Spl binding site is 
5 ' (G/T)GGGCGG(G/A)2 (C/T) (Kadonaga e t  a l . ,  1986). The Ad2 
sequence fits this consensus perfectly, but all the other 
sequences vary slightly. The Ad40 sequence differs from 
Adl2 by one base in the flanking sequence so that both 
sequences have two bases different from the consensus. Of 
the upstream elements identified by Parks et al.,(1988), 
only one, site IV (nt 224-231 in figure 20), is apparent in 
the Ad40 E1B promoter. The sequence, TGTGTTTA (-59 to -52 
relative to the cap site) has a one base difference from the 
TGTGGTTA (-137 to -125) in Ad5 E1B and similar sequences are 
present in Ad4, Ad7 and Adl2.
In general the Ad40 E1B promoter appears similar to E1B 
promoters of other serotypes. It has a potential Spl 
binding site, shown to be important for E1B transcription in 
Ad2, and it has a TATA box identical to that of Ad2, where
Figure 20: E1B upstream sequences
A comparison of E1B promoter sequences of Ad40 (subgroup
F ) , Ad7 (subgroup B) , Ad4 (subgroup E ) , Adl2 (subgroup A ) ,
Ad2 (subgroup C), simian adenovirus 7 (Sav7) and mouse
adenovirus 1 (Admav). The sequences were lined up with
respect to the E1A stop codon, E1A polyA signal, Spl binding
site, TATA box and E1B 19K start codon. The known E1B cap
sites are indicated. The numbering system is arbitrary and
does not refer to the genomic sequences. The figure was
prepared by Dr V. Mautner. DNA sequences were obtained from 
the EMBL databank.
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ATGGTTTTAG TGTtQ gTTTA TTCTG............................
GATCTGTGTG GTiQ gCTCAC AGCAACTTGC TGCCATCC.............
GACCTGTGTG (VTTAGCTCAG AGCGGT...........................
TGTTGCTTTG A&TAGTTCAT CTTAGTA..........................
GGCTAATCTT GGT^Qc0TCT GACCTC..... • ....................
CAGGTTATAA GGGTACTTAG 
CTTGGTCAGG GGTGCATTAT
EIB 19K341
GCAACGCTCA GGTAACATCG CCTCC....
TTGGTTTCTG CGGCGGAGTG GTTAGGGTAG
GCTGCAAT..
AT
AT
ATG3AGTTGT 
ATG 3AGGTTT 
ATG 3AGATTT 
ATG 3AGTTGG 
ATG 3AGGCTT
GGAGTGAGTT
GGGCTATCTT
GGACGGTTTT
AAACTGTGCT
GGGAGTGTTT
380
ACAACAGTTA
GGAAGACCTC
GGAAGACTTT
GCAAAGTTTT
GGAAGATTTT
G 3 
GT
ATCTCC GAACGGCGCT TCAGACTTTT 
TACCTG TGTATCCCTT TCTTGGCTCC
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the TATA box has been shown to be important for E1A trans­
activation of E1B. So the differences in E1B gene expression 
between Ad40 and other serotypes do not reflect obvious 
differences in sequences of important promoter elements. 
However, there might be more subtle differences between 
promoters which are not apparent from simple sequence com­
parisons. As an approjjbh to studying the Ad40 E1B promoter 
the expression of a reporter gene under the control of this 
promoter was determined in the presence or absence of 
plasmids expressing the E1A genes of Ad40 or Ad5.
4.3.1. Construction of CAT reporter plasmids
In order to assess the activity of the Ad40 E1B promoter, 
plasmid constructs were made with the chloramphenicol acetyl 
transferase (CAT) gene under the control of the Ad40 E1B 
promoter. The plasmid pElB-CAT was used as a basis for 
these constructs (Dery et al., 1987). This plasmid consists 
of the Ad5 E1B promoter (nt 1336-1702) inserted between the 
Hindlll-Xhol sites of pBA-CAT, upstream of a promoterless 
CAT gene (figure 21B). It was shown to have a low activity
when transfected into Hela cells but cotransfection with an
Ad5 E1A containing plasmid resulted in a 2-3 fold increase 
in CAT activity.
Four DNA constructs containing Ad40 E1B promoter
sequences were made by PCR. The downstream and upstream 
primers contained Hindlll and Xhol restriction sites
respectively to facilitate cloning of the constructs into an 
expression vector. Primer VS13 was used as a downstream 
primer for all the constructs. It includes the E1B cap site 
(-8 to +9, see figure 20) and has a Hindlll restriction site 
near the 5' end. Four upstream primers (VS9-VS12), all 
including a 5' Xhol site, were used in order to make
constructs with different lengths of upstream promoter
sequences (see figure 21B). The primers were designed so
that the shortest construct (9/13) would include only the
TATA box, the second one (10/13) extends just beyond the Spl 
binding site, the third fragment (11/13) extends beyond the
Figure 21: Construction of CAT expression vectors
A) PCR products containing E1B promoter sequences were 
analysed on a 2% agarose gel prior to restriction digestion 
and cloning (see text for details). The size of each 
fragment (bp) is indicated on the left; numbers on the right 
refer to the size marker. Lane 1: a 67bp product amplified 
using primers VS9 and VS13; lane 2: an 84bp fragment
amplified using primers VS10 and VS13; lane 3: a 138bp
fragment amplified using primers VS11 and VS13; lane 4: a 
379bp fragment amplified using primers VS12 and VS13; lane 
5: a 123bp ladder was used as a size marker. Primers VS9- 
VS12 contain a Xhol restriction site 5' to Ad40 sequences. 
Primer VS13 contains a Hindlll restriction site 5 ’ to Ad40 
sequences.
B) The plasmid pElB-CAT containing the CAT gene in a 
Hindlll-BamHI fragment, under the control of the Ad5 E1B 
promoter, in a Xhol-Hindlll fragment, was used as a basis 
for the construction of CAT expression vectors containing 
the Ad40 E1B promoters. The Ad5 E1B promoter was removed 
from the plasmid by Xhol-Hindlll digestion and the backbone 
isolated from a NuSieve agarose gel. The PCR products seen 
in lanes 1-4 in A were digested with Hindlll and Xhol and 
ligated into the pElB-CAT backbone, creating the plasmids 9- 
13-CAT, 10-13-CAT, 11-13-CAT and 12-13-CAT respectively.
Numbers in the diagram refer to the Ad40 genomic sequence 
(Ad5 sequence for pElB-CAT). TA and GC indicates the 
position of the TATA box and Spl binding site.
AB
VS12
379-
-246
1 2 3 4 5
VS9 »
TA
1368 h VS 13 9 - 1 3 - C A T
VS10 y£ C _
1352 h VS13 1 0 - 1 3 - C A T
VS11 y
1298 h VS13 1 1 - 13 - CA T
1057
t
Xhol
1411
t
Hindlll
i  VS13 1 2 - 1 3 - C A T
BamHI
1336 Ad5 E1B 1702 C AT
Xhol A d 5 E 1B Hindlll
C A T
p E 1 B - C A T
BamHI
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E1A poly A signal and includes site IV and the longest 
fragment (12/13) is comparable in length with the Ad5 
promoter in pElB-CAT (see below) and extends into the E1A 
intron. Primer sequences are shown in table 3 (section 
2.6.) .
PCR reactions were set up as described (see 3.18) using 
lOng pNM82, an Ad40 El-containing plasmid, as a template. 
Amplification was performed as follows; One cycle of dena- 
turation at 94°C/5 min, annealing at 35°C/0.5 min and 
extension at 72°C/0.5 min followed by 30 cycles of dena- 
turation at 94°C/0.2 min, annealing at 55°C/0.2 min and 
extension at 72°C/0.2 min. Initial annealing of primer at a 
low temperature in the first round of amplification was 
essential since the Tm of VS13 is very low in the absence of 
homology between the linker sequence and template. A tenth 
of each sample was analysed on a 2% agarose gel (figure 
21A). The 67bp 9/13 fragment, 84bp 10/13 fragment, 138bp 
11/13 fragment and 379bp 12/13 fragment are shown in lanes 
1-4 respectively.
The PCR products were digested with Hindlll and Xhol and 
cloned into the Hindlll-Xhol sites of the plasmid pElB-CAT 
after removing the Ad5 promoter from the plasmid by a 
Hindlll-Xhol digest (see 3.11.3. and figure 21B). DH1 cells 
were transformed and colonies screened by examining 3 ’ end 
labelled Hindlll-Xhol digest of miniprep DNA on a 12% non­
denaturing acrylamide gel. Large scale DNA preparations 
were then made for each plasmid construct.
The Ad5 E1B promoter sequences, nt 1336-1702, in pElB-CAT 
(figure 21B) are replaced by the Ad40 E1B promoter 
sequences:
nt 1368-1411 in 9-13-CAT 
nt 1352-1411 in 10-13-CAT 
nt 1298-1411 in 11-13-CAT 
nt 1057-1411 in 12-13-CAT
In order to confirm that promoter sequences in the clones 
do not differ from the viral sequence, plasmids 10-13-CAT 
and 11-13-CAT were sequenced in both directions using the 
primers that were used to create the inserts (VS10/VS13 and
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VS11/VS13 respectively), and 12-13-CAT was sequenced using 
primers VS11 and VS13. All Ad40 sequences were identical to 
the published sequence. However, in 12-13-CAT the junction 
between the inserted fragment and the Hindlll site of the
plasmid was created by a blunt end ligation between the full
length primer sequence (not Hindlll digested) and the
backbone. This resulted in a duplication of the Hindlll 
site, effectively giving a 12bp insert between the Ad40 cap 
site and the initiation codon of the CAT gene. Since this 
insert is located in a leader sequence 14 bp downstream of 
the cap site and 43 bp upstream of the AUG, it is unlikely 
that it will affect either transcription or translation of 
the CAT gene.
4.3.2. Transient transfection assays
The Ad40 and Ad5 E1B CAT reporter plasmids were trans­
fected into WS Hela cells with or without plasmids
expressing E1A, in order to investigate the activity of the 
E1B promoter constructs and their response to E1A transacti­
vation. The ability of an unrelated 'universal' trans­
activator, the 140K immediate early protein of varicella 
zoster virus (VZV) (see Everett, 1987) to affect CAT gene 
expression from 12-13-CAT and E1B-CAT was also tested. The 
E1A expression vectors used were pNM80, which encodes Ad40 
E1A, pLElA which expresses Ad5 E1A and MT13S which contains 
the E1A 13S cDNA sequence under the control of the mouse 
metallothionein-1 promoter.
Cell plates transfected with 4pg of CAT plasmid and 4pg 
of inducer plasmid were harvested after 48 hr incubation at 
37°C. Total DNA was made up to 8yg with pUC8 in the absence 
of an inducer plasmid. Sonicated cell extracts (1/3 of a 
50mm plate) were incubated 1 hr/37°C with 14C Chlorampheni­
col in the presence of butyryl CoA, subsequently extracted 
with TMPD/Xylenes and CAT enzyme activity i.e. the yield of 
butyrylated chloramphenicol, determined by scintillation
counting of the organic phase.
The results are shown in table 5, expressed as counts per
Table 5. CAT Activity8
Plasmid/ Exp. 
1
no.
2 3 4 5 mean
Backgr. 334 456 343 331 308 354
pElB 425 512 518 384 430 454
+PNM80 736 582 691 479 622
+PLE1A 1502 729 1503 624 778 1027
+MT13S 1347 964 1012 1108
+pl40 2854 3669 3261
12-13 364 476 340 383 396 392
+PNM80 419 458 385 399 405 413
+pLElA 382 450 388 358 454 406
+MT13S 394 342 412 383
+pl40 518 563 541
11-13 348 522 337 337 386
+PNM80 268 500 318 369 364
+PLE1A 341 446 350 394 383
+MT13S 453 309 381
10-13 387 494 368 349 400
+PNM80 429 497 360 342 407
+PLE1A 382 495 391 377 411
+MT13S 489 367 428
9-13 480 558 416 374 457
+PNM80 427 508 358 359 413
+PLE1A 454 478 329 393 413
+MT13S 500 368 434
a activity is expressed as cpm
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minute. The results for every experiment are also presented 
in table 6 and figure 22A, where the CAT activity in the 
presence of an activator is expressed as a ratio of the 
activity of each promoter construct on its own. The mean 
values and standard error of the mean are also shown. 
Figure 22A is based on the mean values in table 6 and shows 
the effect cotransfecting with inducer plasmids has on CAT 
activity, which is taken to be indicative of promoter 
activity.
The activity of each vector in the presence of different 
activators was compared to expression from the vector on its 
own by applying students t-test on the paired data from each 
experiment. The plasmid E1B-CAT which has the CAT gene 
under the control of the Ad5 E1B promoter, shows a 1.3 fold 
increase in activity in the presence of Ad40 E1A (p<l($) . In 
the presence of Ad5 E1A a 2.3 fold increase is seen (p<5$ 
and a 2.5 fold increase in the presence of Ad5 E1A 13S 
(p<2#. On the other hand none of the Ad40 E1B CAT vectors 
show a significant increase in activity in the presence of 
E1A of either Ad40 or Ad5 (p>108 . 9-13-CAT, which includes
promoter sequences up to -35, is less active in the presence 
of pNM80 (p<5%) than on its own. In order to test the 
effect of a strong promiscuous transactivator on the Ad40 
E1B promoter, 12-13-CAT and pElB-CAT were cotransfected with 
pl40, a plasmid expressing the VZV 140K immediate early 
protein. A 1.4 fold increase in CAT activity from 12-13-CAT 
was seen in the presence of 140K and an 8 fold increase from 
pElB-CAT. This indicates that while the Ad40 E1B promoter 
can respond to this strong trans-inducing factor which 
activates the Ad5 E1B promoter, the effect is less marked.
The VZV 140K protein is a homologue of the HSV1 Vm w 175 
immediate early protein (McGeoch e t  a l .  , 1986) and the
pseudorabies virus IE protein (Cheung e t  a l ., 1989). These 
immediate early herpes virus proteins, particularly the VZV 
140K and the PrV IE proteins, are strong trans-activators
capable of activating several cellular and viral promoters
(for review see Everett 1987). Wu and Berk (1988a) have
shown that the TATA box region is required for
Table 6. Activation of CAT expression vectors8
Plasmid/ Exp. 
1
no.
2 3 4 5 mean SEM
pElB
+PNM80
+PLE1A
+MT13S
+P140
1.0
1.73
3.53
1.0
1.14
1.42
2.63
1.0
1.33
2.90
1.0
1.63
2.51
7.43
1.0
1.11
1.81
2.35
8.53
1.0
1.33
2.26
2.50
7.98
0.143
0.408
0.081
0.550
12-13
+PNM80
+PLE1A
+MT13S
+pl40
1.0
1.15
1.05
1.0
0.96
0.95
0.83
1.0
1.13
1.14
1.0
1.04
0.93
0.89
1.35
1.0
1.02
1.15
1.04
1.42
1.0
1.06
1.04
0.92
1.39
0.035
0.046
0.062
0.035
11-13
+PNM80
+PLE1A
+MT13S
1.0
0.77
0.98
1.0
0.96
0.85
0.87
1.0
0.94
1.04
1.0
1.09
1.17
0.92
1.0
0.94
1.01
0.90
0.066
0.066
0.025
10-13
+pNM80
+PLE1A
+MT13S
1.0
1.11
0.99
1.0
1.01
1.00
0.99
1.0
0.98
1.06
1.0
0.98
1.08
1.05
1.0
1.02
1.03
1.02
0.031
0.022
0.030
9-13
+pNM80
+PLE1A
+MT13S
1.0
0.89
0.95
1.0
0.91
0.86
0.90
1.0
0.86
0.79
1.0
0.96
1.05
0.98
1.0
0.91
0.91
0.94
0.021
0.056
0.040
a for each experiment, the activity of a vector in the 
presence of an activator is expressed as a ratio of the 
activity of that vector in the absence of an activator
Figure 22: E1B promoter activity
Plasmids containing the CAT gene under the control of the 
Ad40 E1B promoter (9-13-CAT; 10-13-CAT; 11-13-CAT; 12-13-
CAT) or the Ad5 E1B promoter (pElB-CAT) were transfected 
into Hela cells in the absence of an activator or cotrans­
fected with an activator plasmid: pNM80 (Ad40 E1A); pLElA
(Ad5 ElA); MT13S (Ad5 E1A 13S); pl40 (VZV 140K immediate 
early protein). Cells were harvested after 48 hr and cell 
extracts were assayed for CAT activity. After a phase 
extraction of acylated chloramphenicol the activity was 
determined by scintillation counting. The activity of each 
promoter construct in the presence of an activator is 
expressed as a ratio of the activity in the absence of an 
inducer in table 6. Panel A represents the mean values 
based on 2-5 experiments (table 6). A background level of 
counts was obtained from extracts without a CAT expression 
vector as a result of <0.5% of the free chloramphenicol 
being extracted into the organic phase. In table 7 the 
activity of uninduced and induced extracts is expressed as a 
ratio of this background for each experiment. Panel B 
represents the mean values of this ratio (same experiments 
as before, see table 7).
no 
in
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r
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transactivation of the Ad2 E1B promoter by the PrV IE 
protein as well as E1A. It is likely that the 140K protein, 
like the PrV IE protein and E1A, exerts its effect on the 
E1B promoter through the TATA box and thus the weak response 
of the Ad40 E1B promoter to the 140K protein is further 
indication that this promoter is less susceptible to 
activation through the TATA box than its Ad5 counterpart.
As a control in these experiments an extract from non­
transfected cells was assayed for CAT activity. This gave a 
background level resulting from <0.5% of the free chloram­
phenicol being extracted into the organic phase. In table 7 
and figure 22B the data is presented as the mean of the 
ratio of measured enzyme activity against this background. 
This is to give a better indication of the basal level of 
expression from each promoter construct. All the constructs 
show CAT activity slightly above background, although only 
9-13-CAT and 10-13-CAT (p<5%) and E1B-CAT (p<2%) differ 
significantly from the background.
These results indicate that while transcription from the 
Ad5 E1B promoter is activated in the presence of either Ad40 
or Ad5 E1A, the Ad40 E1B promoter is not affected to a 
detectable level. Due to the low basal activity of the E1B 
promoters seen in these experiments the results do not give 
conclusive answers as to whether the activity of the Ad5 and 
Ad40 E1B promoters in the absence of an inducer differ 
significantly. Others have found that expression from the 
Ad2 E1B promoter is inefficient in the absence of E1A trans­
activation in i n  v i t r o  assays (Wu e t  a l ., 1987). Early 
transcription of Ad2 E1B i n  v i v o  is dependent on E1A acti­
vation. The lack of activation of the Ad40 E1B promoter by 
E1A, as suggested by these results, most likely explains the 
finding that E1B mRNA is not detectable at early times in 
infection. This could in turn be the basis for the growth 
restriction of Ad40 in tissue culture since E1B 55K mutant 
viruses of other serotypes are restricted for growth in
tissue culture (see 1.3.5.). In particular, Adl2 mutant
viruses defective for the E1B 55K protein function are
severely impaired for viral DNA synthesis (Shiroki e t  a l . ,
Table 7. CAT activity above background8
Plasmid/ Exp. no.
1 2 3 4 5 mean SEM
Backgr. 1.0 1.0 1.0 1.0 1.0
pElB
+PNM80
+PLE1A
+MT13S
+pl40
1.27
2.20
4.50
1.12
1.28
1.60
2.95
1.51
2.01
4.38
1.16
1.89
2.91
8.62
1.40
1.56
2.53
3.29
11.91
1.29
1.76
2.98
3.05
10.27
0.073
0.209
0.615
0.121
1.645
12-13
+PNM80
+PLE1A
+MT13S
+pl40
1.09
1.25
1.14
1.04
1.00
0.99
0.86
0.99
1.12
1.13
1.16
1.21
1.08
1.03
1.56
1.29
1.31
1.47
1.34
1.83
1.11
1.18
1.16
1.08
1.70
0.052
0.054
0.081
0.141
0.135
11-13
+pNM80
+PLE1A
+MT13S
1.04
0.80
1.02
1.14
1.10
0.98
0.99
0.98
0.93
1.02
1.02
1.11
1.19
0.93
1.05 
0.99
1.05 
0.96
0.034
0.074
0.047
0.030
10-13
+PNM80
+pLElA
+MT13S
1.16
1.28
1.14
1.08
1.09
1.09 
1.07
1.07
1.05
1.14
1.05
1.03
1.14
1.11
1.09 
1.11 
1.13
1.09
0.024
0.057
0.013
0.020
9-13 
+PNM8 0 
+pLElA 
+MT13S
1.44
1.28
1.36
1.22
1.11
1.05
1.10
1.21
1.04
0.96
1.13
1.08
1.19
1.11
1.25
1.13
1.14 
1.11
0.066
0.053
0.087
0.005
a for each experiment, the activity is expressed as a ratio 
of the background level in non-transfected cell extracts
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1986; Brelding e t  a l .  t 1988; Mak and Mak, 1990).
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4.4. Ad40 growth in continuous cell lines
The growth restriction of Ad40 in tissue culture poses a 
practical problem for i n  v i t r o  studies of the virus. This 
problem has been partially overcome by growing the virus on 
the permissive KBa+b cells. However, these cells express
Ad2 El gene products, which may affect Ad40 gene expression 
and DNA replication and are thus not an ideal system in 
which to study Ad40. A better model system would be a cell 
line which can support efficient Ad40 growth, but which does 
not express viral gene products. A high number of viral 
particles in stools from Ad40 infected children (Gary e t  
a l .  , 1979; Retter e t  a l . ,  1979; Takiff and Straus, 1982) 
indicates that the virus replicates efficiently i n  v i v o .  
Ad40 is known to infect cells in the small intestine but it
is not clear which cell type or types are infected. It is
most likely that the growth restriction of the virus in 
tissue culture in some way reflects the tissue specificity 
of the virus and thus the ideal tissue culture system would 
be cells with properties similar to the natural host cells
of the virus. As an attempt to identify such a cell line
several cell types were tested for their ability to support 
replication of Ad40.
Figure 23 shows the results from one such experiment
where four different cell lines, EJ, HT29, pancreatic carci­
noma and Tera-2 C13 cells, were infected and compared to a 
parallel infection of KBa+b cells and Hela cells. Mono­
layers of each cell type on 50mm plates were infected with 
lOOpl of a 1/10 dilution of Ad40 p 9 . Following incubation
at 37°C for 72 hr virus was harvested and virion DNA pre­
pared. The DNA was analysed by restriction enzyme diges­
tion (not shown) and by slot blot analysis. Concentration 
of virion DNA was compared by densitometry. Ad40 replica­
tion on Hela cells is around 17% of that seen on KBa+b cells 
and replication on all the cell lines tested is negligible. 
Thus EJ, HT29, pancreatic carcinoma and Tera-2 C13 cells are
all nonpermissive for Ad40.
Figure 24 shows slot blot analysis of Ad40 DNA from
Figure 23: Ad40 virion production in different cell lines 
KBa+b, Hela, EJ, HT29, pancreatic carcinoma (PC) and 
Tera-2 C13 cells were mock infected or infected with lOOpl 
of 1:10 diluted Ad40 p9 stock. Virus was harvested at 72 hr 
p.i., the harvest of two 50mm plates pooled and virion- 
packaged DNA extracted. Dilutions (1/40, 1/120 and 1/360) 
were applied to a nylon filter on a slot blot and probed 
with a mixture of Ad40 E1A and E1B containing plasmids 
(pNM80 and pNM81). The top panel shows extracts from Ad40 
infected cells, the lower panel shows mock infected cell 
extracts. The bottom row shows plasmid control (5, 1.0 and 
0.2ng unlabelled probe).
1/40 1/120 1/360
Ad 40 
infected
Mock
infected
KBa+b
Hela
EJ
HT29
PC
Tera-2
KBa+b
Hela
EJ
HT29
PC
Tera-2
Probe
Figure 24: Ad40 virion production in different cell lines 
KBa+b, Hela, A549, Int407 and A431 cells were mock 
infected or infected with lOOpl of 1:10 diluted Ad40 p9 
stock. Virus was harvested at 72 hr p.i., the harvest of 
two 50mm plates pooled and virion-packaged DNA extracted. 
Dilutions (1/40, 1/120 and 1/360) were applied to a nylon 
filter on a slot blot and probed with a mixture of Ad40 E1A 
and E1B containing plasmids (pNM80 and pNM81). The top 
panel shows extracts from Ad40 infected cells, the lower 
panel shows mock infected cell extracts. The bottom row 
shows plasmid control (5, 1.0 and 0.2ng unlabelled probe).
1/40 1/120
Ad40
infected
Mock
infected
KBa+b
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three additional cell lines, A549, Int407 and A431, infected 
in parallel with Hela cells and KBa+b cells as described 
above. Virus replication on Hela cells was around 17% of
that seen on KBa+b cells as before and virion DNA was not
detectable in A431 cells. However, both A549 cells and 
Int407 show increase in DNA levels as compared to Hela 
cells. The DNA yield is 35% and 70% of that seen on KBa+b 
cells, for A549 and Int407 respectively. This was reflected 
in the cytopathic effect seen on the cells at 72 hr p.i., 
where a marginal cpe was seen on Hela cells with a more
marked effect on A549 and Int407 cells and a full cpe on
KBa+b cells. It is possible that with a longer incubation 
time higher yields of DNA could have been obtained. 
However, these preliminary experiments indicate that Ad40 
can grow in tissue culture in the absence of any 
complementing adenovirus functions. This is not an "on and 
off" effect since there is a range of per-
missivity from Hela cells to Int407. This could be due to
increasing amounts of some limiting factor or factors in 
these cells, possibly a factor essential for early tran­
scription or at least for efficient early transcription from
the E1B promoter. An alternative explanation could be that 
the need for an E1B 55K function varies between these cells 
and possibly the more permissive cells provide a function 
that can replace the E1B 55K protein to some extent. 
Replication of Ad40 in Int407 cells may be related to the 
intestinal origin of this cell line. Further investigation 
of the differences in Ad40 gene expression and replication 
between Hela cells and the more permissive Int407 cells may 
give some further insight into the molecular basis of the 
growth restriction of Ad40 in tissue culture and possibly 
how that reflects the tissue specificity of the virus.
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5. DISCUSSION
The work described in this thesis was aimed at under­
standing the molecular basis for the growth restriction of 
Ad40 in tissue culture. The involvement of the E1B region 
in the growth restriction is discussed in section 5.1. In 
section 5.2. the E1B transcription map is discussed as well 
as the significance of the E1A-E1B cotranscripts. Section 
5.3. considers the basis for the lack of early E1B protein
functions in Ad40 infected cells and how this may reflect
the tissue specificity of the virus. Future work towards
understanding the growth properties of Ad40 is discussed in 
section 5.4.
5.1. Involvement of the E1B region in the growth restriction 
of Ad40.
The El region was first implicated in the growth
restriction of the enteric adenoviruses when it was shown 
that these viruses grow on 293 cells, HEK cells transformed 
with the Ad5 El region, and not in primary HEK cells (Takiff 
e t  a l .  , 1981). A specific involvement of the E1B region in 
the growth restriction of Ad40 was demonstrated when Ad40 
was shown to grow equally well on KBb and KBa+b cells but 
the growth was as restricted on KBa cells as on KB cells 
lacking any adenovirus sequences (Mautner e t  a l . ,  1989).
Complementation of Ad40 by an Ad5 E1A (dl312) but not E1B 
(dl313) mutant virus further shows that supplying the E1A 
region i n  t r a n s  in the absence of E1B does not help Ad40 
replication while supplying the E1B region i n  t r a n s  in the 
absence of E1A results in complementation of Ad40 growth 
(section 4.1.). The involvement of other adenovirus gene 
products in the complementation of Ad40 by Ad5 and Adl2 
viruses can not be ruled out. However, it should be noted 
that none of the viruses used in the coinfection assays 
supported Ad40 growth to levels as high as seen in a single
infection on KBa+b cells, which is comparable to that seen 
on KBb cells (Mautner e t  a l . ,  1989). This may reflect a
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difference between cell types since KB cells are slightly 
more permissive than Hela cells (Mautner e t  a l . ,  1989). It 
also shows that providing the E1B region i n  t r a n s  in the 
absence of any other viral gene product is sufficient to 
give complementation of Ad40 as high as in the presence of 
any additional viral gene products. The finding that Ad40 
can complement dl312 growth further suggests that Ad40 
expresses an E1A gene product capable of transactivating 
adenovirus early genes. This is consistent with reports 
from van Loon e t  a l . , (1987a) and Ishino e t  a l . ,  (1988)
which show that in transient transfection assays the Ad40 
E1A region is capable of activating transcription from Ad2 
and Ad5 early promoters, albeit with lower efficiency than 
the Ad5 or Adl2 E1A gene products. The ability of Ad40 to 
complement an Adl2 E1A mutant virus could not be tested 
since the laboratory stock of the mutant hr700 grew as well 
as wild type on Hela cells (figure 7). This mutant was 
originally described as being severely defective for growth
on Hela cells (Breiding e t  a l . ,  1988), suggesting that the 
virus stock used in the experiment described here may
contain a revertant virus or be contaminated with wild type
virus.
Complementation of Ad40 by E1A but not E1B mutant viruses 
indicates that the growth defect of Ad40 may be related to a 
lack of E1B 55K protein function. However, Ad40 appears to 
provide some helper function for the Ad2 and Adl2 E1B 55K 
mutants dll520, in602 and dl620 (figures 6 and 7). None of 
these mutants express detectable amounts of 55K protein 
(Barker and Berk, 1987; Byrd e t  a l . ,  1988). It i; possible 
that Ad40 expresses low levels of the 55K protein or
alternatively a 55K protein which is functionally less
active in Hela cells than its Ad2 or Adl2 counterparts,
which could account for some complementation of viruses
devoid of any 55K protein. However, no E1B 55K product has 
been detected in Ad40 infected cells, either by immunopre- 
cipitation using antipeptide antisera against the N- and C- 
terminal domains of the Ad40 55K protein, or by Western 
blotting (Mautner e t  a l . ,  1990), suggesting that if the 55K
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protein is made, the quantity is below the level of 
detection. Since the antisera do not precipitate i n  v i t r o  
translated 55K protein the quality of the sera is not known 
and the possibility that the 55K protein is expressed can 
not be excluded. It is equally possible that an increase in 
the levels of some other viral products in the presence of 
Ad40 may account for the increased replication of the 55K 
mutant viruses in double infections. The Adl2 mutants in602 
and dl620 express very low levels of El proteins at a low 
multiplicity of infection (Byrd e t  a l . , 1988). Moreover, 
the replication of the Ad5 55K mutant dll520 on Hela cells 
is multiplicity dependent (Barker and Berk, 1987) suggesting 
that increased expression of gene products other than the 
E1B 55K protein may partially overcome the growth 
restriction. Tiemessen and Kidd (1988) have shown that Ad41 
growth on non-permissive cells is complemented in a 
coinfection with Ad2. Complementation is more effective 
when the cells are preinfected with Ad2. However, these 
experiments did not address the question which gene products 
are involved in the complementation, although it is likely 
to be El gene products since Ad41 grows well on 293 cells.
5.2. The E1B transcription map
The organization of open reading frames in the El region 
of human adenoviruses is very well conserved. Where tran­
scription maps have been determined they are similar, with 
E1A and E1B regions as separate transcription units. The 
E1B transcription map reported here for adenovirus 40 shows 
some important differences from the well characterized Ad2, 
namely the relative abundance of a 14S mRNA and the presence 
of E1A-E1B cotranscripts.
5.2.1. Comparison to other serotypes
The major mRNAs from the Ad40 E1B promoter correspond in
structure to the Ad2 22S and 14S transcripts, but no 13S 
mRNA equivalent is found (figure 9). In contrast, in Ad2
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the 22S and 13S mRNAs are abundant whereas the 14S, as well 
as a 14.5S mRNA are minor species (see figure 4). However, 
in Adl2, although a 13S mRNA has been reported based on SI 
analysis (Sawada and Fujinaga, 1980; Bos e t  a l ., 1981), by 
cDNA cloning Virtanen e t  a l , ,  (1982) detected two related 
14S but no 13S type mRNA. This is not inconsistent with the 
SI data since the splice sites used in a potential 13S mRNA 
are also used in a 14S mRNA, and suggests that Adl2, like 
Ad40, does not have a 13S mRNA. The amino acid sequences of 
the Ad40 E1B proteins are more closely related to Adl2 than 
to Ad2 (Ishino e t  a l ., 1988), and the same appears to be
true for the E1B splicing patterns. The effect of this 
difference in mRNA structure on gene expression is not 
clear.
The Ad40 E1B transcripts retain the coding potential for 
the major 19K and 55K E1B polypeptides. The 19K protein 
encoded by the Ad2 13S mRNA is also encoded by the 14S and 
22S mRNAs. However, the counterpart of the 82R polypeptide 
expressed from the 55K ORF of the Ad2 13S mRNA (figure 4) is 
likely to be absent from Ad40 as well as Adl2. The function 
of this protein is unknown. The 14S mRNA also encodes a 
protein from the 55K ORF, comprising the amino and carboxy 
termini of the E1B 55K protein. This 155R (15K) polypeptide 
has not been assigned a function in Ad2 so the significance 
of the relatively high abundance of the 14S transcript is 
not clear. In Ad2 the 15K protein cannot substitute for the 
55K protein in RNA transport or host shut off during 
infection (Babiss and Ginsberg, 1984; Babiss e t  a l . ,  1985; 
Pilder e t  a l . ,  1986). The Ad40 15K protein has been immuno- 
precipitated from infected cell extracts harvested at late 
times post infection (A. Bailey and N. Mackay, personal 
communication). The antiserum used was raised against a 
polypeptide expressed in bacteria from the 15K cDNA clone 
(see 4.2.2.2.). Although this antiserum immunoprecipitates 
i n  v i t r o  translated 55K as well as 15K E1B proteins, only 
the 15K protein has been identified in infected cell 
extracts.
The Ad40 ElB transcription map was determined from RNA
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harvested at late times in infection. This was necessary 
since E1B transcripts are not detectable at early times in 
infection. Transcription maps of the E1B regions of other 
adenovirus serotypes have mostly been determined using RNA 
from cells infected at a high multiplicity and early mRNA 
allowed to accumulate by using cytosine arabinoside (ara-C) 
block of DNA replication (Berk and Sharp, 1977b; 1978; 
Yoshida and Fujinaga, 1980; Kitchingman and Westphal, 1980; 
Dijkema e t  a l . , 1982; Virtanen e t  a l . , 1982; Virtanen and 
Pettersson, 1985; Hashimoto e t  a l . ,  1984). This approach 
was not possible in the case of Ad40 since even in the 
presence of an ara-C block early E1B transcripts fail to 
accumulate to detectable levels (Mautner e t  a l ., 1990). 
Moreover, although the infectious titre of the Ad40 virus 
stock was not determined in the absence of a suitable 
titration method, virus particle counts indicate that the 
virus concentration used for infections is approximately 103 
particles /cell. In spite of this high virus input, a low 
yield of Ad40 E1B RNA was obtained. The yield of E1B RNA 
from an Ad40 infection is at least 10-fold less than from an 
Ad5 infection at a modest multiplicity (Mautner e t  a l . ,  
1990). It has previously been reported that while the yield 
of Ad40 virions was 3-10-fold less than that obtained from 
an infection with other adenovirus serotypes the yield of 
infectious virus was 100-1000-fold lower (Brown, 1985). 
This suggests that a high proportion of Ad40 particles are 
defective and may explain the low RNA yield if only a subset 
of cells are productively infected, or if the defective 
particles interfere with the infection. Ad41 virus stocks 
have been reported to contain a large proportion of 
defective particles lacking the core protein V (Pieniazek, 
D. e t  a l . ,  1990). Similar studies have not been performed 
with Ad40.
Attempts to select messenger RNA using oligo dT resulted 
in loss of material and were thus not successful. Conse­
quently it has not been formally proven that the mapped
transcripts are poly-adenylated mRNAs. By analogy with 
other serotypes no E1B mRNA species are predicted to be made
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at early times in infection that are not seen at late times. 
It is therefore likely that the transcripts described here 
represent all major E1B mRNA species. However, the possi­
bility of minor RNA species cannot be excluded.
5.2.2. E1A-E1B cotranscripts
A novel type of E1A-E1B cotranscript was detected in Ad40 
infected cells, consisting of a short fragment from the 5' 
end of E1A linked to the E1B region 4-5 nt downstream of the 
major cap site. Both the 22S and the 14S type spliced 
products exist as E1A-E1B cotranscripts as well as being 
transcribed from the E1B promoter. The size of RNA seen on 
Northern blot is compatible with the cotranscripts being 5' 
coterminal with the E1A transcripts, starting at the E1A cap 
site mapped previously at nt 418 (van Loon e t  a l ., 1987b), 
although the 5' ends have not been analysed in detail. No 
new open reading frames are created by the E1A-E1B junction 
but if the cotranscripts start at the E1A cap site they
include the first 40 codons of the E1A open reading frame, 
followed by one amino acid and a termination codon
overlapping the E1B 19K ORF. It is not clear whether these
transcripts could be utilized in the cell to make E1B
proteins; most capped eucaryotic mRNAs appear to be 
translated by a scanning mechanism (Kozak, 1981) and the 
first AUG a scanning ribosomal subunit would encounter on an 
E1A-E1B cotranscript is the E1A start codon. With further 
AUGs downstream, preceding the E1B region, it seems unlikely 
that translation will be initiated from the E1B start
signals.
The sequences around the E1A-E1B junction in the cotran­
scripts do not conform to splice consensus sequences,
suggesting that they may not be formed by a conventional
splicing mechanism. The sequence around the 5' end of the 
junction is CGC/T/TCATGA, and the 3' sequence is
TTTTAGTGTTAGTT/T/A (the T residue at the junction could 
originate from the 5' or the 3' end as indicated; see figure 
170, compared to the consensus sequences (C/A) AG/GT (A/G) AGT
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and (T/C)iiN(C/T)AG/G (Mount, 1982). The cotranscript 
sequence was obtained consistently from several cloned frag­
ments amplified from different RNA preparations. Moreover, 
Northern blotting experiments confirmed the presence of E1A- 
E1B cotranscripts, and the detection of these transcripts by 
a restriction fragment from the 5' end of E1A and not by the 
3' adjacent fragment (see figure 18) is consistent with the 
position of the junction as mapped by cDNA sequencing. 
However, the location of the junction in the genomic 
sequence, and in particular the absence of a GT dinucleotide 
at the 5' end of the predicted intron, and an AG dinucleo­
tide at the 3' end was somewhat unexpected.
There are several ways of explaining how the anomalous 
junction may be formed. Firstly, the virus is passaged on a 
complementing cell line which provides Ad2 E1A and E1B 
functions, so an E1A deficient virus could grow on these 
cells. Thus the virus stock, or a variant within it may 
have a deletion in the El region corresponding to the 
junction in the cDNA. In order to test that possibility
virion DNA was amplified using the same primers that were 
used for the cDNA amplification. A product corresponding to 
the genomic DNA was obtained with no detectable smaller 
fragments, indicating that such a deletion is absent from 
the virus stock. Secondly, the DNA sequence of the virus 
stock might differ from the published sequence. The cDNA 
sequenced was identical to the published sequence but intron 
sequences might be different. To conform to the GT-AG rule 
there would have to be a point mutation T G at the splice 
donor site and a deletion of 2-3 T residues at the splice 
acceptor site. A way to address this possibility would be 
to amplify viral DNA in a PCR reaction using primers 
flanking either end of the junction, and sequence without 
cloning, looking for any ambiguity in the sequence at the 
junction. In a preliminary experiment, covering the 3' end 
of the junction, the sequence appeared uniform and identical 
to the published sequence, thus rendering this possibility 
unlikely.
A third possibility is that this E1A-E1B cotranscript is
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formed by a novel type of RNA processing which does not rely 
on sequences necessary for conventional splicing. It is not 
likely that the junction is formed by a conventional c i s -  
splicing mechanism. The selection of a 5' splice site 
involves a direct base pairing between the U1 small nuclear 
RNA (snRNA) and sequences around the splice site (Lerner e t  
a l .  , 1980; Rogers and Wall, 1980; Zhuang and Weiner, 1986). 
Such an interaction would not take place between the U1 
sequence 3’GUC CAUUCAU3 ’ and the 5' sequence around the 
junction in the cotranscript, 3 ’CGCIU4UCAUGA3 ’ (the arrows 
denote the position of the splice junction). A different 
splicing mechanism, termed t r a n s - splicing, has been observed 
in the mammalian parasite Trypanosom a b r u c e i and related 
species and in the nematode C a e n o r h a b d i t i s  e l e g a n s  (see 
Blumenthal and Thomas, 1988; Laird, 1989 for review). This 
involves the transfer of a 5' fragment from a spliced leader 
transcript (SL RNA) to a precursor mRNA with a 3' splice 
acceptor site. In nematodes the reaction takes place in the 
same nuclear compartment as cie-splicing and proceeds 
through Y-branched intermediates, analogous to the lariats 
formed in cis-splicing (Murphy e t  a l . , 1986; Sutton and
Boothroyd, 1986). In nematodes cis-splicing occurs as well 
as trans-splicing and small nuclear ribonucleoprotein 
particles (snRNPs), corresponding to those essential for 
c i s - splicing in other organisms (Ul, U2, U4/U6, and U5) have 
been identified (Thomas et a l . ,  1988). Like snRNPs from 
other animals these can be immunoprecipitated with
antibodies to the Sm antigen (Thomas et a l . , 1988), which is 
common to all these snRNPs (Bringmann and Luhrmann, 1986) . 
In trypanosomes cis-splicing has not been identified and a 
homologue for Ul has not been detected although the other 
snRNPs have been identified. However, the spliced leader
sequences in trypanosomes and nematodes contain a consensus
sequence for an Sm binding site (A[U3-6]G; Liautard e t  a l . , 
1982; Mattaj and De Robertis, 1985; Riedel et a l . ,  1987) and 
can be immunoprecipitated by anti-Sm antibodies (Bruzik e t  
a l . ,  1988; Thomas and Conrad, 1988; van Doren and Hirsh, 
1988) . These authors have suggested that an SL-snRNP
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particle may have a role similar to that of Ul in rendering
the 5' splice site susceptible to attack in a splicing
reaction. Recently Dandekar and Sibbald (1990) used several
known trans-splicing structures as a basis for a computer
search for putative new trans-splicing sites. They predict
that t r a i l s -splicing may occur in a wide variety of organisms
including the vertebrates. Their model predicts three stem-
loop structures and an Sm binding site (RR(>3U[0-1 non U]RR)
in a single stranded region near the 5' splice site. The
model is shown in figure 25, top panel. A similar structure
could be predicted around the 5' splice site in the E1A-E1B
cotranscripts, where the predicted Sm binding site is
GGUUUCGA (figure 25, lower panel). Some of the obligatory 
features in the stem-loop structure are not consistent with
the model, in particular the GG dinucleotide at the splice 
junction is absent in the Ad40 sequence. However, it would 
be of interest to see if this site can indeed bind Sm, which 
would raise the possibility of a mechanism related to trans­
splicing having a role in the processing of some Ad40 
transcripts. The requirements for the 3' splice site in 
t r a n s -splicing have not been analysed as extensively.
However, it is unlikely that a transcript from the E1B 
promoter could act as a 3' splice acceptor since the 3' site 
of the junction in the E1A-E1B cotranscript is only 5 nt 
downstream of the E1B cap site. Therefore a splicing reac­
tion in which the 5* end of an E1A transcript acts as an 
snRNA would most likely take place on a transcript over­
riding the E1A poly A signal, extending from the E1A cap
site to the E1B poly A site.
Adenovirus E1A-E1B cotranscripts have been detected 
previously at low abundance in Ad2 and Adl2 infected and 
transformed cells (Biittner e t  a l .  , 1976; Berk and Sharp,
1978; Kitchingman and Westphal, 1980; Chinnadurai e t  a l . ,  
1976; Sawada and Fujinaga, 1980; Saito e t  a l . ,  1983; van den 
Elsen e t  a l . ,  1983). The Adl2 cotranscripts are reported to 
have 5' ends and splice sites identical to the major E1A
mRNAs and to extend to the 3' end of E1B, with a splice
corresponding to the splice in E1B 22S mRNA. However, cDNA
Figure 25: The predicted secondary structures for the 5_!_
solice sites involved in t r a n s - splicing ajid for the 5_*_
splice site in the E1A-E1B cotranscripts.
The top panel shows a predicted RNA structure around 5' 
splice sites involved in trans-splicing (Dandekar and 
Sibbald, 1990). The model is based on RNA sequences in six 
known trans-splicing structures. The lower panel shows a 
potential secondary structure for the RNA sequences around 
the 5' splice site in the E1A-E1B cotranscripts. A 
consensus sequence for a binding site for the Sm antigen is 
indicated. The arrows denote the splice junction in the 
E1A-E1B cotranscripts. (The top panel was reproduced from 
Dandekar and Sibbald, 1990).
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sequences have not been determined. Berk and Sharp (1978) 
describe an Ad2 transcript consisting of fewer than 50 bp 
from the 5' end of E1A, linked to a site near the 5' end of 
E1B, resulting in a 22S type E1A-E1B cotranscript similar to 
the one described here, but the precise structure was not 
analysed, so it is not clear if it is made by conventional 
splicing.
Hashimoto e t  a l ., (1984) report i n  v i t r o  translation of
Ad2 E1A proteins from E1B selected transcripts, indicating a 
different structure for E1A-E1B cotranscripts. They sug­
gested that a splice acceptor consensus sequence downstream 
of the E1B cap site (CTCCTCCCAG/G, nt 1809-1819) may play a 
role in such transcripts. A similar sequence can be 
observed downstream of the Ad40 E1B cap site (CTTCTGCCAG/A, 
nt 1472-1482). The use of this potential splice acceptor 
would account for the 170 nt protected fragment seen in 
figure 10. However, no further evidence was obtained for 
the use of this splice site. A cotranscript with the
structure predicted by Hashimoto e t  a l , ,  (1984) including 
this splice site would have been expected to be detected by 
the cDNA-PCR amplification across the E1A-E1B junction (see 
figure 17). This was not seen and the only cDNA fragment
obtained in this reaction corresponded to the E1A-E1B 
cotranscript described above. This suggests that this 
alternative structure of an E1A-E1B cotranscript is absent
in Ad40 and indicates that the 170 nt fragment obtained by
the SI analysis (figure 10) may be artefactual (protection 
of a transcript from the other strand cannot be excluded). 
It is possible that the shortest template in the PCR 
reaction was preferentially amplified and a longer template, 
corresponding to the structure predicted by Hashimoto e t  
a l ., (1984) was therefore not detected. However, Northern
blotting experiments (see figure 18) support the conclusion 
that the cotranscripts described here are the only E1A-E1B 
cotranscripts present in detectable amounts.
The presence of minor RNA species not detected by the 
methods used here for the transcription mapping cannot be 
ruled out. A possible way of extending the analysis would
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be to prepare and screen a cDNA library from Ad40 infected 
cell RNA. This was not done here since the main purpose of 
the transcription mapping was to determine if the E1B 
transcripts retained the coding potential for the major E1B 
polypeptides predicted by analogy with other adenoviruses.
5.3. What is the basis for the lack of E1B early protein 
functions?
Although Ad40 E1B transcripts are made encoding the major 
E1B proteins they are not seen before the first increase in 
viral DNA in KBa+b cells or Hela cells (figure 19). 
Furthermore, E1B transcripts do not accumulate when DNA 
replication is blocked by cytosine arabinoside (Mautner e t  
a l ,  , 1990). This indicates that this conventionally early 
transcription unit (Berk and Sharp, 1977a; Evans e t  a l ,  ,
1977) behaves like a late gene in Ad40. However, since the 
first increase in E1B RNA and viral DNA is seen at the same 
timepoint (figure 19) it is not possible to determine if an 
increase in either E1B transcription or DNA replication 
occurs first, perhaps triggering off an immediate increase 
in the other. Although the E1B 55K protein is not essential 
for DNA replication in Ad5 (Babiss and Ginsberg, 1984), it
is required for replication of Adl2 DNA in infected cells 
(Shiroki e t  a l . ,  1986). This protein may be eqiMlly 
important for the replication of Ad40 DNA since replication 
begins earlier and is more efficient in KBa+b cells, where 
the 55K protein is provided i n  t r a n s , than in Hela cells.
However, a sudden increase in Ad40 E1B expression in the 
presence of Ad2 E1B gene products is unlikely to have a
great effect on DNA replication. Inefficient transcription 
from the E1B promoter would account for the late detection 
of E1B mRNA. The increase in E1B transcription seen around 
the onset of DNA replication may reflect transcription from 
an increasing number of templates. Alternatively, the
promoter may be more active on newly replicated DNA; such
activation has been suggested for the ppIX promoter
(Venkatesh and Chinnadurai, 1987). Both explanations are
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consistent with the finding that E1B mRNA does not
accumulate under a replicative block.
Transcription from the E1A region of Ad40 as well as the 
E1B region is severely delayed compared to Ad5. Ad40 E1A 
and E1B transcripts are first detected at 24 and 30 hr p.i. 
respectively in Hela cells and 18 and 24 hr p.i. respective­
ly in KBa+b cells (figure 19) whereas in an Ad5 infection of
Hela cells their counterparts are seen at 2 and 3.5 hr p.i. 
respectively (Glenn and Ricciardi, 1988). However, the lack 
of E1A gene products cannot explain the late appearance of 
E1B transcripts since Ad2 E1A proteins are expressed in 
KBa+b cells. Ishino e t  a l . ,  (1988) have previously shown
that the Ad40 E1A promoter is weaker that its Adl2 counter­
part, and the effect is cell type dependent. This may at
least partly explain the late detection of E1A mRNA as seen
in figure 19. Mautner e t  a l . ,  (1990) have shown that El 
transcripts do not accumulate in the nuclei; however, the 
possibility that El transcripts are made but are unstable 
cannot be excluded.
The most likely explanation for the lack of early E1B 
gene products in an Ad40 infection is that transcription 
from the E1B promoter is inefficient or absent at early 
times in infection. Early transcription of the E1B region 
like other early regions is dependent on transactivation by 
an E1A gene product. E1A activation is mediated through the 
E1B TATA box, while the Spl binding site is essential for 
efficient transcription from the E1B promoter but does not 
affect E1A transactivation (Wu e t  a l . , 1987; Parks e t  a l .,
1988). The lack of response to E1A transactivation by the 
Ad40 E1B promoter (table 6; figure 22A) can not however be 
attributed to a lack of a functional TATA box. The Ad40 E1B 
TATA box is identical to that of Ad5, which does respond to 
E1A activation, and also to TATA boxes of several other 
serotypes (see figure 20). Moreover, the Ad40 E1B promoter 
is capable of responding to another transactivator, the VZV 
140K protein, which is thought to act through the TATA box, 
although the activation is weak compared to the Ad5 E1B 
promoter (figure 22A). It is not clear if the GC box in the
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Ad40 E1B promoter is a functional Spl binding site. It is 
possible that weak binding of Spl to this site results in a 
low basal activity of the promoter. Mutations in the Spl 
binding site in the Ad2 E1B promoter result in a 5-fold 
decrease in activity (Wu e t  a l . ,  1987). These authors used 
SI analysis to detect transcription from mutated E1B 
promoters. The CAT assays described in section 4.3.2. show 
an induction of expression from the Ad5 E1B promoter by Ad5 
E1A similar to that seen previously (Dery e t  a l . , 1987). 
However, if the basal activity of the Ad40 E1B promoter is 
much lower than its Ad5 counterpart, 2-3-fold activation by 
E1A might not be detected in this system. Because no 
activity of the Ad40 E1B promoter above background could be 
detected it is not possible to determine by this method if 
the lack of transcription is due to a weak Spl binding site, 
the absence of E1A transactivation or some other factor. A 
substitution of one or both promoter elements, including 
flanking sequences, by its Ad5 counterpart might distinguish 
between these possibilities. This could also give an 
indication if any negative regulatory elements are present 
in the Ad40 E1B region.
The lack of early E1B gene expression in tissue culture 
raises the question what happens in an i n  v i v o  Ad40 
infection. The growth restriction of Ad40 in tissue culture 
does not reflect a defect in virus growth i n  v i v o  since a 
large number of virus particles can be isolated from 
infected children (Gary e t  a l . ,  1979; Retter e t  a l . ,  1979; 
Takiff and Straus, 1982). Efficient virus growth i n  v i v o  
suggests that either the E1B region is expressed at early 
times in infection in the host cells, or E1B early gene 
products are nonessential in these cells. The cell type 
that supports Ad40 growth in the small intestine has not 
been identified. Early E1B transcription in enteric cells 
could suggest the presence of specific transcription factors 
essential for E1B transcription in the enteric adenoviruses 
but not other adenovirus serotypes. Alternatively, negative
regulatory factors, interacting specifically with the 
enteric adenoviruses and present in most tissue culture cell
129
lines may be absent in those cells. If E1B early products 
are nonessential in the natural host cells, that would
suggest that late mRNAs are efficiently transported to the 
cytoplasm in the absence of the E1B 55K/E4 34K protein 
complex. A549 cells (human lung carcinoma cells) are more 
permissive for Ad40 than Hela cells (figure 24). These
cells are also more permissive for an E4 34K mutant virus 
(dl355) and host cell shut off, a function of the 55K/34K 
complex, is less affected in these cells than in Hela cells 
(Halbert e t  a l . ,  1985). This suggests that the need for the 
55K/34K complex is partly overcome in these cells and is
cell type dependent. Moreover, Adl2 E1B mutant viruses are 
less restricted for growth on A549 cells than on Hela cells 
(Breiding e t  a l . ,  1988). An indication that the 55K protein 
may not be essential at early times in infection in all cell 
types comes from recent studies using the intestinal cell 
line Int407. These cells are nearly as permissive for Ad40 
growth as KBa+b cells (figure 24). However, E1B transcripts
are not detectable at early times in infection (R. Ullah,
personal communication), suggesting that virus replication 
is not dependent on E1B early gene expression. It is
possible that these cells are more related to the natural
host cells of Ad40 than either Hela cells or KB cells.
However, even in Int407 cells Ad40 replication is ineffi­
cient compared to Ad5 growth in tissue culture, thus 
indicating that these cells may not entirely reflect the
conditions of virus growth i n  v i v o . It is of importance to 
identify the natural host cells of the virus in order to 
study the host cell functions important for the propagation 
of Ad40.
5.4. Future work
Detailed studies on Ad40 first became feasible when the 
virus was shown to propagate in KBa+b cells (Mautner e t  a l . ,
1989) thus providing a tissue culture system in which to 
grow the virus. The work presented here and by others in 
the last few years provides the basis for several
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interesting lines of studies.
The identification of the E1A-E1B cotranscripts opens 
several questions: (i) how are they made? (ii) are they 
important for virus growth? (iii) are they unique to Ad40 or 
can similar structures be found in other serotypes? An 
approach to study the mechanism by which the cotranscripts 
are made was discussed in section 5.2.2. Binding of the Sm 
antigen near the 5' splice site would open the possibility 
that a mechanism related to trans-splicing is involved in 
this procedure. Mutational analysis, in order to study the 
importance of the cotranscripts for the virus, is difficult 
until more is known about which sequences are important for 
the creation of the junction. It is possible that these
cotranscripts are not unique to Ad40. A report of a tran­
script with a similar structure in Ad2 (Berk and Sharp,
1978) suggests that they may be found in other serotypes as 
well, although in this case the sequence around the junction 
was not determined. It would be of interest to use PCR-cDNA 
analysis to look for E1A-E1B cotranscripts in Ad2 and other 
adenovirus serotypes.
If Ad40 E1B proteins are not essential in the natural 
host cells of the virus, they may not be functionally 
equivalent to their counterparts in other serotypes. This 
can be tested by removing the E1B coding regions from an Ad5 
virus and substituting the Ad40 E1B coding regions. It can 
then be seen if the Ad40 E1B proteins, expressed from the 
Ad5 E1B promoter can compensate for the lack of Ad5 E1B 
proteins. This type of experiment is currently being 
performed (A. Bailey, personal communication).
The lack of expression from the Ad40 E1B promoter can be 
investigated in several ways. A comparison of protein 
binding to the Ad40 and Ad5 E1B promoters might reveal 
important differences which could account for the different 
activities of the promoters. Moreover, it would be of 
interest to see if there is a difference in protein binding 
to the Ad40 E1B promoter using cell extracts from early and 
late times in infection. By substituting individual promo­
ter elements by their Ad5 counterparts the importance of the
131
Ad40 Spl binding site and TATA box can be individually 
assessed.
In order to fully understand the growth requirements of 
Ad40 a system which supports virus growth to levels similar 
to that seen for other adenovirus serotypes must be found. 
It is likely that the virus is largely dependent on cell 
functions unique to its natural host cells, making it very 
cell specific. It is not clear if Ad40 replicates in cells 
other than in the small intestine in an i n  v i v o  infection. 
It may be well adapted to one particular cell type, and thus 
have a very restricted host range. The host cell functions 
involved can only be studied in a permissive cell system.
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V
GTG
48
629
D
GAT
G
GGT
F
'TTC
E
GAA
E
GAG
D
GAC
A
GCC
N
AAC
Q
CAG
E
GAA
A
GCG
V
GTT
D
GAT
G
GGT
M
ATG
F
TTT
P
CCC
E
GAG
R
AGG
67
686
L
TTG
L.
CTG
S
TCC
E
GAG
A
GCT
E
GAG
S
AGC
A
GCT
A
GCA
E
GAG
S
AGC
G
GGT
S
TCG
G
GGT
D
GAT
S
TCT
G
GGG
V
GTT
G
GGC
86
743
E
GAA
E
GAG
L
TTG
L
TTG
P
CCG
v ’
GTT
D
GAT
L
CTG
D
GAT
L
TTG
K
AAA
C
TGC
Y
TAT
E
GAA
D
GAC
G
GGT
L
TTG
P
CCT
P
CCT
105
800
S
AGC
D
GAT
P
CCT
E
GAA
T
ACT
D
GAT
E
GAG
A
GCT
T
ACA
E
GAG
A
GCG
E
GAA
E
GAA
E
GAG
A
GCG
A
GCT
M
ATG
P
CCG
T
ACT
124
857
Y
TAT
V
G'TG
N
AAT
E
GAA
N
AAT
E
GAA
N
AAT
E
GAG
L
CTG
V
GTG
L
CTG
D
GAC
C
TGT
P
CCA
E
GAG
N
AAC
P
CCT
G
GGG
R
CGA
143
914
G
GGT
C
TGT
R
CGG
A
GCT
C
TGT
D
GAT
F
TTC
H
CAT
R
CGG
G
GGC
T
ACT
S
AGT
G
GGC
N
AAT
P
CCT
E
GAA
A
GCT
M
ATG
C
TGT
162
971
A
GCT
L
TTG
C
TGT
Y
TAT
M
ATG
R
CGT
L
TTA
T
ACT
G
GGA
H
CAC
C
TGT
I
ATC
Y
TAC
S
AGT AAGTAAAAAAGTTTTTATT
176
1032
P I S D
TGTTTGGTCtGTGTTGGTTAATATGAACAAGAGTTAACGACTTTTTGTTATTTTAGGT CCA ATT TCA GAT
4
1101
A
GCG
E
GAA
G
GGG
E
GAG
S
TCT
E
GAG
S
TC.G
G
GGG
S
TC.G
P
CCT
E
GAG
D
GAC
T
ACT
D
GAT
F
TTT
P
CCC
H
CAC
P
CCT
L
TTA
23
1158
T
ACC
A
GCC
T
ACG
P
CCG
P
CCA
H
CAT
G
GGA
I
ATT
V
GT'G
R
AGA
T
ACC
I
ATC
P
CCG
C
TGC
R
AGA
V
GTT
S
TCT
C
TGT
R
AGA
42
1215
R
CGA
R
CGC
P
CCA
A
GCT
V
GTT
E
GAG
C
TGC
I
ATA
E
GAA
D
GAT
L
TTA
L
CTT
E
GAG
E
GAA
D
GAT
P
CCA
T
ACA
D
GAT
E
GAA
61
1272
P
CCT
L
TTG
N
AAC
L
CTG
S
TCC
L
TTA
K
AAG
R
CGC
P
CCC
I<
AAG
C
TGC
S
TCC TGAGAT'CATAGTAATAAAGT'TATTGAC
73
1335
CCTTACCCTGTGTTTATTTCTTGGGCGTGTTTGTGGGTATATAAGCAGGTAGAATGGTTTTAGTGTTAGTTTATT 1410
M E L W S E L Q S Y Q N L R R L L E  18 
CTG A'TG GAG .TTG TGG AGT GAG 'TTA CAA AGT TAT GAG AAC CTC CGA CGC TTG CTG GAG 14 67
L
TTG
A
GCT
S
TCT
A
GCC
R
AGA
T
ACT
S
TCC
S
AGC
C
TGT
W
TGG
R
AGA
I
ATC
L
CTT
F
TTT
G
GGC
S
TCA
T
ACT
L
TTA
Tl
ACT
37 
152 4
N
AAT
V
GTA
I
ATC
Y
TAT
R
AGA
A
GCT
K
AAG
E
GAG
E
GAG
Y
T'AC
S
TCT
S
TCG
R
CGG
F
TTT
A
GCT
D
GAC
L
CTT
L.
TTG
s
TCG
5 7 
15 8.]
H
CAT
N
AAC
P
CCT
G
GGA
I
ATT
F
TTT
A
GCT
S
TCT
L
TTG
N
AAT
L
TTG
G
GGG
H
CAT
H
CAC
S
TCA
F
TTT
F
TTT
0
CAA
E
GAA
7 5 
1 7 3 8
I
ATT
V
GTG
I
ATC
R
AGA
N
AAT
L
TTA
D
GAT
F
TTT
S
TCT
S
TCT
P
CCT
G
GGC
R
CGT
T
ACG
V
GTT
S
TCT
G
GGG
L
CTT
A
GCT
9 5 
i 69 5
F
TTT
I
ATT
C
TGT
F
TTT
I
ATA
L
TTG
D
GAT
M E R P N S S V A G L Y S G L
Q W S A Q T H L S Q G Y T L D Y
CAATGGAGCGCCCAAACTCATCTGTCGCAGGGTTATACTCTGGATTA
1 5 
117 
17 6 3
h g n g s v e n l a t e e e g l r l l a g a a s a
M A M A L W R T L L R R K R V L G C L P A Q R P H
CATGGCAATGGCTCTGTGGAGAACCTTGCTACGGAGGAAGAGGGTCTTAGGTTGCTTGCCGGCGCAGCGTCCGCA
4 0 
14 2 
1 8 3 8
R F G S S A G R G G G G G E P E G R P G P F N G I
G L D P V Q E E E E E E E N L R A G L D P S T E L
CGGTTTGGATCCAGTGCAGGAAGAGGAGGAGGAGGAGGAGAACCTGAGGGCCGGCCTGGACCCTTCAACGGAATT
6 5 
] 67 
1 91 3
V T E P D P E E  
GTAACT GAG CCT GAT CCC GAA GAG i
G
GGT ,
T S 
ACT AGC .
S
AGT i
G Q 
GGG CAA .
R
AGG i
G G 
GGG GGC .
I
ATT .
N
AAT
84 
167 
197 0
G
GGG
Q
CAA
J R 
AGG
G
GGG
T
ACA
K
AAG
R
AGA
K
AAG
M
ATG
E
GAA
N
AAC
E
GAG
G
GGG
E
GAG
D
GAC
F
TTT
L
TTA
K
AAG
E
GAG
103
2027
L
TTA
T
ACC
L
TTG
S
AGT
L
TTA
M
ATG
S
TCT
R
CGT
R
CGC
H
CAT
H
CAT
E
GAG
S
TCT
V
GTT
W
TGG
W
TGG
A
GCT
D
GAT
L
TTG
122
2084
E
GAA
D
GAT
E
GAG
F
TTT
K
AAA
N
AAC
G
GGT
E
GAA
M
ATG
N
AAT
L
TTG
L
TTA
Y
TAC
K
AAG
Y
TAT
T
ACA
F
TTT
E
GAA
0
CAG
.141
2141
L
CTG
K
AAG
T
ACA
H
CAT
W
TGG
L
CTG
E
GAG
A
GCT
W
TGG
E
GAG
D
GAT
F
TTT
E
GAG
L
TTA
A
GCT
L
CTG
N
AAC
T
ACT
F
TTT
160
2198
A
GCC
K
AAA
V
GTG
A
GCT
L
CTT
R
CGC
P
CCG
D
GAC
T
ACT
I
ATT
Y
TAT
T
ACC
I
ATT
K
AAG
K
AAG
T
ACT
V
GTT
N
AAT
I
ATA
179
2255
R
CGT
K
AAA
C
TGT
A
GCC
Y
TAT
V
GTG
L
CTG
G
GGG
N
AAT
G
GGA
A
GCT
V
GTG
V
GTG
R
CGG
F
TTT
Q
CAA
T
ACA
C
TGT
D
GAC
198
2312
R
CGT
V
GTA
A
GCC
F
TTT
N
AAC
C
TGC
A
GCA
M
ATG
Q
CAG
S
AGC
L
TTG
G
GGC
P
CCT
G
GGG
L
CTT
I
ATT
G
GGC
M
ATG
S
AGT
217 
2 369
G
GGG
V
GTA
T
ACT
F
TTT
M
ATG
N
AAT
V
GTG
R
AGA
F
TTT
V
GTA
V
GTG
E
GAG
G
GGA
F
TTT
N
AAT
G
GGC
T
ACA
V
GTG
F
TTT
236
2426
A
GCT
S
TCT
T
ACC
T
ACT
Q
CAA
L
TTA
T.
ACC
L
TTG
H
CAT
G
GGT
V
GTG
F
TTT
F
TTT
Q
CAA
N
AAT
C
TGC
oo
AGC
G
GGT
I
ATC
255 
24 8 3
C
TGC
V
GTG
D
GAT
S
TCC
W
TGG
G
GGT
R
AGG
V
GTG
S
TCT
A
GCC
R
AGA
G
GGG
C
TGT
T
ACG
F
TTT
V
GTT
A
GCA
C
TGT
W
TGG
274 
2 54 C
K
AAA
G
GGG
V
GTG
V
GTG
G
GGG
R
CGA
N
AAC
K
AAA
S
AGT
Q
CAA
M
ATG
S
TCT
V
GTA
K
AAG
K
AAG
C
TGT
V
GTG
F
TTT
E
GAA
293
2597
R
CGT
C
TGC
I
ATT
M
ATG
A
GCC
M
ATG
V
GTG
V
GTA
E
GAA
G
GGT
Q
CAG
A
GCG
R
CGG
I
ATT
R
CGC
H
CAT
N
AAT
A
GCG
G
GGC
312
2654
s
TCT
D
GAT
N
AAT
V
GTG
C
TGT
F
TTT
L
TTA
L
CTG
L
CTA
K
AAG
G
GGA
T
ACT
A
GCC
S
AGT
V
GTA
K
AAG
H
CAT
N
AAC
M
ATG
331
2711
I
ATT
C
TGT
G
GGC
G
GGT
G
GGT
H
CAC
S
TCT
Q
CAG
L
CTG
L
CTA
T
ACC
C
TGT
A
GCA
D
GAT
G
GGA
N
AAC
C
TGT
Q
CAG
A
GCT
350
2768
L
CTG
R
AGA
V
GTG
F
TTT
H
CAC
V
GTA
V
GTA
S
TCT
H
CAT
P
CCC
R
CGC
R
CGC
P
CCC
W
TGG
P
CCT
V
GTT
F
TTT
E
GAG
H
CAC
369
2825
N
AAC
M
ATG
L
CTT
M
ATG
R
CGC
C
TGT
T
ACT
V
GTG
H
CAT
L
TTG
G
GGA
A
GCT
R
CGT
R
CGT
G
GGC
M
ATG
F
TTT
S
TCT
P
CCA
388
2882
Y
TAG
Q
CAG
S
AGT
N
AAC
F
TTT
C
TGC
H
CAC
T
ACT
K
AAA
V
GTT
L
TTA
M
ATG
E
GAA
T
ACT
D
GAT
A
GCT
F
TTT
S
TCT
R
CGG
407
2939
V
GTA
W
TGG
W
TGG
N
AAC
G
GGG
V
GTA
F
TTT
D
GAT
L
TTA
T
ACC
M
ATG
E
GAG
L
CTA
F
TTT
K
AAA
V
GTG
V
GTG
R
AGG
Y
TAT
426
2996
D
GAT
E
GAG
S
TCA
K
AAG
V
GTT
R
CGT
C
TGT
R
CGC
P
CCC
C
TGT
E
GAG
C
TGT
G
GGA
A
GCT
N
AAT
H
CAT
I
ATT
R
AGG
L
TTA
445
3053
Y
TAT
P
CCA
A
GCA
T
ACT
L
CTG
N
AAC
V
GTG
T
ACC
E
GAG
Q
CAG
L
CTG
R
CGT
T
ACG
D
GAC
H
CAC
Q
CAG
M
ATG
M
ATG
S
TCG
464
3110
C
TGT
L
CTG
R
CGT
T
ACT
D
GAC
Y
TAC
E
GAA
S
TCC
S
AGC
D
GAT
E
GAG
D
GAT TAA GGGTAAGGGGCGGAGCCTATTAC
476
3172
M S G F
AGGTATAAAGGTTGGGGTAGAGTAAAAAAAAGGGAAGTTACAAA ATG AGT GGC TTC
T E G  
: ACG GAA GGA
7
3237
N
AAC
A
GCT
V
GTG
S
AGT
F
TTT
E
GAG
G
GGT
G
GGG
V
GTG
F
TTT
S
AGC
P
CCA
Y
TAT
L
CTG
T
ACA
T
ACC
R
CGT
L
CTT
P
CCC
26
3294
S
TCT
W
TGG
A
GCA
G
GGA
V
GTG
R
CGT
Q
CAG
N
AAT
V
GTG
V
GTG
G
GGG
S
TCC
N
AAC
V
GTT
D
GAT
G
GGT
R
CGT
P
CCT
V
GTC
45
3351
A
GCC
P
CCT
A
GCC
N
AAC
S
TCG
T
ACA
T
ACC
L
CTT
T
ACC
Y
TAC
A
GCC
T
ACT
I
ATT
G
GGA
S
TCG
S
TCG
V
GTG
D
GAT
T
ACC
64
3408
A
GCT
A
GCA
A
GCT
A
GCT
A
GCC
A
GCG
S
TCT
A
GCT
A
GCT
A
GCC
S
TCT
T
ACT
A
GCT
R
CGT
G
GGC
M
ATG
A
GCA
A
GCA
D
GAT
83
3465
F
TTT
G
GGA
L
CTG
Y
TAC
N
AAT
H
CAT
L
CTG
A
GCC
A
GCG
S
TCT
R
CGG
L
TTA
R
AGA
E
GAA
E
GAA
D
GAT
A
GCC
L
CTG
S
TCC
102
3522
V
GTG
V
GTG
L
TTG
T
ACC
R
CGC
L
TTG
E
GAG
E
GAG
L
CTG
S
TCT
Q
CAG
Q
CAG
L
TTG
Q
CAA
D
GAT
M
ATG
S
TCT
A
GCC
K
AAA
121
3579
M
ATG
A
GCT
L
CTG
L
CTT
■K r
x \  .
AAC
P
CCT
P
CCC
A
GCT
N
AAT
T
ACT
S
TCT TAA TAAAGACACAATTGGTTGGAAAAGTCA
132
3642
AAAGTGTTTATTTATTTCTTTTGCGGTAGGCCCTAGACCACCTGTCGCGGTCGTTTAAAACTTTATGGATGTTTT 3717 
CCAAGACCCGGTACAGGTGGGCTTGGATGTTCAAATACATAGGCATTAGGCCGTCCCTGGGATGCAGGTAGGACC 37 92 
ACTGGAGGGCGTCATGCTCTGGGGTGGTGTTGTAAATAATCCAATCGTAGCAGGGTTTTTGAGCATGAAACTGGA 3 8 67
AGATGTCCTTAAGGAGGAGGCGAATGGCCAGAGGTAGCCCCT'TGGTCAAGGTATTAACAAATCGAT 3932:
